From c186fac0d31353326ea38d898c1c7de4264c3d8a Mon Sep 17 00:00:00 2001 From: github-actions <41898282+github-actions[bot]@users.noreply.github.com> Date: Mon, 10 Mar 2025 01:18:33 +0000 Subject: [PATCH] [automated] update diyhrt.market --- diyhrt.market/about.html | 2 +- diyhrt.market/data-privacy.html | 2 +- diyhrt.market/index.html | 356 +++++----- diyhrt.market/login.html | 4 +- .../media/files/labtests/AlZQTm2p.pdf | Bin 0 -> 135164 bytes diyhrt.market/meds/groups/bicalutamide.html | 88 +-- .../meds/groups/combination-minoxidil.html | 2 +- diyhrt.market/meds/groups/cyproterone.html | 8 +- diyhrt.market/meds/groups/dutasteride.html | 116 ++-- .../meds/groups/estradiol-droppers.html | 2 +- diyhrt.market/meds/groups/estradiol-gels.html | 20 +- .../meds/groups/estradiol-injections.html | 268 ++++---- .../meds/groups/estradiol-patches.html | 2 +- .../meds/groups/estradiol-pills.html | 68 +- .../meds/groups/estradiol-sprays.html | 2 +- diyhrt.market/meds/groups/finasteride.html | 96 +-- diyhrt.market/meds/groups/gnrh-agonists.html | 2 +- diyhrt.market/meds/groups/minoxidil-10.html | 10 +- diyhrt.market/meds/groups/minoxidil-2.html | 4 +- diyhrt.market/meds/groups/minoxidil-5.html | 6 +- diyhrt.market/meds/groups/progesterone.html | 6 +- diyhrt.market/meds/groups/spironolactone.html | 2 +- .../astrovials-estradiol-enanthate.html | 124 ++-- .../astrovials-estradiol-undecylate.html | 124 ++-- .../astrovials-estradiol-valerate.html | 124 ++-- .../bicalutamide-binarex-50mg-x28.html | 104 +-- .../bicalutamide-calutide-50mg-x10.html | 506 +++++++------- .../bicalutamide-casodex-50mg-x28.html | 102 +-- .../bicalutamide-castramid-50mg-x10.html | 104 +-- .../bicalutamide-procalut-50mg-x28.html | 304 ++++----- .../meds/products/climara-100mcg-x4.html | 604 ++++++++--------- .../meds/products/climara-50mcg-x4.html | 622 +++++++++--------- ...il-finasteride-3-solution-morr-f-60ml.html | 304 ++++----- ...-finasteride-brintop-f-solution-100ml.html | 104 +-- .../cyproterone-androcur-50mg-x50.html | 304 ++++----- .../products/cyproterone-procur-50mg-x50.html | 304 ++++----- .../cyproterone-siterone-100mg-x50.html | 104 +-- .../cyproterone-siterone-50mg-x50.html | 508 +++++++------- .../dutasteride-avodart-0-5mg-x30.html | 406 ++++++------ .../dutasteride-duprost-0-5mg-x10.html | 606 ++++++++--------- .../dutasteride-dutagen-0-5mg-x10.html | 506 +++++++------- .../dutasteride-dutagen-0-5mg-x30.html | 134 ++-- .../dutasteride-dutaheal-0-5mg-x10.html | 104 +-- .../dutasteride-dutanol-0-5mg-x5.html | 104 +-- .../products/dutasteride-dutas-0-5mg-x30.html | 518 ++++++++------- .../dutasteride-dutas-0-5mg-x300.html | 134 ++-- .../dutasteride-veltride-0-5mg-x10.html | 406 ++++++------ .../products/estogel-estradiol-0-06-gel.html | 104 +-- .../meds/products/estova-2mg-x84.html | 132 ++-- .../meds/products/estrabet-2mg-x28.html | 104 +-- .../estradiol-epic-pharma-usa-2mg-x100.html | 104 +-- .../meds/products/estradot-100mcg-x8.html | 404 ++++++------ .../meds/products/estradot-50mcg-x8.html | 404 ++++++------ .../meds/products/estradot-75mcg-x8.html | 102 +-- .../meds/products/estraheal-2mg-x28.html | 204 +++--- .../products/estreva-estradiol-0-1-gel.html | 104 +-- .../meds/products/estrofem-2mg-x28.html | 598 +++++++++-------- .../products/finasteride-finalo-1mg-x10.html | 406 ++++++------ .../products/finasteride-finalo-1mg-x100.html | 104 +-- .../products/finasteride-finast-5mg-x30.html | 606 ++++++++--------- .../products/finasteride-finast-5mg-x300.html | 104 +-- .../products/finasteride-finax-1mg-x30.html | 406 ++++++------ .../products/finasteride-fincar-5mg-x10.html | 520 ++++++++------- .../finasteride-finpecia-1mg-x10.html | 308 ++++----- .../finasteride-finpecia-1mg-x15.html | 104 +-- .../finasteride-finpecia-1mg-x150.html | 104 +-- .../finasteride-healpecia-1mg-x10.html | 104 +-- .../finasteride-healpecia-5mg-x10.html | 204 +++--- .../finasteride-proscalpin-1mg-x100.html | 104 +-- .../finasteride-proscare-5mg-x100.html | 104 +-- .../finasteride-prosteride-5mg-x10.html | 104 +-- .../meds/products/finasteride-ricit-x100.html | 104 +-- .../fiolelabs-estradiol-enanthate.html | 104 +-- .../fiolelabs-estradiol-undecylate.html | 104 +-- .../meds/products/gynokadin-dosiergel.html | 134 ++-- .../minoxidil-10-solution-hair4u-10-60ml.html | 304 ++++----- .../minoxidil-10-solution-tugain-10-60ml.html | 504 +++++++------- .../minoxidil-2-solution-hair4u-2-60ml.html | 304 ++++----- .../minoxidil-2-solution-regaine-2-60ml.html | 306 ++++----- .../minoxidil-5-solution-hair4u-5-60ml.html | 304 ++++----- ...oxidil-5-solution-mintop-forte-5-60ml.html | 406 ++++++------ .../minoxidil-5-solution-regaine-5-60ml.html | 404 ++++++------ .../minoxidil-5-solution-tugain-5-60ml.html | 506 +++++++------- .../open-gate-labs-bicalutamide-x100.html | 123 +++- .../open-gate-labs-estradiol-cypionate.html | 53 +- .../open-gate-labs-estradiol-dropper.html | 55 +- .../open-gate-labs-estradiol-enanthate.html | 69 +- .../open-gate-labs-estradiol-spray.html | 55 +- .../open-gate-labs-estradiol-undecylate.html | 81 ++- .../open-gate-labs-estradiol-valerate.html | 150 ++++- ...bs-progesterone-suppository-200mg-x60.html | 53 +- .../open-gate-labs-relugolix-x100.html | 55 +- ...noko-estradiol-cypionate-10ml-40mg-ml.html | 104 +-- ...noko-estradiol-enanthate-10ml-40mg-ml.html | 104 +-- .../otokonoko-estradiol-gel-55ml.html | 104 +-- ...onoko-estradiol-valerate-10ml-40mg-ml.html | 122 ++-- .../panacea-pharma-estradiol-enanthate.html | 104 +-- .../panacea-pharma-estradiol-undecylate.html | 104 +-- .../panacea-pharma-estradiol-valerate.html | 55 +- .../progesterone-endogest-100mg-x10.html | 304 ++++----- .../progesterone-endogest-200mg-x10.html | 204 +++--- .../progesterone-gestheal-200mg-x10.html | 104 +-- .../progesterone-microgest-100mg-x50.html | 406 ++++++------ .../progesterone-microgest-200mg-x50.html | 304 ++++----- .../progesterone-progestan-100mg-x30.html | 204 +++--- .../progesterone-progestan-200mg-x30.html | 226 ++++--- .../progesterone-utrogestan-100mg-x30.html | 104 +-- .../products/progynova-1mg-3-pack-x72.html | 436 +++++++----- .../meds/products/progynova-1mg-x28.html | 304 ++++----- .../products/progynova-2mg-3-pack-x72.html | 204 +++--- .../meds/products/progynova-2mg-x28.html | 606 ++++++++--------- .../products/sandrena-gel-sachets-x28.html | 104 +-- ...e-labs-estradiol-enanthate-in-mct-oil.html | 104 +-- ...silvermaple-labs-estradiol-undecylate.html | 104 +-- .../spironolactone-aldactone-100mg-x15.html | 504 +++++++------- .../spironolactone-aldactone-100mg-x300.html | 104 +-- .../spironolactone-aldactone-25mg-x15.html | 304 ++++----- .../spironolactone-aldactone-25mg-x450.html | 104 +-- .../spironolactone-aldactone-50mg-x15.html | 204 +++--- .../spironolactone-aldactone-50mg-x450.html | 104 +-- .../spironolactone-spiractin-100mg-x100.html | 404 ++++++------ .../spironolactone-spiractin-25mg-x100.html | 304 ++++----- .../teahrt-bicalutamide-50mg-x100.html | 102 +-- .../teahrt-cyproterone-12-5mg-x100.html | 102 +-- .../teahrt-estradiol-cypionate-10ml.html | 102 +-- .../products/teahrt-estradiol-dropper.html | 102 +-- .../teahrt-estradiol-enanthate-10ml.html | 102 +-- .../meds/products/teahrt-estradiol-spray.html | 102 +-- .../teahrt-estradiol-undecylate-5ml.html | 102 +-- .../teahrt-estradiol-valerate-10ml.html | 102 +-- ...rt-progesterone-suppository-200mg-x60.html | 102 +-- ...arma-estradiol-cypionate-10ml-40mg-ml.html | 104 +-- ...arma-estradiol-enanthate-10ml-40mg-ml.html | 104 +-- .../vannapharma-estradiol-gel-110ml.html | 104 +-- .../vannapharma-estradiol-gel-55ml.html | 104 +-- ...rma-estradiol-undecylate-10ml-40mg-ml.html | 104 +-- ...harma-estradiol-valerate-10ml-40mg-ml.html | 104 +-- ...eleste-estradiol-enanthate-400mg-10ml.html | 104 +-- ...eleste-estradiol-enanthate-500mg-10ml.html | 104 +-- ...-estradiol-enanthate-in-grapeseed-oil.html | 104 +-- ...leste-estradiol-undecylate-500mg-10ml.html | 104 +-- ...eleste-estradiol-undecylate-500mg-5ml.html | 104 +-- diyhrt.market/profile.html | 4 +- diyhrt.market/qr-codes.html | 2 +- diyhrt.market/register.html | 4 +- diyhrt.market/resources.html | 2 +- diyhrt.market/stores/4nrx-pharmacy-uk.html | 2 +- .../stores/4nrx-pharmacy-uk/reviews.html | 4 +- diyhrt.market/stores/aipctshop.html | 114 ++-- diyhrt.market/stores/aipctshop/reviews.html | 44 +- diyhrt.market/stores/astrovials.html | 4 +- diyhrt.market/stores/astrovials/reviews.html | 48 +- diyhrt.market/stores/dashpct.html | 2 +- diyhrt.market/stores/dashpct/reviews.html | 4 +- diyhrt.market/stores/felicitas.html | 2 +- diyhrt.market/stores/felicitas/reviews.html | 4 +- diyhrt.market/stores/fiolelabs.html | 4 +- diyhrt.market/stores/fiolelabs/reviews.html | 44 +- diyhrt.market/stores/girlpotion.html | 2 +- diyhrt.market/stores/girlpotion/reviews.html | 4 +- diyhrt.market/stores/inhouse-pharmacy.html | 58 +- .../stores/inhouse-pharmacy/reviews.html | 4 +- diyhrt.market/stores/open-gate-labs.html | 97 ++- .../stores/open-gate-labs/reviews.html | 46 +- diyhrt.market/stores/otokonoko-pharmacy.html | 2 +- .../stores/otokonoko-pharmacy/reviews.html | 4 +- diyhrt.market/stores/panacea-pharma.html | 2 +- .../stores/panacea-pharma/reviews.html | 4 +- diyhrt.market/stores/rxaisle.html | 2 +- diyhrt.market/stores/rxaisle/reviews.html | 4 +- diyhrt.market/stores/silhouette-beauty.html | 2 +- .../stores/silhouette-beauty/reviews.html | 4 +- diyhrt.market/stores/silvermaple-labs.html | 4 +- .../stores/silvermaple-labs/reviews.html | 44 +- diyhrt.market/stores/tea-hrt.html | 2 +- diyhrt.market/stores/tea-hrt/reviews.html | 4 +- .../stores/united-pharmacies-nl.html | 28 +- .../stores/united-pharmacies-nl/reviews.html | 4 +- .../stores/united-pharmacies-uk.html | 28 +- .../stores/united-pharmacies-uk/reviews.html | 4 +- .../stores/united-pharmacies-us.html | 16 +- .../stores/united-pharmacies-us/reviews.html | 4 +- diyhrt.market/stores/vanna-pharma.html | 14 +- .../stores/vanna-pharma/reviews.html | 4 +- diyhrt.market/stores/voix-celeste.html | 4 +- .../stores/voix-celeste/reviews.html | 124 +++- diyhrt.market/transfem-hrt-guide.html | 2 +- 187 files changed, 14384 insertions(+), 12984 deletions(-) create mode 100644 diyhrt.market/media/files/labtests/AlZQTm2p.pdf diff --git a/diyhrt.market/about.html b/diyhrt.market/about.html index 2ec67c22c..139e42b92 100644 --- a/diyhrt.market/about.html +++ b/diyhrt.market/about.html @@ -141,5 +141,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/data-privacy.html b/diyhrt.market/data-privacy.html index db29c48a5..4c59ea369 100644 --- a/diyhrt.market/data-privacy.html +++ b/diyhrt.market/data-privacy.html @@ -146,5 +146,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/index.html b/diyhrt.market/index.html index 30c08c540..7aba964eb 100644 --- a/diyhrt.market/index.html +++ b/diyhrt.market/index.html @@ -1603,153 +1603,90 @@
- +
- Otokonoko Estradiol Enanthate
- Otokonoko Pharmacy - Otokonoko Pharmacy + Progynova 1mg (3 pack)
+ Inhouse Pharmacy + Inhouse Pharmacy
- $75.00
- $0.19 per mg + $36.72
+ $0.51 per pill
In Stock
- 03/03/25 00:28 + 09/03/25 19:54
In Stock
- +
- Otokonoko Estradiol Enanthate
- Otokonoko Pharmacy - Otokonoko Pharmacy -
- -
- $75.00
- $0.19 per mg -
- -
- Out of Stock
- 02/03/25 23:43 -
Out of Stock
-
-
-
- - -
-
- Panacea Pharma Estradiol Valerate
- Panacea Pharma - Panacea Pharma -
- -
- $65.00
- $0.16 per mg -
- -
- In Stock
- 02/03/25 23:38 -
In Stock
-
-
-
- - -
-
- Otokonoko Estradiol Enanthate
- Otokonoko Pharmacy - Otokonoko Pharmacy -
- -
- $75.00
- $0.19 per mg -
- -
- In Stock
- 02/03/25 23:33 -
In Stock
-
-
-
- - -
-
- Otokonoko Estradiol Enanthate
- Otokonoko Pharmacy - Otokonoko Pharmacy -
- -
- $75.00
- $0.19 per mg -
- -
- Out of Stock
- 02/03/25 23:17 -
Out of Stock
-
-
-
- - -
-
- Open Gate Labs Bicalutamide
+ Open Gate Labs Estradiol Enanthate
Open Gate Labs Open Gate Labs
- $100.00
- $1.00 per pill -
- -
- Out of Stock
- 02/03/25 23:00 -
Out of Stock
-
-
-
- - -
-
- Voix Céleste Estradiol Undecylate 500mg/10mL
- Voix Céleste - Voix Céleste -
- -
- €70.00
- €0.14 per mg + $75.00
+ $0.19 per mg
In Stock
- 02/03/25 17:42 + 09/03/25 08:27
In Stock
+ +
+
+ Open Gate Labs Estradiol Valerate
+ Open Gate Labs + Open Gate Labs +
+ +
+ $70.00
+ $0.18 per mg +
+ +
+ In Stock
+ 09/03/25 08:27 +
In Stock
+
+
+
+ + +
+
+ Progynova 1mg (3 pack)
+ Inhouse Pharmacy + Inhouse Pharmacy +
+ +
+ $36.72
+ $0.51 per pill +
+ +
+ Out of Stock
+ 08/03/25 11:53 +
Out of Stock
+
+
+
+
@@ -1765,7 +1702,7 @@
In Stock
- 02/03/25 14:22 + 07/03/25 20:13
In Stock
@@ -1786,134 +1723,197 @@
In Stock
- 02/03/25 12:03 + 07/03/25 20:13
In Stock
- +
- AstroVials Estradiol Valerate
+ AstroVials Estradiol Undecylate
AstroVials AstroVials
- €40.00
- €0.10 per mg -
- -
- Out of Stock
- 02/03/25 09:12 -
Out of Stock
-
-
-
- - -
-
- Otokonoko Estradiol Enanthate
- Otokonoko Pharmacy - Otokonoko Pharmacy -
- -
- $75.00
- $0.19 per mg + €120.00
+ €0.25 per mg
In Stock
- 02/03/25 00:26 + 07/03/25 20:13
In Stock
- +
- Otokonoko Estradiol Enanthate
- Otokonoko Pharmacy - Otokonoko Pharmacy + Estrofem 2mg
+ Inhouse Pharmacy + Inhouse Pharmacy
- $75.00
- $0.19 per mg + $32.20
+ $1.15 per pill
Out of Stock
- 01/03/25 22:25 + 07/03/25 09:52
Out of Stock
- +
- AstroVials Estradiol Enanthate
- AstroVials - AstroVials + Progynova 1mg (3 pack)
+ United Pharmacies US + United Pharmacies US
- €50.00
- €0.12 per mg + $24.00
+ $0.33 per pill
Out of Stock
- 01/03/25 20:15 + 07/03/25 03:52
Out of Stock
- +
- Silvermaple Labs Estradiol Undecylate
- Silvermaple Labs - Silvermaple Labs + Progynova 1mg (3 pack)
+ Inhouse Pharmacy + Inhouse Pharmacy
- $90.00
- $0.22 per mg + $36.72
+ $0.51 per pill
- Delisted from store
- 01/03/25 11:47 -
Delisted from store
+ In Stock
+ 07/03/25 01:51 +
In Stock
- +
- Silvermaple Labs Estradiol Enanthate in MCT OIl
- Silvermaple Labs - Silvermaple Labs + Estrofem 2mg
+ Inhouse Pharmacy + Inhouse Pharmacy
- $70.00
- $0.18 per mg + $32.20
+ $1.15 per pill
- Delisted from store
- 01/03/25 11:46 -
Delisted from store
+ In Stock
+ 07/03/25 01:51 +
In Stock
+
+
+
+ + +
+
+ Estrofem 2mg
+ Inhouse Pharmacy + Inhouse Pharmacy +
+ +
+ $32.20
+ $1.15 per pill +
+ +
+ Out of Stock
+ 06/03/25 23:51 +
Out of Stock
+
+
+
+ + +
+
+ Finasteride (Fincar) 5mg
+ Inhouse Pharmacy + Inhouse Pharmacy +
+ +
+ $13.10
+ $1.31 per pill +
+ +
+ In Stock
+ 06/03/25 22:07 +
In Stock
+
+
+
+ + +
+
+ Estrofem 2mg
+ Inhouse Pharmacy + Inhouse Pharmacy +
+ +
+ $32.20
+ $1.15 per pill +
+ +
+ In Stock
+ 06/03/25 19:51 +
In Stock
+
+
+
+ + +
+
+ Open Gate Labs Estradiol Undecylate
+ Open Gate Labs + Open Gate Labs +
+ +
+ $120.00
+ $0.15 per mg +
+ +
+ In Stock
+ 06/03/25 19:05 +
In Stock
@@ -1962,5 +1962,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/login.html b/diyhrt.market/login.html index a63a90d9c..96ba7447c 100644 --- a/diyhrt.market/login.html +++ b/diyhrt.market/login.html @@ -95,7 +95,7 @@
- +
@@ -142,5 +142,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/media/files/labtests/AlZQTm2p.pdf b/diyhrt.market/media/files/labtests/AlZQTm2p.pdf new file mode 100644 index 0000000000000000000000000000000000000000..6d8502ecff60d67c915fe22176a77449138322fc GIT binary patch literal 135164 zcmYg%bzGBg*u8`TQUjDBIYLmuF+fVXRS-m!kOmPE=^72vf`kP~DJZCvlyr}fM!K8P zj2t7j-#x$Y@BO@g_^9LAbJw}fb*^(gTz#Obep3W4e(`Eu)x_3CNf-j=WcA{rtgNt> zjiasmbC|f4m>5D>-R`BkjVnx8{iUV5jjD~c(^DIH`HODut~Qnq7m=wOwGM?scRkav z{sArL$;td_u|q#P@*=fVBw+V0*)+dZbA9O#qq3IrEBczuEzNgTuYUR<-8Wwfd-&u- zbX!$O6#J@Xp>dXnQ7rxLuC+i;QqKmt=nJsMN=gZcn zqd++5#pBHV35RDQD+9fRHQT^l;pypV&o;tV9DyU2Ag5l-Q9$scEbQE=KL|X-V}#)Z zb4Tx-oz-KXx>io}?KQhuXd3~Klb-7hz}FKtuz_`tDl_QJJx```&YTMz6#}jZlvhNz z=1d)_luh~3H=YPjmw6=B(VXa%)%ho9PvsQ#n6J&P*iUZuIQF*UF#|JaFU`Hom(Liz zM+2qVmvv@FgqL0t6atRBA2xWX#d!=0S2s^svi1;`@$)=~KR)h!zkG3QiW;{Sr?B1O zRevNKJ9Botx8-oW<)lFGG;_ALw?Ac`-YU=0R(CQZpEy@NliEsH+e7$aC36CgH&-*X zuN=HRrEiNNxSww0%<;>6Wyg9-dt04STd|z6>pPw%AFa8aPPp=N{F2e4Gy}MqN%Pb) z`JrZ)&!Mh|<*u;-f%pt3CUcp9G%uDO|A4$WgCEU1LEgUgZwR}4rS?6Uk$8FJ?x)Y%{WXhYO4^5K?t237fmZuUdR6J4P(! zGakmS<&fcuJY?-Tz8$uDV{dO4RSc{K4k^<$8}vRUw4tl2g~kKr;EQ%2!UuMICr8ow zgx+b>(%iD*`BYcqQYS;|2nX3JIs^LZ^{CB$m38NI0@7+wCwoLXV)xq?XYIF&dzWHZY+gB5!{>@wd$#mE~w7WuY0Kr>7@2m&MxdO%7p9CJ82)E4_I=;@Bz4xS!W^d=g?dinyUZ<0V+NG?v1>JSS!2*_? zq4m;}RX?tp7n@!Ob9-x>j=Sdd)wAWpcf2BJ%rH*K8X>8IF1zb%Th5hwlNr#pxewRd zR%iGZw7k>20t3ok*i0`MroZWNP!R6T>D`-HibWTzqvcNGu$_MtYN~G;#I22P zyB6awPWeX35rygI_=DAXPak2wCpm#NLa0&`jsUm%Pp2sZ4jnEo5!(UYzSREyPG>z; zQ(Xdi6Xjj?^^P908H}AfXIPw>tBK3z?H3$3wXyJqzDU(97f|CERaKFy)xca^xKOfUV_aB1$Vv6Ma8%EW2Fhb-MvM+1}YIJ0$PDy$2s-#{yd~y5#0+o{k-=+ zm2n(g^_OMtaulvDbywUr$&steHT4zH@7T%}m?!L&`Ud*m=1OC8-Wv7LpwDR;^S99q zbkHz271&%UJPFub(eT_~l8JUr5}x7CC-h{pUszc4Nt2wDi5{piuZE{V@xo35iv%p* zX#ODOq63$C{+71wiua~GK71^$ByPLgM1D`o7C?hkA>;H!Ppw|IJAn2|!HneT^6#ub zx3Mn=RVlrM{fU&axh-1y5ViTmH=f6ZJKC;+b-_0yrj{<|PFV+TYVYzL{)owP*>g!V z^wZhtt_`ST8`7Ck_(ka5?mJYdAQbv*juB?A&6W`Y-=8U@)y2p<5_XPn?xeUg?R+ra z&Kk}UWii)|u;aoTZvMRGcQ!GtaCO%s1u*Vem8;W&L@dY|@2jdc4Q+!{{#u{Rv1 z6P}Gb716&!mzeV2yW3z-AYaEuflc!Ih<8N!ka>5;^4Yit0iEGhZF=-TES2e=Z{lv* zlrPwU5fdB7YAl;$VBXY8Th8E~S3kCTre1b)$$Unl17D{Lul_XQIc;36hM5USkLYX@ z40Jv|J(@|!+lmC#JxQ) z4(b&+!s`Q%DfdsM+h?YFw+NW&Gc5ji)2HbSJ8c1R+YKqVey{dqeYKYRUMJ{OR`%8qBPO6RGGUPjiB&xnT`ffBnVQQMmuv)V$>6 z5|7G)+b7eWU|fhS@+$h8J+b17k0V$=B2o;{_t97nx1?%3-- zVa{EmcG{GafUcj+Jql*a=!{xDezRYHJ8}1HXHuRDc6kmVBrTsgx zS33TO)J!?eNM)UZQuczQ*Q@(*!lQfN*N$-=*yf3?pW;(qcPgDiU87mO%EJ^)Ngc0h zVdaYbLfv}U3cag;n4P%Aj?bmnIM!~{k0i}h3s2#84`y`E69&$-Hv@`JhBoOAvD(nG zz5H=;d=gG_M5b`gv$o~{f3nbG@qN1hga7?0qDcDEN0n!ctPiJgQueF#xA?S+sxNMT z=SFw#b7-9|fjyq`hA;uS9kq`; zo9g_lA6NToRcgfuw}qjFk6ZV!8s*k2 z2IVq&ODe5_6}49=)5dCj72hZfCQsE?Oz@BQF8GT%`(BXM?8VA?dI-l( z+uMEx<)7OEi~K&HC`_HD*P0Y&R@;rmWsEOyD6E{>oUZs&O3Y0CX_LI+;pZj574W=v z`Q+lHa=iz09`=4sD%rh~N1YeUKfch>6z_YO=9F8wt(M}8`8E*fW)3y`>0|cuj9z$1 zYI3xE;-P7IH$o^HlmFp(&$tiwyk?XToqLEhk`|4zUF(c}^08oJ+O%pH|MziC5G}Td zON#2Iz~NG$V_UB)BkK;|t%0AW^xr4iE{uq#(4BSXtJK#7Y9B_gOHL-fJ1{r#sgE{@ z+Uu0#Qs^uyC#=1SMP98anCc#Kth_vC-n<~wy~9(Rid(jm3|Qi~tH3VO>X>wLyWECs zm21k-m~K%O7`$#$;^jb91qt^Qw>)0g`n-|fT!jIIO~a(b#?<5oh7aVt(F)^1JB4;IPmek?xg_F>F@02cjQ$-cF%{ZSxKe#R2YQ$jyMuL zQ?sqTJh|}_ySaPqmN(3=jB$8o^bBmpdFhr1A05Bn)nvIo5}Be}c^73A;B7u>Z5{Ty z@Zjutpe*XaHa#|VplCs}-jQwB)#yx|{&elugSK6K19CC~-D|hLg}+@R+d>ef>q-m^ z)T9><{EadXkjfAI?R%WLaa7;tc5D#9SX#4cG)+N=t=?XG(=?$M_rXX0=XR&3uQzVg zS30ZR{|DM!Ddu3mAA90&(zyH2A} z!RxhM}2#_(4Zhl+jxCcg;0Sm^XdIXi0}PDE#WWr=mBOsD*w0L8q3uI?YzBI zJFw4X*TQXk3WqtHWj+OZ;TwAYD71JzA~dfnJQ-W4{__)?kXM*t?06DsO8C{P(;I;( zRzcnwp^n>u!9H>}RsRaab=`qRf{DUmp|(B3ScOopTZEGF^6G$~K%CWL#CZfK`PXA^ z_P=GM2zkm#+E7dvF2jIuB}a_hN|rM6d?==1*+9}cW;+vaWpdlvT}xj;SnqIhH`st* zYAfC7U@7{!oI-0z(29JhN>!DO^{G9+xZcmMS|M=dq!|a{94K4mmd(~|X4W&2kTT_k6hG%jps2 z-g|`wgho7<&@!}{+ccM;*tOo4F=MGM0?uTq83}o?uJQbL7O8#@VdI!9ea6Cx`!;`W zx57pdwy=^b!`Rf>B7dZ3v#%Ab`^AivAH^P<`L~ws{#0SO=D6QDKFEn$;gNq_msgv5 z%hN~-lI~lUKhL^^9qC%#B_9NZbulYHiw0NKXWPO<({Bc=Vk!fFdMMn+($+rSvj)@M zO1L%McRH@2!jfSWRJ9XT2ItQ+W*NT8X>SrKuAORb+Qbrg={vuJNwP!%r-O0SZ&NdS zW6A|LYUF6+8?MLyw*98+blImG2b<|b31{3yW>v#g`5dwqoIXjDb=7!~sO1?Q?n#1Q zJ}2%;lwWu9NirC}TqBjZSz8H6Q?uN4b<~c7;^}i}lNdVi7ygg3hJdPu0KIVD??9Fm#HY1DOCz90wi&&;glIJ!vL?Y(MJm-Q-0BWm-#&VSiZlp zLh6;it_AbG2$Ic9;XAe@ z^lWKY*wW-)dhowI5GSnRNUk^?ao={>iW{#8 zaqIsK&it(H2=*B(+-iIK&Ps5_nevhJlrq(IPI45E#D=EuTRHqvhBRUAc!&eCQ0@Gy zdg0BdbFCC42Z*L4Es7URBKRd(XX6{UN5tL#eidfOdf{tHBVA)p7tX*_QQ^InpRGOS zS4fDP9@)Q%SQ2_Rd~iX@@WK{a7Tw+hH{6KIn~IHb|6j{hKtY+ss22;Em zBmJi@2=Px%%!5KmtN=e5GSWnh4IOf;CE1v7%PU86`QsavVF2;sCu9sU-h1{Fwx21| zm%9s1ohV2VVyw>@-h)xCD1v5b3WqK?2z*@bCg|nQoZ}|OLM<6Y)XuTY>0E|7rqN9t|yM=sls0FnE-iF25yKq2-3b5 z9P~l4;e}GHOI<1JO{*n2v71QF6%3du{FIc&ghqw_uqC z(Y_T;6mR6EGO7~iI+NOLZ{2N)y4&(c^`?OOO(u@#)M|N86*%GzIOpBiW72~Ymbq$I z+py0@pcY^8GJWXKKHK5R!j7p9xk)#xNw-~2le;^Wbf`mK=TC_GHZAQgEjZZ=YHL3O zx_vQ&7=?>n{75M=q*ThvLf48lJzbuy!b2j`A%3GFWaym_EOlRVCm>A&&!9T0V#+}! z6eK<5B+rb@rBB2J17A8ubA$qr)H2D8_MWcQMeWq%Z`B%6!ou6!|0saVH(yAa6gKOF z@gO^hf;Fxmm5CuGLFe(hUbd%R-wDFX#G7`v% zp14ITmIq!i*ARdY3ZBX&w1pZy`zbwuZpEveKk@eHY2!uqa1{XL^!Cb;Q=N<%*cc4p z{~eiHdChRFF(96^q7M3DJ2pUSsrYk=Z$?hbN7kmJcCPFh)3AZ1JURC;bix%@K;j(A zRUg!txq|o?ak_pS-Gw({txnyIA@;LDK_HX-^d~224jNY^C)p-jn<6OohIF~b_l4LN zHkP2xYf0&uEgC+9kRO^Sxd8b2TXTujNUx*rzaZV7^?siW0HqS^UQ33q-5ce<=Me2Q zV$hRQb{#L_(h|e@S%au+sIIhOp4`%ju{I-FYq8^N6)6eJ^~L0gJ4edUnEyRE&+>zC zrDVM&u5f(2%=k0x-%05H(W03DLiT+zm#mPE-P}0uI{0{;yikf69XLY5_cf=Cb+jM=+5!8+Yp&^^sH0r6zp3>Vp!vfoGBe^8Hyg< z-1(+bYbEtHcRIm`mh8oLq|beKOe)=_IRBfdI_7`ZXWj6F0@y+In~scI)fyAb*$#;$ zE=#l9bzZmXJ%@lWc`y=(M5DbLGEJy;3tGs-s6(0xadN6g^o;p5QTp3dX_sa`koog2=-sPc38wg|f8lX% zRENI0%>es~9PH6=p9H}(JM1iS7rj1N5&Ck#K`MSckRQTT5#)+myiKgA}@OaiymVqlf zk2=z3My=DoR5@;U0! z0xiyWplJT|(hwYn5F;@>o>AIlcf$`IQNz-KcAU+Uf2D9NYL~D_Qq%$rUPi8}WKO53D9fmfgmR2}-y(u(Fqq?SYTF3&U1Aa_bJh^D zHlRZ>lhS?C4GK}QLTW*$G}v9wCYfo7KZkS9#}nfTb}o5hts#W&kU2FH@VSr1#W}l@ z+^Gp()-lb^ztdA>kd#L_9rrQzPmDm~rE$9SEd;eN5gCgPQ&M_7)5{nP;}a8se=BGlJPGpQX#uLGcf0W-1zmO&$aV+xL2LGh;w3Wf0$@S6 z<^F!dlANtX@60N0a*-B$UzM#6%ay^@h&$IM-EhbpmO7H?I-(N^2tJa@=p}nbO;XZA z{*0Qeq&H(mS(5roO3Q*awM)+bTuD8tNvm`7eH*MSEsB!Twwe9M8Wc5lUs%yNJOwut^wP3$kb$H zYJNm8;5B>N)GJ9^LbEtJ&X->(1bb)%dpPr?nDV4jN|(AyZLCOoy?zyk(f4le#ER|3 zmfZF0(ekTf7b0Ct6KO?D{Tl5}9_<}l5VoBcc6&Bb9Wl9ncChOEocHV!zR|ec*LUxi zhPEQrA2I<|DiJb7DK7v`eg&Ju1Ry>W2seq zEfU*as~9UX7Usz@IhUoa*LlY%?lPRclo&s{=Vd*`dxQH!oADZ}je8uj9+!n0;+Y;O zZ}GZ*`~it>8aI$aHpLWFRS#r93qWqK>xsH;qeG`?1q1cm6wv()F20MZ32Y(JTK=aS-R4urWU? zlAapGI6f^4`*wu_rOh76bRV8Y0o}bq&GgsAFfb?`Onr{Df8Z%}HowU_!2Xi5`~X;6wBB8PVJooS2z9MHo|gMO{4ak(hio)O09=$2-1piAUs3%D zlbs0r^Km%*W0f*JraPvPh))` z(H~Z0gW#SDLz=aPMx&nJh}pi#@;JsMG=fGahQ{{8ukqlbs~Xb@xhc=Be(Ht%(1r`i zi2vH?RCBl7{jJwLp$$Kf5g*)MEN;_l<`k$%GS%{ML=4%e%65o=g@kp{I?4Fz$S#FG zh5DC@HMW%aTE1#_Bcq#9kMV2;Fr&T_W%kL`&)X5Rgfh!>onvShV`?wC3+vT_^>PNw zG6hfSf^fz>r@p_&0>EDenLpWs74m%Z3Q{yNdpqncO1D>E9J~7p}BJnW(>2C zifMO%Jt}8|a(=!C0-_rB$SWE?SR2*g>}4Z664o~MQ29Ngr$U5#EUcf}D%QOA$i=6q zsikMp|2lE=i>=qBB43AXuw?YyRP`NEqq3{TSeV|6WDKWP4i__JiN1H_&e9K8mGL`= zxgeKkNJ|gRCPoaT)Q?NVlb>WV8P4dF@UY#@)No%I)KDhp8AsV%Eli{!^Jd!?PMMwW zgBYzYCqb?*-agb)h+uFL$7(6mn*>o)XSD*9!c5%f+?9-Vm30$a-70CE0h$?dCLJVuGmu6p_2~W)cs3GRtwt}%1FYYN) zjgdFbVHvEiQ_}Ui?`)VMou$BRO(?n7k^$tenh=JfC(YQkhSM1zD7(8@)Sb%nVCNhB zyjd88%_*L3ika^B_dJHn)}?|i>esdcAAm&;%f~#=BSV>!3w03d2uCv4Ww65Q7?&kG zx`25(%pI?P1Ba}YGh{LB$84KGcX7A*`7S@yny*FdnEkt^FDW`I&&_b~Ng;F({(fF- z@oSQ}%2$ohe^+#7Abh+Y_NO{A+)Eg~ZN@q+*B|EBiVD32<+n3q{aaHJ<7LOPJuf=_ z&9dg?+SjTePlt1xYgY4RjVN=t#A?&xlznrxFz@_z3cyXelq%yfNiQmbA9F*T0c-NtjXE3E{JikXey;*Ur@Z$G}589k*j=vF!*5johGvm zt&wcy)1ATimg{iYVlS&=FVP>vQ9p)-DAc*43e&fOejX;Up|XNra`S%B@_j)7^7^Z90-r0KXP4Y0bi0yuyM!p#wkfTEINIfb(53V#Gx?{o?YnrAbXAfdn81m|07m=n zr4NZC-F+MqGeSFpVBOBRvMP^ zFdGnkU%4|&S;}_tnC*{1SL^xCS|)%XDvnBu-)LI7YMIc+Kp&VDdd>2ZGQ`XlpymzL zUAQN|k_MHovLiZnr+gt&Yg%SM9u%N5x$ggXk=6&b+lA9^AixmL7ijzCw9p~Z@3@K*tCtmKnXWZiwOtNcE`e6W3X>d>T}T2!>U{F}1SDIExc z0#cHOiJ<GSRjIQ$Mj(K$4SG&h3h0&7jHx^cDY;T@%Kkd!?g)dDL_({4ZMZj*bc zTukllG#q|5Wg?uu+4R-XUS&#uyFZa7j?`6v<*T+(^Jq#8B1dAc8QYW6%4t_@6X4c>I6@K%i3Z40X|y$}%{c!;bx z&8}$Xp$ICgfeP{Kk~Y;J&g17x7onW@Jt)B~Nh+Ic01X#^ zu%narq|b|ZX$7Xu9BD_x>&h0%?^j6)&)dg7RNH&*x0JUl5=zlG?e~N@%9N~1a$02{ zG`_#j(Z{kenT3m-hI&DtgC)gsu@-a6iF6kv#>2(=dt#>F>z{rJ#rs%p+?Y46He#UH z`SyviWIS>p_ zq2xT_44W`EN}BG2UsX)41u&N4l!IT+s(=7I$&dxBKeqWD*J(EnsoKpqIQN~26 zwCocvqonh$TgbYM0=GrQ^j9X~7bokg7V#vgzJc%gD(RGUdwg*e3bihO*xLB@9+>4V zdI}z6H@V1M7mMPu5>b6$2)&Eeon2>@M~{O6&AReZy`K6+;Voj_q&9ycyn_*_%R$k2 zVLCEb!Ki1nyt{MvwHykfBV;T^%0RS&Q+VDD^sWWf4C=Jys-33FUpVg*TJRvN%ikK` znsYjG${w8q{@`!Ljb?vE2hxWvpyjjG&_T+XK~R?Nbm|4dm4%))_czp7lbQGE(QaQ{*B=zpmd$>=I0@95N%*VPxpdae&(bnJ#NNAIoV!GFk! ze?45}LFt@dEgLRlu{lnRBG zD;rPRisNu+r9l0U~K>YGmAG*inyT-Mve9+>Kur|0J zP=@1oH(X<>>C1`uF$i^@IEmD~qqR~9w4b0)k=PHSpe?2b^#_<$Z2yd-335~rJj#Sp z?lKmH@C&V#{uZ~1)&3HYpj^3Cd!JQ3P$10;eRHThohCBJV<~4rwAOUb&$pjRA%+=) zXX);Zru0%|hhF1O85J91S4U}YU1{xh-vPELipO3=o|2^&C6IUZHl!B|nbD-;e6I<( zx}2N8#^hJ@z_=lt2pzapQ??0>SGJyeF!*6rLnz*)J%?IrZzQHmh_5BgGm&yfF2C)K@cXO8C4@l+j$9Mg z=bh2iWwlhGAo=KGktq@rX=9=6dWCDUnO6J1`>5|JKDC7}ieZCse*v=iPfEZ;KT2u8!Pv)usfvP(zVMRPzp(1mi7GYhLsZiX(KjEGTOHY1+Kz7h<*xhNxX9?Ir-Hc; z@0Jq3wIIqPLCW+N==Eq&e@I)sXz#fM<$NzC@?I+0a1mv=$j^@Kr6h9pqej^Uo*N@d zaaa5+&q1NG{f2`e?-oZBb*dTSG0t@-s{*-ImsFVgZG#kO6l*RRQ9w~?t@MV~NQ!WG zhyC#+p2gbT0zBYWS4iINl$y=18V52~h zjJx~OQuQUf9D8}SsDAZ>IOM&GJBAH#(8tVroe(`56vE~uxE=maHlU7|s~*tjLo${d zeO<4C1GZL+a_V+265DwMg3(pR>vXXX!NXjaw=xZ^$d#$C)TSzN%z7`IYDbgB znBYW<_>yzEC=v-0sJApmsRh){LS&*i2hQ z$=*o@QXL-pVD%)jU%RQbIr2z?1YneJpT|;7;z49fJ$QSd{V~kjpAB(4Y6Bb2{?g)d z%sVoCB&<2OEtSZ#$9KBCSrSIxChwt?W0pQgczO-@T!!Zf=j^1|p$l8WXX#~fCv8sg zwG|s)cB9+#j4R)``}9n|PdPm}ey=PWS%XkDtFd*m_RA)-zOHT-g~m2~oz+xngeEEq z(*~!nG#S$Py!4c;t+3oIR@G9Zs)VSoMpN%6URcp_Pw0!j9QFumT}az%W_qDkg2qRj zi{(Dm+2yyh%G1y?++)QT!uolUQH~=QrV8MSW^6$%1GNkUxUW zi$ka}!G#TBiX0Lq?zVpcNa>wPz3{&CK_FLcl2*L0RlKjL(pHqxR(0m+-N@~{P=VVB zD$Eb=27yGC3|6|cC7vq8&gPHCaslY~4A#%`Lt%bFq7M`*+jj?Ho$sQBbZCoZ|NBoA z{CGv}6*aDoj_IvQ7rahR^5}5m)qoqBb}w8?PI7jC*@Q1IvZm}=K>U#l$`>g?ly^`q z^LmqgbW`X@^o1wsra``r=e81~xmv=C%2;?aOgRG_kw>b~-mS2RhrKZmd-=8H#kAAW zie~ry?w##vUUTAay-#)R3r8A2(BIzA2>E;(YAfKiJg_$e&F6x1REsE5{o4=9#eiGm zsc3ns))10Ngpz*@)hc|k1r{$;5>Hzpb@uKmu_A)=@$auF%jt$4;bmnfJJS9H0~o}c zS^#Wy6KiEmgAE9TN(gD9IlS1^@SF(Xf(3+{pJaD%zeebHF?M9lzf606t{JH0jq6r{ zauib4;(NX&uk)LK=ifRFHM;-wBY-sMQnB*1_aZ*Hg_Bj+^Sn?Ck#ZK$ zRy(V>x^*Nq+gMCw`5TlUyWP3#HQPep95nHo62sZE6`bV$tM4-i9xhAOGtXf_yHuNg z1<{SFp5W)IP%_?XEC@fch0e;b=Oc=d+l5TK45A1^YBi^z&zwm8zwALd>R;LJY5AoZ zh{Ro&*j}>jKfylf*PRQ~9tRaM#Mf^%1#7T_xN1lLA=0xt;_4ALJWUvkWl4UU!;%5jyW17Rv>kl6d^p_ERK2wKCk)5{3B=cwC#}u! zJSW#2FHkQbjU8)68YIsP(iSE?4iF1<3QadyXJSUb8)UFd#`chIOM(2!w@`^8)LpTrX}*OG46*kjVZUWv|War^;g_K5@;bo!m5 zUqMKSdu!ZW+GR`yS={u$A`k^^?$&Vr{bDxon`Om(R>ULz2Lm@7tvjwFNt48iwlXa# z2#zwdP_6=X3C39kaK+g9xo|8)7BuwBGa%7gN~nu|DS!=8zZ@x_Esgj{+TUiQ=(`7P zmJytFq2S!V19Y%~QlGUKd~h=e@*`oJ&W9~{B` z5Ck+e14x7{`7k~=-`bVtmYc!cbGgazQKr8+{8e-aF5ZBsUbrd3J!IUt z%Rz8rI@Nwt$6<+u2lW*Vd3D*RNsMo)jh33M9EoMXW7xq&7+D;Gc&16Po-!tA%U4-y zz4VqvEo!&ye@Te`CN1X^liww`UZO>L0#KkG0@pui3T4nF<7I|M3DGi+B~s(&4OnH} z-H1~wF+lk`3IW}=@rr6--nHP{oC%X@jZabTkeZEsNQXX@t$~exMU%ydW$27Y^IH9}N?=^AxIypk zph+c3khkj~oG;pm6bAauMVCTd&qhv);sY?xplzx=kcE|@{iq)_}M5o% zT`NxCpaUrhoUfdI{KP>{Eo~o{Yf{SRe0oZ>p12zj~fN6Y=Uvxhe;F+q<1 zfD}3!!LZqy%=oV+xC|UylonuJ_|rD$lYbCu1$`BWPQ6TPNBLrtRWT7fDWpFz4pJEB ze-F4!{=sYBYMXlqZ0}QQ-&a*owVjGrN0W@GPAL@na2A&fVv}AV2LQ30RL)y^Ago_g zdA%HMHS`)uDgIAbgub(_0@_*%=Ynbu2N~iiH1q-ZL_ZX=rtKq=v?v1Z!tD~P(cf+s z@iIA(xZnTfno@`VjApwq^TCMGhRq39iOu&o{o3w1F5E2dr3?dTSpU-0$p4TZ2%aQ5E;C%?k$ z@C>w8MwE)L2BLrOkDUsnu@-$#h(ftj3lNdxrrj@;(iB`g22kePkM znFsGPw({Wh2CM;v6{lu)N45XtmLKM0__~QYN=Fs}XgTh>P}e19rf8uUHD;!JLNr%F z!}A646$n-e$>ImoJ;c=b81dTBM5^?b^K%iBp{Af0KO-)uAs8C|!h%}-I^baN@h(Wl zmZgV4Omj#=mk%0;S|9@&%Uzc(9MK;(*)wht85LGzlB%x7QY?XZ>S5VF-ViSg?GK|+ z(+}s_CUd=PlgVR7w?#HyCJ=7^*C{mT6Bn>>3Sb~yl+5m`TZ2x=-Prz7a_GCekF~WP zYxA?qh_F{vQSe`s7QeQ*m>I7ZqFiSJ+B(TSKP+zxB(A2iW|s&5}LxM|# z=x|_P^$&JmE+&EUPu-SuU*C9J=caP(*b`RNm@K)~8Fos-4*GDIUrWhFOJk^ywyhs+ znT*q~7^mMq^nG?H)7jW8mo%d_o&-|Si&uiPBHVvkdiZ3B7}-RTyK^5Bt7aK(&~{Ma z0=G9U-2NvR|LVzr?%5_^tH(da2eg`b|3Ah?RMS#$ekVFA-(NY8ZB`;;bu!~*R>M9_ zXLl_3A9WZFd3AFmH}m)%K*#mVC)@E`17UT}Glc0&lwa^7`_a53sZNvsb>E zaDj1s;^j*26>ju}TnE9^OfFIg+A=M$80ogKwiKc^8oxVepADwI|6tfa*wt4gshya? z##$QM*E(AyOp&wyf-c@=k+x0*x;r)2aLp~2dYz=`AJevz)U&IScniX)!Eaf}ULfwC z?s<_0OVusDoxWuFL!Y8#Wlm2KpWcc85vs4X-C#3pvHODy0X{IN_Jq;>|44?ozdjvK z+0@nw437fXcOcLH5f}MGP`9Rqx^Zd9`XvE%;i+`w4DL~jRGiiprsEGL_Dz{xE$D88 z)l?HZCfJtX9Z*55%S2Vl#Uf(_{v!;7e}pmUAX)qCnkGp2;pa1j=sDM41IHO9&qWf#kbmD?xf$0-cf4!rC9Mol5Vj?)AFfgF1fX2*wG}v{4`k{HVk<1 zBMDbVCL;SUEc+AtZcnGnp-=%4+q){jZ?^#gh2E9R3OG@%JuzU889<{H0~zuiZW~Qx zUUDWgcmO$+Km7@ttj84wNhx6QBYYa;H$-{TT@jY=;QINI2azWKrpgnLd-qhIKcM8E z;pXfQImDHTam4Q-o0s;@qx^tC-+3>PLx)f5e%$?F9JwtO_@bm^gvZZ`@b!slxaSL& z@jq9+bHW$Xx-=N|lwG;moaY+9Gc|vIcUN3TOWal(aX8p+{GyEPU3MDlCr{A~YfVtE zTjpI8s|D#h*5ifL@E^Z)II$Z${)gQj)TrB#uh)ny%`7T8yVR++u3Q(_7#bZK71%?I zm#&^&nhZ)Ti6;Ihd4=Z-wDmQySIb#1C038*iqE~qbh-acNXY&lSDNi_=a?jcet(bx zA<_uZLs+PIx+qe{luLcrIiZhwK`ZLo#*Vqs5%JyfK}zuInHAeL{F24Uh-iTeLMo%# z8Azwcuxjx3jAk(TDnB(20~dlNf_O6JyyidKY4#@;b- z(f()7w$>>=@Fn~Pzu(_QTn zXax#5Xs7;p{)A^er|M$cKlg1&!z1<^*U!WQ7?9PcVH8HQtX$-;{b+8^ar-0CTu8j6 z6V`k|m^7zzGC;yp2hiW{RaT}~sHdr;Kw@26^WY>}=@~$kBgK4O?o%=z?4onsqwGoV zA)|f3YDxlnAxu`np2x{I`BkGrR_8wjRqNG_wuY+ByAP%wT{fEk=$s%$_-@`kG3~YI1#@n5Bz~z-Zr(4`Zoxt^VrFfP`p* zU{{%c3mV3D!u;e>A(fK!*jj0mK(4PB75yN6(GBG9ul==B^n1o|Y|IBT{LWw;m0T4> zI0UHCMaldm=Y)#WiaP=8#NY*f_$nOrPJw@aasE_{TZJ1qVuu03;q}Y)^&g#bV4UQo zan0a;x#)5n8D11_iSMM(-N%O=UHi;N34H1DbAj5!DHJ>Te-#z%CgQ2r$<}t#9`(xx zh&uY02bl}yrFy94>mWAH@}j{?9Mc1?Cax)O%b!)e)T?z4SX3vr&RJ$WEJ`gG;Wg}& z6e#R0B#_}(KyoX{63@Yin@gmohV@zt0IYG2r#9mkOj#l*@nbP(6OAYLSp>ivDP?r~ zprCRC9f<$O)R)IY*?w_j?E5~p#*j4{V+m!KtrDU{*~VJ-oor$36q4*~vXmG}_MMPD z$-c|J@1lCI+w*(h&->5J^JwmS?)$p0bI$jC&-a`O3NVMOxB0tdbN+UCPrJ_V3HEV} zNem%AnD%j|=SPbce!Z&hVkWGb@`P7k1{cuN2EGIxq+lJDyJtx7JaPCASNpl(-MOsq zjQa%=q0evY^<*(H{k?wg4Un>E2+T!N_slfBUaA!7j_`JE0!CNN`;V=tsQ?furo`M-Yo5(-&k>Cy7~mWdSm>ay=n>9k#*2kE7n&N3b^i@!TP z?dev1AHDXMpg^**sc5S--ge(EPX)e5T-sY2|Aua}mIBZzl+P@Nm*Dq?|Bz`r1hnW) zancVjg{#z8>v*X~%-m;Pa&ofWpGaH#8&N2!!2N!!-^+G?KLZ%DZ`pg=Z4%+c=S{l3 zoVfdc@w>Z~g0Wp^L##mP2Bbr{TkyTP7oa-0-0!UeEe_?G$)!%a>l;r6Nk|AI=c@M= zrdzOHQ;@>ygYd91RzIGZ&!Syhc=lq z8mh&WG=(fGFCNc>4Tt-yNdUxhZ!=Ch*mOZeX;PRUd@K_4G4#3o+bkxRzk4vyCiXU} zH8X05WhRAnMwsMlKILw`#30Y(CrpPh{rkGHoYzi=NDl#-+WN>d*&;KhIG2x4C^GNy+> zIzw9$RN|Y@Dv!9l_JtbkW)Wi1l4`4BXUrc~GN8c(NorLXT{W$_k&IjX_dc5G=nS$# zkkm%-r(fD{NI@-{Y_KFikr-m)stRR(TQEbOnf~d-3yNqDh!QeToCbtl8CTr#W-bZB z2BN&5!2YZTqq(Jmb*3hj<*TCWNqWrvXydMKkR=;4ws(KcEL@Nv*~6PBWSplH% z^)~$`yV~NW#%HG;-s4xZtCJ=?jC*s&-sw=0p{_7=tAHNDTT9+|LcK2*VUi-a06;LC ztH1Y&fC7bIv}3|9xl;sCsKti;# zw97;N)uF}CqSA2`5Gz15-(89SmN@VE5Ql6diMEF`EYgYs)R8S22t{VpV|o>L_Ku8- zAH^qd-r)wqA|s9eAZJT=`xz?c!$VE!TO67MsQ@1d69N}9sRh+%{E{(1-ATg%U2PT8 z8EEzDk*|GyQJMAJ%wJ<5r=l2BeWAzEn9`%kQ%E43GyVuN3WPtPaJkYV$kJRf{;HTglNND=mg0wC9!0qYEvbp?w2-Vd-2tHX9i#as& ztEr;(dWzfv6!WI42iMlP;^eSummT&Me@&e4J@(gil_pO}Sb^G1Go)6M^jM5LiH^a? zJx5Z!?f6He`4p=X#DbCXZ+{JP@ng_6ZA>PWf@%|lmnTKw(a~Lt+5Ah{{0ZS%$>CX= z>Hg;Fe|}}hT1jAzih{=YlNvJFe*3ttt{3H$0tRm}vmnej(`f6NZPhYWHQI2d2;3QrV8CsF;tc+D2RXaD`ZIZ76h-Wgs_eFv68WHW*J$9YD*M3pjB5VPd?x2LU zw+YRw(&-l?eY#DOfPoB5MihO^moq-e-7HgT2=Hy*go4n~q;z>8{$0?` zj8K*WSJv6_G~&=KfpR3j25IzQ+A7e@1+lJkfZi6!>p3ftUKAdY_7_WoRRGVNC6qRp zP30F85TE8u*(>|ig!f9gd2sc6LShm~q0{!m`g)wx0W#pSoB%53F&j%|l^L+lMGztH z-D5*nCz*Kb*kS}KlJ7fU-h0YWFW#(08yjnWsYXwv55N*EuTphAGRpiSA?x5$H2qzt z9?JO1TA`ZmS@7;6NN*^@Fbou{t?f~sKg*N30P@e7vbgD2LsFKKJdi+Kc}MYtysR0knmkMWOw~kBW&kj03y@xNIsx#BU?xK+Ui>Edwc!k zvPs+y+Lejn@Aa{{GJGKp@N0G9s~H%n3qmtMMCMyk{(MsY1dH@!i;b^Aeyo|vztWBH zTx{{$y8NoH@Ip*o)kE$iG5G;09G~#NEn;__8_WP0@ zmv0P60`^-sxT69xl=sLQ&pW8Pjvk2dt$jc1e;-5-cw2>IKVVfCk0dZ-ssM%peP8p5 zym>JxJ}}GQEA8ZPnf={Xu=UNkWWo|bNNV@%$a7(#J8pk@YhhAZzjjnnMD{zhrRIXY zmjUk{MSC`NS439&&BdP#7J!bKU*6{>5U5c6fTHaI{q+gednNeSCnQL|4u)#qGcj$M zwtNg?eOqE%2;iQ2L+eD3dt_;RX?{YVzaLcWkP4%V3fgh-FnfVzM+rGCLxk;>h*GLt z*Gnp=*393-qirhpFNhG3#lxYcsgJlQjhd^9gbBF`)dH|h>l;KS0{5?}YHs~sah2eW zDXIx51NC0Ru;Gf3Z-Fz|rnP|x( zSBl-c=idx}y_sV_9u9lHT%Nip4l?~I{Dgi`Mb~yv3rO8|X)}+#;8bFa+Mf7p;qTs} zmequo1ruyG1%ZpEU+7%pyMUT$Rl8AE6Z2r=+vS)4ncQ*RB{&H~Jc#LBwbJN9cC|LQ ztstl{PgWlnI|PGGf?~%vsBmaP=fmQ7@f?3&5HQ~VE!pT^t^g;Z^Ze+3%kBSYI>aWR zsB)%WDgw)?PEg?hLH$o#n+v3>+%Yr9hXrOorg@wi93xefAS|t*=ZqqBSSah*4Ue{PghY^kJ-L~ zW`jYkrOfD4Z%aUFl;y&QL-p)n1^V##k5t@eK#ZImVeddYw#NObLdo(&bmvdv_|5K6 zzi-VU2PVY^_Y)33QmsEW{`N)k^(JUQm}~x&h#9lpYe;+sfzD>70e30h^Sn!%s0A6I z6kZf-&}%)(uficBF2p=aG3%CMB@E&v$N0N(!6$k2n)wU>l?)PF-_SGetha2as8rVf ze??wL8>ltovp645H2`==C{Axg zkja7KtBehwj7`Euddddy4P~^TTA~N^NPG`&NZnuE;LdTwhV-H6Z%Ao8$&K#t6>VUp zR^EB_ewZ_u!TP~ERdavIgWta`BK^&u-=%~k7!8_~t=2UIk2|#=OuwRtE`p>^S7TPG zW$_Zgla^HCcORy zPy{1eBRn5};TO0z(i(0`Ln99&)j-4BY=8k7mCwzsL2(5@4Wo5WK)J^@LvhoXlG1!y zebEHGH5k>co44osF!DmI87=p1sI2Y{{trOtij~!}3qAL})P)uTd|+6eBa1-@yjsdm z2gNs{y-Lb7`fqlsu!DqL;C>+1-NLaeG}ICbx9=5mU2g&wZ9~Ig&HR=uPF>ke+{bz0 z%Ksp4n=7btjnb;TUaFFgGz6~WBI5>pJme5hcYrHlbVa*B6zm|;fA}PBgZmwPJY0*m zaq!S!Dw4^{+u$PNlC_uvy%<+WJJ8EKq(x<{&JRZ~f=nP6VafHEdsa3AexX88nzK?g zAtekorS2m@Sb$1M%V=K@i__Q8!(nuQh`m4W<5a_6HM_ND%T8rsvmu5LfBc@iaSkMm ze8y~=HC0cXpAO8<6MTDz|5|F%Tmo*nc!y_?I} z(sx{MyPpY~H?JBUKl>fo-0r67+v}S96F%26IMP_ z4L&x`t&~)80?-h2Bh`Q~ZtrCE?xX0Zoq_Hetmaa;*{?1J;mTGVU<9ZFQ9W2ar)HCslffSLMGC(5Dh!B{ zFmn1A38y0In!Pek{3gzjI&%g~NU~;a)Ka_BG}pW61@=%Op8!7ZXEmLcuSNzeD3B$6 z=I4_23aBO`$u{9Gi@Tf5~Ulo$@LHCd90b}0T~EH zBw#bg0ZbdeWp4AT7L>9r;XoxezXie_h38y+?gg+6se?A*Ea9~0LQ9K01WJD??nnS3 z389~^i#g3_-`Y!i-KUj30~^ z^Sy!|tW-aXEeoBtyl)uB6cxY$|8NwldURnAEY%TO94vO%_jDbzNf6M70o&g+3&OW8 zJx_f-)Sp!b;oZHc0a!Lv`<;79Zs)`WWCD?)%0^q0pIb>Z%`_R!U8p6Bf=l95 zo;yp3*t!@XP#8-1C)5p8LSVRVr6|`BDA}Jp1H)eA^D2g*=thkS&I2|7nFpjFy*}l= z4Yvc@t0xW-a}%kiM#1sUhk%mbvA-yJ1h)a#^$cTaCJ)ItfV)}ff!vjla{4nU?1j7s z#C#2uc%nk2_aS9h?vyyx7S;UrgD7;hB>5j&BSs@(L&F)>abE2~S!|co+C;d~bKEYz zwq?Q>DxZ+d*Px$k{MKu){Aj9!7T-}Z;C@<(l*TbC@;#(X{T?})<#FB$)Y5TcU=GkE zVaV$w{AwaX!R6~GU7p!h_HIu{m#kFQx!W3LRcH|Dk6HTaX$pzsochvCC;Mo#)@Oe_ zQlDka8f)p0F*EN1kKUFFY6F=hReLL?_m!&W!jbF9(9I9Yb!LFHccTr9Sj$)&CIsu< z#tm2+n)x>^P{&cX5&N6!8b%iff%*IJ`3f4ayQY{9}82NJPP{h8N4d@k3K%_TWe{G+CJGbr`k0`KFeIhV}MyHbZt0|%E0fdll$cxI4 zVFyWbi?D@tscoXmlKa&tSiCL z6(VqUwHl}60#T>_r*(izNzVX{w#z?5Ao*1o5=3KK+M~G8Wv6tNfN!GARC@|go`;@}rbPlaCgm;&H3wL(`RwggW#=Kj#Zzh4 z{i2HIiy~oo1)%_-Y&Me~3Z0CG!CI#dm1WL2NoV_Z&A2{+R-JK?RPg}l?q}RRFla$YBPVe`Q>m=&VPGZ>XdT*#F3I6UMkCxFi zz=AE-cRhLH!qxO$F|a)p?+y&V!RRw+f$EB|^=Pgf4|E!C-?qih@Lo_vj4o~v!!-?i z4*4lm@?}kTuB-qdg>&gj(D-1E6nmG!7iGZCSXLuo?x53VVq}0e<7L66qRp)S_qub# z%>El~*1VakQd1E=K0mxAjg53$l3R*^;kVG@7)mzN(LB>pEV3aovO$()Jm*sDS@I0e zDQM$cWMgT)0!vPs*1P#FVV>m#pt1|li0y#qNQjC$zohA9Y~auCr2lpEy_<9 z^>42LnO;_JOx6_1XE!g({tVMC?q-|v$j087Myu;5omUTVl__PFR*L6q^bD`$I{hsV z96h<(s)J~2o$t-W9MIO~*)H95ZYf@);|T6Ag1Ygb%5X4hB-EYI3=q$2;p*VAthp*H zKjLEU55K4<$at6uw{@;VjXgW;0N~jN&sKtJ^B2Oo2$0-F#R5QlkMy1&E6|FZtNo`H zAvMXTc;>am^1Rz+j_xre3G;k;((VG0pem&fr9g*<;WE1*B}j9w!uH-MQkGDVAOh8Z zb*3RHw|>ocxNyzvLj5V~aJgHbx8#Ir!6vfDXzQ4y!k%3_4p9RjH$wgb`bD;q(EC zER}(;1t=?uwPFv6)SvM`utx@zmig#^#PCXX{}v-_yyc_&4i#v?hF6x1XO6)W9mb9~ z5&v0l4-Ic%Qk#i7RJ=(FHk)Jf$r_#)=m5D5`@;mU6ryqjtX-5UMeM zraWTQ@vA9)LNGRn#k=h*3)V*W;r_)`zYUBJ$|P47y4zzHm1R1w$kB*(U=L+Az^BJx zdU?aV{B}3B@@u@U`Ag7my>|nll!{i)@NPi4SYyhvqA~Hw!sf+fp66dKfgaA1!1#VE zl`ZbeS(S9Bf3AWwP-C@y?J!Q80;D^wtsm1hUER%H-NnX+Bgcl5u;^@u5SHmXB$_|m zZFPpah)fEIy+KpP!K=9$D;48jNbaJ_uW9aS8!^`9dqwc;+d%JE5M3qH{A0^fUiUSS zLjg@ILv;q*qNnTFToESR*DYtOmv%;*-#URKGle75c*DyPHzO}QS@mG}W(0Iomm5WB zHk2lRy1_0LRH09QRL|+zB)!UDzkT#8*MrMceL3uLWAIZEXSc156w{wybK44`QIk zG-2SN0m7@R0FN64_J{oD{GNQ5AU@&QDBUG?;x_#)mc9DeLMiIkanq4Zq2AB&pcd`9 zU;#jL97C_UTjY7}ZgO=uFm$azU2IF$q{-hWQp!W$Z7jWmHU;6(gO&CgHEdkH0RRZ4 zEuMQ585Ls9t*se2j@gZ$JzeFta^V4wCzvZYzFk+)^}5>zK|Xty=A~-H4`Q*U41k$q zpp@{~)z_zQJy&1^)RK64q;y!!I^^{G}zi?0H`h*QM8#qXS@gtOu%v3e)On!{!yD&PBTk$cQ z`6&n()b(16Bo-S9twCsD9s66wA1;{5_d-Aibj;^T#5`GdK^A++AY_>#I>1DSTN&Wz zsh%Ltu(VYmKa-7vB(k1L(#uDXx;7hXNK#4!kHnQJ!h`RIj<)`e^yFuPn2&+>TRtT1 zyvlcOhA=1Hxk{Dv8w}uRS-8msYRwDWV5EqMS3Kzyf`g;ZP6{drwFi|2POdIC6EkD^Hz2U%i}zMaFiK>d+N!Os92|3rg3>t-bk^j5F9guMM^ngI2{X zJ*>YL%J0Utou}_94lVDmC+?nfqt!}gpbArK?&v%_ZS=&~%^K}< zgrJK7B};ho?CQpRsT;O2zvhB2FrZn3*qsSQ+O-WOoVXIsaG$*(Tx@WRt02@4z;^-Y z8e(IbP=JzQ3A*c%v&A1ARQWyfwAbP(*g|<)$|qlzM)c``1_E&hQc}u&7KCP8+#z`7 zM!uW54#~Gxh(teUKrM&f^XOcJX{SUu{)-R!Ko%tQdlnxDoWNc%eV8w&=$8jTv0Ns8 z%LD?Y88UpJg$PK;LNblKX(3Ldj+?OgLcFBt%yQko_UWy3dLPhBVg{j`P+Gz>*WH&C z3oKkn>6j-YViDT=W?aqCcH)mO^uONejB6D8xF;F}uCTwe0{V)l)G_kZzP1+nG@ltPDI4=Din~jDXDoxl{?s_TND=m-S0rdxxo1ftFOnc0^k>3RH|3tTaOy)|N7 z)ADw$kcBu({=~=N^;MA9j1y=3F)SxN4vgDkzA;Pp4t&&>s`IC{Pn=T-8sE4xEof(Q z(i$YmAW*f$+5h*N33Je6ZV8b>H7CjWo!iepwbbI@YVqwYb3ChZd{TrZu>bNWB8bI{ARFIfC=f{D5wm!b|bGZGr9agZQ2Fh&#B8ns#A*Lxo zr9Nhts7&>Cwvv?|ZgrEHn=4D)9krFKWC3H`l4>;qclH6XJ0Ww;ep@W}DhzCdlNbDa zJiZz$*eVvin{aJDLkb{_{DR*#UVQpXhBktP#Fd6Dw$E;Efts3RJpf{GG4qP>S}T<) za;TqD>ubn?n0^)dmOi-6iWIH}I8AwEc3(_33O4_Y4FKAR7wPPjo)!rG;!u*TKFX{< z6rPL}o_#J!HH~OamOMxLx+i70`xu^5Re2TdY?F%CGV%2c;~fvjrV$Y8yJ%;! z!iPV;b_%xk$=ljF$}i}cef<83Jh6h8zDv8s&bXnR`5Ta}U(;^0e^22*x3XK)6)Mni zsoj*2!}>Mowcc9ne9_|ynzH>GVX<&CxwhBPT@WbsOLHI7xeWa^DqJUN8G>X*)G z6w~*{Y1{*&t12k7A1nmc717ohtHr=5@fQImlF*wT7v(C7$xttL1#-kBcXjQrcRjd{ z&D9SapVzPC#63U>FTRF&DZ==nyVcH}cfn}6>L{^$bcWQQ^_Hkdhj$*yVwAzGVRnO{ zj!TnhgUH*Eu%|yhVj6W>?GkDI5oigxr{bh%v>_r~I7tpx)YYQmOCS1&!3@JiyvW#^3Ctr^hrg(-K|d*ccX!8Z)U zc3Qg-i;78PeXQVnF3|67(&IbY4358pHh1H{8X&S5V>w`tHu+RWX7w8Tqov zz==dyMR>TsE5%hu=+-2IPMqFToTBCj25Qq>K!G1?+9_@Nq`A`2Zpr=n&+pE~?TZE! zZpB65qJ^j!jf@1UBy^l_b0G#FB|o{!_v$fAm;ZHA*xF0P)0+y7Fg|J{Hjb*QC+<%N zRv;lxO5Rnz-p9#HcMoy741DK?Y$xT(ly;b~iYiLGrz}5JXygvKnz414lWj{-evjBs zKG!Thap)Xed-b-0OZ~&4fN2zP==5n7T#_HUU;GSXpUS52xTT&)tt;z&U}@#^$>;nD zZ-9goU@Ri1C$&g2B^$f!pwjJ!&N}P&6cq_Ol+$w#dx71Nf!$qsO#Jyw1v1ur(>|bq zu9J_&Ax*Q>$-Gl!7+aN-PrR3AB<5h-`MJxtfsg+}?P>qWRzyVu!5}#n{Q#vY>0mqh z*-AxD>!zOw!g@XO6(bl}K<9SzT`!7VO3Ho`C>FK7lL5aG{<=5jbua3tq?Ey9Q^X>X zRVOZ1%Ug52M{|6`)y1u~y%&`sCFO1ci0#V~Q1^7~P+H1R+Fe~|Yh93fyNk8i+yKK% z5S}>SeNs691A7TT82m|mTf=L&N6X+d0(j#`uz}#m$^XoZML?YSEVT=HV|HriE;(ug z4LE@LMvx@Cc1W;QN4kUGcO{4BgB*{9s|S3ML3r?4ZAN4TG@=G{iA{z6?74&=fKi;( zl?kJ)oSzF@@9Jg+`@%#kn6lOln902kEm?zNXh5$mo$ZCZ^nA9I*rd}duKA2}u(l6vWfOWZ z$Neq?G%nnS8iFRf;~$^8;wne)lWM2Vyyb$J78E^I%DVC0%2#doz)zSq9ddA%e@g;&O91fs;;SV6gLoVQ}VT$&M)`*Cg)Uf$rK&9yjl1FGm z|BCoIpMsDrhUme=Km)gzBs6a!tl(t@#SVr}o8>oU zX-OH85#Vd10BG+KNM&Us?gWv+Bb$G>5d!aC5^Oeo7C5dR61iR4E>7NN)7Mz@x8vcg zGtN;FqL;2vyC)i{{g6lO+^%P(kt)=G1Kdu|8zmlRuz_I-DH}h;7A>$TD+v9!H7f27 z5i4u1V-<6s^o*bM7WZ6!m=sw;#qh`0dZLF3p_x}Lso{1le(9UW{*r8GS`^punp^}k zM8*fNtgH==C9Z5ZE+zG&R0^El{q0zmir*SXP7M=v+ri#If%;a&AL|>K`db;(w}#nB zonC${t=m~INpy?K`06!i_h`|4N)PLyjna|3rg#`;M%$X0{^##LqfnK`J}7&B3=8O|)cvJ@RhM>H%s}2;O<*0EL{}ZH zd2>c>@s0vW>_Ok6wny3X{U#FtL!VkGgK3lePXY7t+~dzUy_p{;k+%fYwDJf>-;7b* z;+8w9E*GPh_1n?%HiHIntl^(-B!!pA8kk*!?46LS*VubBg#}Xk>3@BR9`BQl82NL_ zVwe>n%*+D8bbKgZ_EG%(S)69ioIbR6W-3n85EAk}f+-ev+f_$L#O3$?ySF~$dvXPw zag;!FG@E3Xn3m!9DmHWwnu~r7Pwg!A-_ax4Y*0&d#+AH;X1`FFw-C#9-l1cV{6P}! z+YXAp(MSU6A*`P#-(RU1kk;-@X&F)SZ9>+-EQUT#U00r9g1M9emy-g!*_MKk_vUn@ ze1B00xe6PbKqD((jZS=gwt~63C{C!<(-Du|&tL%3t5yQtf$qR@!oVjFS}naj zWaXDH(o>f3CVOQ7%g3C1X1Ngm%YFwcrfmMRZ>XeWK*Mh>i`K_x*kc-*m!Igra6)3exdBW=S<6SW=@L?bEPiKs1_LOOHsfKDa zh|J3L_BLw@i}LojS`_yRrofL7U|W9J>Eo~QKN78r{e4&CvqanzQLe!j@S3H1F~dhw zn39iqpX-9fFrgrph(2XByS-9CnSc|f!Wi~+EbA)QP*kL}r84hhzP=ua4!2cKP2}ob zYk6N0^ngJw!oQHJICXZ8IO`h%ilZO%)JMYTDkzn$r5=WPziR$3dy8*O?3!8o-cgYg z%OGp8Xve!(k-BJSwRg=f;4~1qCsi6)a6MVmj0wbt&w*eNRhztdOZUxnC4V=f-KPlR z<@s_%4MYv$2{H{v>llx)4WF=0(q20Iw{j7h`Q~dF4o_6Tl=>$&%`aBmEV!>qnh((zvmrBWD&ays^V*a-O^+W(!dbKPDqd4`jN6*?vCyf-a zRM7&U_ejT%r6?r*^za4xyZp({zOM!!u*aG(Qf|i%Z2L9_>`uhWV3zT-fn)cG?RPXX zG)isWjI`0CyEhHCFWX+en0h5|uz|cV=`w7Fw{w#W&;{*!V$^46#E=gI7fl}F_h&x$ zfN^HbT>b^9+?8c4ZPtd86YRSWZ~(q-EWiU9v}Q(BPXyMy^5t3jzVuM0N_}x_xapAU zz*zxs%RUs!exFF{sUqZ{i=u!`20>cibAaR=ZWDHF$F`G0e^R9tPgzx()@c)(RzG0S zjL;S|-_cM4Xrzn+HWc*?@k3JC&q=lOv5(n-L@QR63_9io&#V}TjvCxdtr17Oyu5j} zD>)3DKI-0+0v8^udJv5~4$6F#wwen+vK@CK-U{pt$>q z8ml4t{QS4vNg{~V6@hq;EOGFl%zHK0Xg-W6D~NN)$r;Q%n}=uiRc7owC^%FV4Y;#$ zF4{%wr{!@v{(YySJ7NtF9BI#SxuyuA@7@yZPN7uO9&(@J=KFT6C56%_!=qn+Ul@Pc z-aWl5@kQc^z3A>_i?<_)$S)MNuk`NBx_k_+{%I~>@S5IdKl?8i?6x9&ujm@z!HDK* zr#*jUPKPaJkKN(IED^a4!_HbXc;DY6Z4fV0_&T_RT#?P&R*SI-b z?xDo^)%8H18OB!e&F7Ox&(gs_xxh&RA7#6Il4`1+$BnW^vYLDnvZ4~Q&jxl>2Ark# zqidg;ulWLwb5%xkRi-*``$t?u!YyNMO=E4;s?4>#ZAH?*CEOokti<<|ro^_(LOIQ1cDfqFprPD=7rFbyWeFtjaZvZAXC^98n7&YyW(DNF1YZ z`;XAF)R(4Cnc1;@-&v^5uRaWNlT4yq!#6qoS@J}z1ah+UAN3bNw@^&Pm4s1|E9E*G zOAHTZzwS)~24@Ilzd_UPf%)T-)G>aZzqoSZg=D?k_@Gn8fSVdfBO#Fw-HCI&A9!Fb zvcFzHl>IQaRL=AD#eVOxWC26wdMqCz4n79<-$kg?)U|;rxoj-EPb<3ZcJs;R_m@nK z8*9ka2o=CljtPK~pC(w8Yz_3@hsx-s7GOjegU~mDw})hs5Z%bo7E64uf`LfH<-#0% zw1mE@5fJS+bn+nL5blp2*BA$~tNB z%lfLNQRGeul*QoDTwamP9 zj2!(&Ywv;oV;rw=IK)ioCT`g8Gnm4bw43wzX+2YGC8lqJ(|dhCRWDV~cu3GrZo41( zV2BH9!!`Hxa6KI>nzI>_kiw@hNC}gQaesZ=BxsakpI= z?DBON{L1e;aHg?hqm77}>LJ~*3{GOeCMDd7)uNIcPayHvrf*K2#dvmgRdey%BuuBL zOluxwe{r>rs)*&*+;DNkb&UBw5r9te_|}S*sXy%u9HXpYhq;$7elNZJR(zjkymhaL z2!TBIaG`%YCySPoD2B=M+@1BF9g@(Kbs+OTq-YQ!9BPXM<0$8zc0cnjH!}dgEjIr$ z4E!L~79>xSpax0BY>41>f`Sv|jwc_NN6;NvQjUM%2fzN#yb8EJ(z%+n6ZiLDgwppcJ+k0zVu`r8K;jn&(kC7;0$qTD|1@x~@J#i{>RNrR*PRS! z!oIJu84+`PO!GXh>_xzzxTV(8IlP$$x&7V8vUJ|1TC?6rmU6n9c33m7(5#intcSub z?vFsIY9L;A)gR4lZ5J4_{YXAE&>Xy*na~jhGV<5Hp`{^QZm;7e#}f?0(M#d!5+?By z;l^(91aaKS8idHuvjJYbysDECK|*A^w|@kwfFw9KzcfK%%7|0$t1uIM4bk6T zm%u-!_O@TbV=QQX?yiWZd*byxVurNj@m~dzfFlobe2uc-{dlB!Q4{P6{!#3Bg24eu zJOM|9f7U#)VpR4!QpKn)g`2d2jLmwi1aanvB4?y#6g zws@|l*fhiWkI7F9gQu4a3(!4Q|43fWOu16VJk39nAdRV6SI0*6P+Z2#$1x}=R+Cr0 z+vr@qjXleV!~0#-I`zv!n~)&6ML!5H-&v@6Iuk#qrPQ@|9{ys7&*`R1a3fdVgM%AlyeH zK6>4`EGb!xk0@W6d zK0E8SN}uRU5(3kvovB?cJ>{byF8kJO<3in?Pvn*XqWI|0G??#C1VuAPq!YD%ozorS zU7DY~yW`5%Vd7vJN`qc_;mor1NCkeH9TVWcV>^$uJf4-dek1kLhM=6B(u}-3g;L<* z;7wki0kf@POp}_6)c)8NTChaCqY9%b#J)H>oi|?@r|JbWNjHS^RbLhA&PoPPWAC|~ z*S_nsR>ae*x{iz9E;F0)WYu|}lSh3d!4)XDA;d`V?LnO*U;f5BW)2#{lE7Or-X0xN zcG5)&PUIPW2{%sj2fCz+5=v2_NrydRvcjrQr2g z{;sOj3z4z>LsiL-|2P!Hsf2CW3|cPzjNZbTeD7WB#+3V{fIF%gs*Al5lJ+^Nm2Z=G zGOvCGyiM6Pa2%yd*%`Ec?E2t%*JS8p*E+_|HHEk~WgU~|&H2>wEb8IZ!@7Lmw2{{7 zCI5C``?n|NRJ|UgOG;jn$2nXR#&v63^Vh)JH}Ez&Rll~ibjpzNBfE`H`kVI-T=oQSOM^ zy@NQ|tI%V0!h+)Ese9(#3jdO~b8pPRMoX#KSPmtUBAU{hj0}6CC)~jhl-7zAynks1 z5vs(WlR#c4A7o85y#;$YL%LP#=0Hq{4$U9}c3zTae`^g2Pw~h_HzQ=C-;UQ2YH-&ANhY{7Xf9hw`-_ZRgzs|`td?okp1cx@^*8Rc! zU8x%lQv}mr{;4r}ADs*y*@L|=0~_O>2HX3UW%>EpgIp3SZLbB6P3Z#X;I!-MRvl*z zX4cMc?w*|mpRTxrcP8>JnbM0pGFBhkoXQ~g%JiP`eGz6~`vot#1+~P}FC2PhV|lfF ztC2*vlC$o(KF!>^wt=XL@eBFb=RYs6Ocu>v+8N@V^hbfsGgP&*-RD)%BDAFX1?Tmy zx#5SAyU=rfk17@RMaVm`(f)hGwvj-AZ*?X2;{os`U!b)#CIc_0ufGMlGL?Q*{al^3 z5ZUwwM>!*eOT*vIcsEeoBv;zWwY#@KlfoakkkZr>h_8w1ql0~WaG*oxmdT2{XOz26 z-p&y8m{^Qu@l8{`(DLD>iCZ#UJ8qOxvVYEglwobnAYV zUUSKd{?Ja>=3SLp^6absj-OAM2E}~()wpuv6!&kR%+hxetj|$3vLy0YkIwymF*62N zmJgk1=AWYei|VKhHydCrygmDjXpVYo6^He`?d7Z;erZy#iq8N0iZ~sDex?oqC)Q-2Sh%Ppjx#b^xHIs~3 z3Ouv+hdy-ea6G{`>pjGbAc{6*4su6{;OX|5X0gD+>}2URM@oMXgi$pyW`0bbk2gEe z76FmmdFp@}0t;2=rxi>R*`weqMwV9kiG0EIHqyS4vvO@*J43UXK8A+mWc9bpNQVsf62&p6RGM>MkFB|Ad`|Hjt?P)<166&i}Hrzc!EpoBRTl( z#Af8anRFoVUtxuxt-yM%||x*MdW%T zaalz0Ddxry_I>zN^303iC2q;eGTzVuW*mn-{+$}$=hyAKL>^$02=L{GxhJU`Ili=R z3wd6JAcptT5LJE#*z8p5n&+WnMNe9bw3qdaduG-nYD*shhQXI{?4$k0Cm zEx>BBUa|%TETWR+PS`#EVKe<0Wsu9CTKeHXk%=;aPf* zQZXvp7iQh0Itb=enxHMsBu)Xuhg!G$%BTj1%YPj2J0;4xxnbRyIV&Td10FZ}_&gyy)G z6d;XLo>sh)P~VCWZ~G?_x|DZ6ai03IY%q{R=X2Ya&HBSm1w8^WC0W{H?3o-b%rmMx zd`3QkBsk#@X(wK`wCNND%%z(*&*a)3B4z>%0#7oU{<$X4E0D=& z`AhD=1z{t+ILmS z>>KzMU=cP1j|sqTLZ|@OB^O01@Njox#N5r4h!H?b89KByZsyFlgZ%IPa`3vbYwje4}{ z2-<%p;-P`LD%>YtI^`6TL0{jF^Dem7 zYweV)*BcW2xy%qKXhcMKa&K2#Z;nP3UoxuGpmSG|meG9R1|^1-_@nZ{d*sW1w{nC- zdrer-kadVfyra|DR7Pe?$4lvyJ=-T>0uVa8Xs?CGVAoS0ILeLn^eTEGJ34nlU{>;V z;@MgGCdw9XLBtSVR(0P;#qcZTW+5kJn z*G&GcuAhydY$;Ow3mLdtVF2ouQo2C&SlVZVeWULZwgPCnmf76ix0uk4>!{{7)7^@y z-)8g|cfm~ReTPX&9UOD?G%S#tX<_s5sw5E%Tsc1gLXKBpKDQTNZKj%oRlS1xWVhBp z|C#~6{mOJU^TfJdunP2DU44P(OiEX2o33oUL}nK}Qjuu_o5h}tR-4e1m+S8oV_gG9 zV`;G9RFJ|Y&spu942-T!>%>!Z?e$CNv}aMz^hM3ycAnEF{N~Dcmin7lyIatsg^tXa z^?&JftV7AGSK}XW!#*qP``z;)48!vx@><54$bT9zv0sB32m+-d&0k77;Vx5zcN zy+FT9J1J=8`x`8=}6OKPA$ zoa*2#%0C4pJW-WJp}xz3Cy2A%&rvJ;%X?HmgpmGQf27JrI^8`SR^3G36DpISYjOJkBX#X4iPdiO4TY*=xYTi{KR|%4e1G{nd5)Sw~Hv7zJDd;|Ef$_{glc0k%pNoiXHKYs=7yI>_n=yGD8B>8d)D(9fvb{PKIN z0-;Ja0|2w~$w6rGe~HdEP*u9RF(C%~W*g6HKp4oV#7!!oPv@@EBa1UP5n<6O$qj!* z_?EXMZ(N1##;fZt;MgzZyRhN+xNgC(`5m_h?w37$@czkrRm-Pyz*1$ty?LWd!I-Jk-Uh9}eyVhcEsbA53OnTR>zK^4U z8`4todo)!9Zo{$cHd8Zea9}2Vq>%-H%||*rA5498XH9sHc5)YNj`#o)ysEr$7iZr8 zR{E#y1I8b@$oPT>l+7ws(prPZH_qQ_b&EQ{nHn7{jY|yY=F-+u|NPpX4l`}$G&-8S zWNWf}JgeWFBd&p`IVX8LLkVZz2mhL6xAK1|8K9gmO0g%Le!;EO%4l3cY)B&dCf zeY5M&ScjuXx%1yz17s;}UH5RZIk5@)Oi%Z6uDv zH^gvLAJCyQhDu9uV1-8wBeXy0hstTs8?I}$5B*Bt`pLD;9Xcm7`ENXOe)Ytfn9;P* zY&7NzS+ldq>8=LGT$R;Fr=P0Dw8C;Ap$tJl1H)1&~yUZw^5e z6~GCHzht#Xwk3thLEQBpQUQb#+z0@VUyG*J;4C-uG12P5>yL#luF>eZf-th`E3DaP zSLBp*R1n3<86Wl-U|X(c9>V5#%mCN!mA(cLW&g`@Cm_Qb1eSWayi7{Ys;S6{@!FT= zrqVQ`)CrD7L%=6pI0;z+WSY>5QV)*yt+v6_rQ9-(#@Cq3ocupDeRW(^-S;)!-J+x* zCEd~`(jC&E(v5UTO9+V4AR#3UBB4Xe2r8u@p)?9eBdH+1`##^_`_Ft(nVEafJ!kK= z*IIi^lZJC_EP}z~c)~t_QFbd&+WYD@xfzKf(b>pwWXkf!N52P5*--pUMn(pX+dZ&V zg5+v@dBSk!VLXa!>>N4J;8U6vP=eOPZR_WzWlcFSC?a!jzIr3FR zS85&KvE#m%`XKS9nyRZ7OUu>HiVW`^XA7AC{-#|O(ZP(1bP%hSNf5TuzE?S0$lPV5 z7{>1O+&T98*I#k^a>eYsSCNs!^Q}_shC0RdV@op6ZchI*e*89DFW#+y7yn+WsyRuK)wrje)b`}WZX5G?gqy3S6?rRK zQoBqMt;at(5%n56@!VW5S&?V;ii-=>;$;e_&^cwQolKkn?C>W^`7cJ=jSak8&` z`A8pa`>e))WV=aF#?iT$24dI%y~<{I?}g_rj7-L_8x)sL;5%lo;Axa>obFt@`mQ&; zSI!bGJEMndkyxOi`F_349>lu|pSfH1SPd`)oC|Ae&P2Tj-J& z4u)EB)ZbJ&ms=rh^F~0KDc6>^@Y+nJc--+)?8PW<9505FKr7gA#W^>geu~Xk+E zLxZ(gf%I55L5Iq8i2A(DaafsF?y!_Ug(o<#&pY}X*0jfMzwEnmx=nTayC} z`=(4;MH7i4d1l!a;S-+50zWC?;Tu*Lzk1`<;c~%k6X^)9y^o6fWj%aY@$}dBKCIYU z2M{7qYZ!AmiuETu{3KJt-DRpm?(aM~CP8j=SgQ;mQH*+-kM=ZM0sy`Bpaye05wQ#T z1P6Ixxl2cDj@cbkWnelHCbTZ8tct*ncE?UBOu@y9*{kQ^GjeO=2;>#*1!yK`{9GqS zfs$mJduR1pJ{G1TWm&H&hj}BHvP~vFUw~x)uyNMAWUbubAV@;+M-AhezB(M4L{~9Y zT{?(llK3x|XD^-&QCmjcknZ|xoV0{tC9vj|=4C_9-Sz9#<2ODN$G^{O-2+>gF_?6%sOU3T@!ZBO8^&I(wYh(~Bfn$<~LXUGBHD;#9D;nR~>twBXNlsWs*a&Xq z#7-LL9@E!{vbsHlnu-)EfCKiozyOa&p8gV>SANSEn%M?3I=GcUt|x3v*ajJmYnv(wVDr;>Aa7P#wsgT0uZ)X4jsFzwkn;j@bf zW)J4YXW0A>w)eH0g{dWfER6`ICGTr5u7>T!XqT|uHB`98qH#AMT4Nh04OjA^l41Mb zZ(*(gv%S{{R^0f;Y8PjyY$R9kgP?#x;UMIx871aDm)QKt%C{9q;pjS?e&8z!aXM1s zrRR?1SpqtD`3jL+Z6+h(o*YwQVicQgOG7cj)^{g;V;@c?S!)#LLv^gkwpjUifMWW4H*Ft1kc%!)5V9Q^NErgzSuojYpl*JZMY%! zN;Fh14YG87>{sr|EmDOmwuLwI58s5D(S93l}wj4hDi3I@3|e$*zB*P-9gjm7{vq}k50?2NBEgQ+Zu>vQx-5Q5w) zaaC++mxFf9NSN9(5uScs)V4T~!KhxcXA#C65|I9=JYm zs2SBG)S}^7rAh?K5nm#EF$oyar18dw>7B~uj6@q_vnh*N$w*a-8+OS3U_{P^rA6RF ztJHXWsl~S^LhXw$NRPtnE6Gu5e7OLfcv+FMIC3k4S9hgt@^MfmMF~- zFm=L?z0>@kyf0WGueTSoLIEl}?HT`O){+o2$3X~KLhU{OLUj^bKoJe2YzXg@Bz%`4 zb8!H63(%WHyq5+y(pj1s8!Q~}v^oV;G@$(cC_9a@8QM)Lxi`tduJRh|L_UPCNH;D`DtWb2HtB?iP zmN=cq0QQ?xZ-AnePs8K8CTQHVpHbT{;lXMCzCo(;-6JE2eb1L+(9%3O%#Q|7LjCx$ z;&(S=_$K!0tOULQCd#op?4-Qxq6LsQbYtbh+n33%1^>|;Z`?hL3HtMg$MHM65h!^r zc7Ds3tM_2mOJciSTLynH+C{d`VW{9PksXmJB_2&pBYrYmNW_SpVpCFu?@dP`T%ou+ zEX-S!6IhsDph0EuKxw3UZDzZ%VH#Wh{bXDh6(L^O6CF~8L>jIq(-W{wwyv{wnMR#x z3ndxU3q-wJ>F&Z7cRTJ{l^kK=X*|=sM&Tc-FTRCT`UX@D@`esQl+ zkQVpHE0&v=^edKkY??nNLhSlj)z!^&IIFYqns0)Fh8j~1U0{Uz8rE1dTxIPcKm7&j zz(O_>ZY_@cA;b8UQw4v9S7R2ox~Mp!kvAtswiz3YOe<_% z3$F697mK8>6jsdr{gRcbHNO|zznX2`U=bC@lkpyW& zE&2&ZlRlP~5FxQ{?`Eot?uD|^!u6>w!3P7)v$7`g1sJ#NZ6&i~sNFSm{6F>@o8{eV zPKvfTZB~qwtWjGXwU{V6GH+~V5KCmlRpP_jR@EUICW?-_a-TV$HdaCgg6%V4sx?h= zB`0qI1&^(O0jV$#u|XP~%~FPXgkMduDZWzc^?U*Me=Lhu z%<|c|UF%cKA1*mD!;wXr-kc)%Bxup7XYpUnBE&LWa-QoY(ddD&CRea{ER{t5^JpN= zX0RNxg8p~#1y6fhj-O%rqsPG4+ zxycVfh!F+7xZTDalcr|9go>20;=AbwfXYQ^>V*-RaXVWzG`n$byc{{fdP9buTYG4@ z6&9pM8A6?AE`z0#b=%zQhx*MNH1vZqS6QsbCD@81hSDr>;s#5k6x=Kc3{=G7HPO6vcmGz)W@Ijh6 z2A+%U$deEvHRG zuPoDU@8$c=%{W{faAGsbVF|J+Fwu;8n|1+9%vQ!xABS;QOe5j_vgM$6I5LuO>%Mj8 zfB@tAo!KhvFq)|2C9&knqlaDiSH-y5u>MGg=s$q!$?`#hSA9>8EQ`HV&oFk{+KSJ1 zUz$_ZnOD&F;qyiM%kY7P;-K?aF`vtvbxinrr|Fim(>-@*$LNx!HfPRz%BGJme-6t@Op(J;+WD6tG`1Vudwb$7 z6Qe}U5WPVP;q&iciuePIAn$szkZK8{w0XsTxIcL%AV6Z~B7&*MQC~_FRaAJqObN*& z$ZtA(-$$-oH9_zROTqB6dliq(oz-6O0JTTqs=4b6&ude93PTvxCM7xjw5RvUj!Xj9 z;ld3Yn9Q>pUw0xLR<*|ju#EgL6|bWAjr>+`n0qMmk2&S;gHP04q;b@<9YSf#9B%}1 z-s>fQm!CF_OflR^1q?7i(DS>9qskm;Lg1Dm|Amz~Q@hJGZs&n*L>Ym7m)SVF)^of3yR%`H6 zz{94CeU@}5xF{@uQO#KN(?`<-pJK-8G4B!1{uNqvvVd=t!G$W{k#_8#XyrxG@5O&S zPgx3X5vs8l0H8;O2>oW$)>Tbp$Ymdwq?bf5mxN z!M~vs`aAvaNK@5z+lcI*JpcD_3&YJx-$qaV5`Q;?&B-o1dbcL2!J|MvU z@Mg>=Dx0~}9#469#&@rfzvQ2X!M|@$a;E4+8ssj1q>*DKrOp=ws~k;@3A9vOyXstV z;*%a>{^wgW8u`3b(#g{{W-8{khplkY^GiUgy{1~dB2s)kW$fQO2wQw?t1X74$Jz*L zai~sd5TZPoRlT~v`1LC{)R^)wsl7?9eA1>ZmIBt^HH+1=AFSd;yWQxY;vM{R!qv8y zJO8jy3i!NW@B816d=87Z3G9;edy0-2iINx!dI?U;q#oc9v7VCo`*!2fT^SyxMnvwE zuXnUkXCD9L`!4S{^sr`BP5{nQKIbdpoqr;FDwuGZcAN9K?a{TJIoy1k3$-Oxv3e|_ z1mi4XXZ_~4z@MUSH%9nEI>PT_o(m&&_iEIj?%@6{yVPB|_M$uAGO6h~YNyBf1P1fq z7#HTQ<0#Tl78EPt_uo1-_xUHmi_qg-{kP1GZk}*Bs5n)fXOn#9@w@PmrOpxcHe6$= z%~6xBirQ~-FtH;SsPFOOT?j-e2`R@6q22KL>cb>>11fsMo`BpnZMO2%!Ypb+o*FIj z=e3BM-d#uytvCTo+r*xHgE!m%ePhOJrOaab*YZ1m?U(1m7V9pG>l0$$m>#BQ;izrD z_g@L77$covw^8e{GEOVy6`^j416nap6l_8_%=ke6b9%bHoy_~9k&rF?C;}bJ@eZLC@b@r$6NC`t)f|a86)jv`(WZzcabr zNP%9&uLM3cgM4T3L+Kfs* zh3qvNony@>KK+)%bLKzJuTTdnWf|fCGCE%GP>uQb$1CLIE7`ZP;7IZ~=yx;L2Hj)m z7oEz*JNPB?;%B|#Td(;Mt^58ZAb55Y76-AP`d;G1vE9$)!SPr$`@T(lEcKGd+twR( zD`2n>r%*29JNF9QVJLUQS`00Uz#(-@H%?Axc`vjm;;vUNH8^H6?b?{GPiI2P#mT+} z0x_rN3galwu?ZdKUz6ubXofc|F%NJv6GUHs*UUkgJA<$>iR_}5dW0SNy^exJ?=T<`&G~W{5)N6CVLxVnfn>G% z@*B-W)IUpdI7L6jBt>UQkW6OuRC*Ox1kIxuk)3D=Ai4r9Jv1q}k{-JpnLt`9S&e zFecFwd&~eH3`G(Va+85JEuk>WsAAHXfRd*)Hq~|qA-E)nU`7d8XlY@PAd==njc)nl z=k~La*>Nhk?Rso1O>rD*ggX&D+Gyo7rW7;wh*4;nb`w^xad5KPW$2-qcQ*`sjn_=o z+||(_N_%W91gfC2-q*0bvf-){cX@^nL?$>tRD1HjI3yK%Ady51{c0~0gtQUvE|I9> z_+|Y9mCCQRx-Bqgl_vvZpW(zV_y2g~EEhvLJY+;C;w*Wk)@aX@&}bp2ESdeI_{QMMDy4=WYa zY<0lv@ZMS|hx+QFq%xUC-&OQsKMoQt?kFH_A$aDs+55Y-;sSNF*o|s{B?6bt2}P3N zq`o0xC@)2$LF{VNksY(8(ZO_xP#SGDfol}dQ^!`U#RIC0#&;vyP5yejtqxeC)6D$O zi?b>8h_)mW%9}K!{g54h=@A zXeaG_!*b&XrxBI)@M(DBS+tyy`{pJO?j}2U|4uI6yxs52@P1Ut2`-U&e;bS+yjzBk z&ZR7>*cmi@uJt9!(JX79TfKke{+|FO{1UUuT37hUKRW>!AObqHHPT-@W2E4e}li#`?o0WvhFn3i{bb^ik#=Q ze{cnCd+9Ul5Hof(dL?d{H==+gBHdYuebdD&emIsq<+e9UobZpmefE)&04BH{^83_g z!4{a64tuMRmfpYM%ZtHB77%#PL_e$X8#X#bOobbinwArtG5UO(dfl5OV~)K|30jXH3(O3Y;=7CnnLu;9Wk`KpCXr&#c60novX}Gc=4d!6@@yONX7g#R5z}nSVY7w1R;Yo#=GjnIo4;e1^aUf&AB*&E!$(~c-vz~N1C3E1wC=@i z6RzxDk_;_yDf$|7QX0a=6)yg|On&Ic;#(_a!S&}hV}_)j-A6xCceCOjbp6a1aWlR< zKdaXHTFcSXx_|af?CPZ2aNX|Ho|?3OVVJwjCX)X-RiYW)viE*G!9wUhLR9_+xxmSQ2Z1WlKxrwz>^bxPP%`pN#iaY{Y!__yj=ZiQn>$(@vo?CT6XLy2 zhioE2CKmyxr%6LLud6$KNl6Q97-dlg6eOJ8`THq`&IS};wcw#d5d^0!%2e;Q(iuSg ze3eZwd#jY{t-9mU_aOF0=BwNVi#B*5oO@mcIM5;C9d?gsSZA9cG(QoBCqP+Cf4hx?OpA$!r)s;hBLy;m*XG(b4MaN=s>-IAv-m58tBtcIXBgX9Y z03hP+BxAN)PvThd18R02&GS>g#q_j(#?o}(D)b3km&C!luL`zrghP|=!F5R|NVb>) zpPulqN;Q~MMEwQaO;>x;)mJjKJ05s&+HsyDgjXdNrrO{3SovFE#14(n2Uy=m3ST=z z4h)ICLs4PGf`1V^-L}wxIBMU!BUmFcz z0G9jG%Iy&0o8*-=3%SwnsN^46|TXCWNG-Y?rWPXS{tsiRK z;DOz`m6@9txFXjsZFHtNy1;wWmgm<=BL7ji6y~tIa3SIBHA)cDJTHAw{%yX0)<6fl z02h5nfmC-73}Pt<4rVesNIXjd~^sYF%x91SHZP-mY{8k0_f8qNI~=!Aht=;2=zLpO`h8AIpPQm-^60t5 z1$9dfybRZDpJ92`azz-eU1s|Cn=F>D<)@uNzG3O?eW4HAd;x6Vt;;icBV6}es6tQ` zF>P*|OpfEd_7dfj=%04hTUv2{S*4g{AC$Lv3!0seOn4?;%A2T&(eTimvmWoAGkL)- z^?u^-X+X=KlMzX19O!>6ey-&CHhx>8c4Fm9~>QIi9@UcJ%)?T=LD+v~BK;o8Sgd#rqq$ z$E*pPz8WbZAA4W4m8HJ@u_$F__;l7+=>1V%A%EAI(IwJJXFS|B2n2>Nc z^n1xum-s&hY+|Nd7ju$XT<*$r-NfF8hXFYeNfi}01%H1BvGFAZ*LTQ*(+{B#zsz>? z-5a6~3nd}E^XKEEaa$>m0TmXLxH@cUsR?~@EuZzDAx#gwe{3+ae>GBNk7*-|BAPgL z!;~r7Hq^LnfFdj|{+$SDT1V!+`#%_Gu{LD*SokhFs>UwBKeZq8V+(n}J>Z2iBf|%~Ie>1NI+hkN54@hl zE=oEDWZe|XSf;M!cU0ofJNqP*`{}Z*G$Iiq3S*m*Y<^niq65F_01<8F9&Is#$F`)Z zh8qpz!UGBp)yf)|b))*l^C(6iGMP!yNCDetW%)n4jnFZY>Rzo%bkquRZ=63}wh{jd(vCHi1<>KA#br ze*nhq$op?==g5@a9%$~sXx5Gj_rH-$d6eS1heu>_Q@XhaIlv+bziCXjd}xT>L57Tr z1FYituw&qrVa)H|T+GXAj<|I2C8BHex}_@M+7?UOTtMGq8DNw=WWj|| zM&QcUU>-}m>v(G)%{W_gqE=hkXcwq*CBOJXq4vHed`?cH8BB$Hn1>Huj@tZfoUJCC(-zjw3qvo(@5r%)8i*_C!0f{MczmTmuin@e56a zVn+<%T4v&vo|UH2q9|hiaPm>}=r73=LE_D!|D!ZqDej_Lp#V5o5$hY-!Yw6li@kg; zVz))ItG6S;?p`{$3VU&glN*wOT7p(1gghc2?a6D)$JEPbo9ar!F@D6bTB|h3BY_gE zrqL}5!_+k9VTQr`z8m&*}Pt-}qnYL-vd76j^RYi~Gi!*iH zHag|K0lET#YZY13XVoE@xDKNRkrX@biFJuM!G7RFrqRX^CNustSHvi|**3W$68D8M zXahkC<2*=FMe4y&Bi-_57{BIQK}i2cIU#d*ahblDh?n=Qj zPManDw%hw^HtV1ayg=x+iMx~8Np_7B8xjwht8U8~`mLwueYtv6TFi&L<08!;X4=(- zRic-Q6xnP)m>xDR%PHxH`7kQ+f8jDKb|4&9OU_Hq8k>LhqOQ8v~yI2mUG}Pid(iAqJE;o@B*bbxJ70W-Ot<-V z)X0~UQ3j81st8X_P`5D48n|tcTasTiii-!<;rp4D5TU9zd&?)a_?2xZLiW_^s#M(N zq!6N_Mc>HCg?;{ug9*yoHj_ZtUp%)nJ!x#>6|=UE+XjUtIayOUn(2B1Oqk}b2x->j z`=qX5V>vQZ`l?#pg;Y+nCL{wKn{|uXoIAv;Y5w|Q9+cZ3GtB3z-+(*9KSnG(mKo_j zGsA;N>+Qx9d12gMS%DGa>U#Hh8G^Ix`-qnC-g*vHOMnJgAw5lVqL0p%medADhma;d z%UJVTDA2C`4XBI1%WuxH)6MQj+;Jw)G_?RJrO}a2#G4%UUS9PGMpGf<+=$>pEm5vO!bc3MhN zZwVa@Cl5&7ZsHtpf6*XqD{Gk&T_oq~4F8XuQ9IFu>9P6#!Ib2m-X!Vk45K)nYhUcl zZYM@Z9H!q=QHUo|2qSOfavh6G(hj(S5F{jD<8*1n==bAvhOYb0wfO2n`tWIItk=Ef9%w|)E2i8ubT4RIHX_XKhN2CBtJ{wd^@yG;MwbkLh z`_HO^{G~;WkT>eHO-h(IedNKDG2d^MB!D#v|J(Iqo658UpBNzY-q)%GD+h>p^K$Eb z5^aAMj-?uh>x81#XzyN=1Ze*_j$z0SJ)&aMKbf1f*g;Wgbq~br_#vKmkQ1DQ6O7z# z_eO@Jo;jR#58IIa5_$O&Cr`_{C@{?oMF=NH<#}?dsD-v$j&n$^;C4d zCQ@zGV5&ym(&*%8jPG=h9hWH>7RWF6zly_r)((wwFbHdkFJ@V`h@}nX?GKyDO{%CG zoVP;?cawzITTN6G%2vLO%X9HJefayLfftzh;=<5rv$}v=*zV98YL!O^2sRp~WSC*wRrqfe%+kd>* z#_T!!!9AUgk0IB=X4+DB6?b*b39JW!tTUIVRImaqGl#+L9tno-6MPyMj8@+}qgIC|)jJ3zBz=vLu52Tuodhbj->KcPMA%>lcRXXT%Lgd#4% zMJy_h-{r`DLz+Xb^k+&w?CQB49_3HO$Y=ymx{Y@i}NXqY<`3?+^5erPmKA?Z~)KnM1Ihp ztWC}VZENR`y>YE&0dIcTRiYZE>-vCm5X>Q26q_ZZC>DdZtYfjkZ`ca-&rc>1ASO+c z*Z0`O=P`SLZ&(}V+rT3)*${7bk`QLGY%jm)-!Mjm+G>^(j4L>|5vU`t3=clq@asxs zSi@q(z1C_J7OAz-V@XEV(I=Ltbx9isD}?7q-k z14z~l;v{ovM*r@;OIl8*71LH-zpy0V={`$>j}wiW)5ghg<$e*PKz=@Q)4Z{P(zW!u z#?>=Bbznuaq7;_uO8mV{Hf_G_Up_cdPgi(Pe?{TdrZB)@y%{J^+ei_^6&nP=2tL*> zbFdi(nZ7+w|2>D)^67x=yxYos!pgCl<7sRx`<&8PW^e&OZV@GQlbUX^Cs;Q&i*<-X ziEnR{E7etWDGbDmU9bl9-n<6Hs)XF zTUP!wy55!;-HHucr^l>~HD0#hi?X$udK$f^8AR537XiS$!?1&km;w4HSZXCfl^bj* zQp`e{D4YrfsbqAD&%J>*;-0QIeKP2`xT-@Hro9a@RM^56-XH*K<}%A5Oa_L#PRxFN<%fTuYWlo|I* z!CtsnTkY=q6{JL2%*Ne$BjH* znt$?M8o0j|zWnvqcj3#tXS1xaT?ly2ZO-{?*IU>2Re^83QHHha{f8SghkbI^6Q~(A zCiVj^AYQGZil_KZ5B)e@7q1Hc=UYFR2H!d;>VA|l%^_n?-#C(;YcSt^TvM?)v*J{t z4jV}@sxv>6@q80A)ZD(883)3S+@oLeA3unNaNmoGAClyOm^E&UB3|_lse8ne#%TJ``~h_nZL|q!c3u4_~h;-s_KceA=r+Kz+sk^NhZ~2uA&Gbm7N+<8LZ5dWZ57i*C|xt`tIJe#(AyMZ>qD#oWlYEm6>>(#kfvaXZ9l|30A^Yaf{o&v>2uwJF0e$X?b@C~q34zoA|7aXV!TFQV0v6yOx4|) zbhIC>{WKcxwj~4V$N!Wnc?AaOIMNctPNL>nR~Kw?E+9I2?QBB6`)BX@*EvM5Mqb+e zDeyh2;#W1NvoDSoodjxQ!^uG(OL8yPB7okP#5m?I0Z6?2mIH|!UGi*xjN0|!}gd_*m6r0 z=O6C8Il$}fE}b31c@Oqs&8fhsNtZphVn==R{Vp47MIXk=dr2$Fn`4hv9dOIMBk?bh z1vJeem~uIl$4B3oCRKxuvMJgFny;)dX5<*XQ|746dh}T; zvGkQ`%#1!fS7}qkqiQ}Bo$IW5RdfJxxNA0Y($GPFkoB3lPtil&UpA)ZLJBhlhn=;J z4n<7M?sePo;Q^4cXBGD0*E!9sjO;a~(XuF`~rq(hS%% z1HV-wkfyO2d5E2mk*Cv`z&zF8YY7khTc6bYITB z(eK?%p04fb5>gCHj9#)2leh#DO90a){o1}lF60S~!xI7(Y4?WC{$-_QYZx@}?UL2V zlb#<1IyC)eyaay+cYcTW7IGe^(jWC)1S#!jijEch+mzWmr?^)U2=LsSH{sJ|(;*ZI z_Pj_s7HzNH2Xc&w4AFyOVt6F91ncVP)5hOLhlZvwlf@&;O^Q(fmzGP&0KmYYNOTDE= z_U|ffM2?xY6qsqcY(xOs@Lhugy&tNFq1*4lf%!+P|8J|aA@%*lc(%I?U7Q4Xeq*m6 z*=&E@&m@WtX1rezzc<8q*k4_xq;*;4?C1T)BHgOL_is$=?ee{y!uuAv1YU^%KBO~M ziWQ!%+!umrZsn8p``&5uX0Q;jE$N^M(O!}k)0XC7_>a^7H53DoNrXo6t=Bo^$D`6m zIwSZCckS83Gn%tsJDYwIqc5TKmuE0on~0ER*~<2F?Jgic{wUpIJA!|9&xL&$1a^Bp zF02o(!fK=DAUe#K;>J%gFYNqyb&F5Nfa1QvP_eii^y>e33j>70evnMBeSS4qb^oOG zD?hU1?;v~sKwoPooRb0fNH=Tpxpevy-#13M`)V%N^RIpyiC&KC*;#uoF@|3{qm$I2 z-CNI&o~qdEh(@J-5j33NM|z42av!@;zJys4tP(i>W7b( zru~u$AwR%BDllFUGM@8E^q&~T<(mvSLM&<2)7h`6E0Odt@%qa6=fL!6&EyMf`+>47 zk2k(O`M=l(7RftV(upwSBIb)4W`?U!GK`{FJTkyQGj`Ym!5QR~0fvG0%5sbkREf1F zKy*bY2s(MLaklpvN%eMaVhubELq%sF1mcq5MKL`&iw@Vd9`V%_=VN$^uMcf?#n5O% z8gS`mMEqZkmB;a+x=LZeRLA;Bo#dulMn>B4MSOuz^DQ+KpwWYhU|lc9S~FNqsCJr^ zHpbqXGx`8-c&YF*fbwI%D_EKv-XZNPLy2~9S&T?Oy^T<@B{4W-joDa?fmH*Twx4EMl}oD*^S zo3Sk>vm5rPr~O)+eMYM)YWUzQ$cD0&bn>U>RlFF*VFaT(!(xO=FGl0np}gw#-aYLPR8=4NL58iF$QfY43v9WyhMNON5!!;#YpmhPj=k^15b{B8GK?g zICmB^G2TK4P|*3>!9wjzC1Qv(tptE{t<@332=q|M(H;C0t6=+jh=xopu6_P}IvX#P z7YsVbst}IQe5j_^?%_xo2SZzE+!{j>FUEg$_SVA?yo|t7>GY{;29_=-1p3%tgTWSi zcy2V^CwF@P7KkR@zRWP(e8>20kTn%L*vpe)4qKJIqr!FQgUhBy+XHT$X?tn1}#aCrX{fZ zv6Z}E$07iQ_GGVUg?y9d>m*l8-7fK}I6NJDI{O>#ySseHtRj&nIcB(cG+c(ypT902 zW`t${t@}~1O5S|$FHYX9eB*2{=&tGU@6J!_hTfy|MV);n|DL~(q~7ncXqVg$HEcfa zvJ3RisB8^K*DrC8j)hkd)DseLH>mk(T^5_Q9tco?Dz~>P5!sKz=tjBn`0bx|(*pbz za=8TS3)@%pMzYW@{MQ0;FVVeq;lD8u|G)VGoj5(E1L^fdUk#dD?!_lE zbV1-i`fA3oXmvz|Z|coJUxyMK;B7xwg(%M zQQoIuJWp6;GF|j%e7?(k8v4-rY~3)}_-yrq?IktaCwuf9@26A`X+QC8Zt8rArapRJ zI6qW>kxmGL_as9a&P60eq|EJNtu-6mslv;r}!S>M;B+u zw7$FgdGtH7Buc%b9N-Kt)PnpcuHm@uVul@ z+2@MZpM9!%H(mxi#iYW6hJXY2fiR^fRGbw{%A}m=SAr%`)j}J-cncW}dD-f9z^D<@ z^G8%inZC$n-(!Phn^iCx&XKtp{alj=2>epAIC8^Gc}i+N+W3uNv@GD6wFw#(5o2B@_ZXgu3K z{FgyNo?WI2j8vRTkmIfpBsLiD;fe2c5ifa1TQ*+@H1s{j1X84j9SbyjOzbP$N@ZXB zoJ2$L@edsNOK3!cm{&FO~SOSuBNFEXV1c zM(r!LxdiuGBII;gO8TJrul*+V>GkA36YxRr;D5UYmE7dsH%YO5SxrFj8jWj|W?P<( zXMVOmEP7yo-wI%l9B&*YJzmZVC@slIj53B`jd_qh$Go$IL2mdEj!bgeJDt zZ4DoNQrRo3F6dynT~3y+WB^xLWJkZ>NmnB@`YAc+$_edBvS*TDL+qSkK0-9*#s_$2(60ud(B`1yFnqlj z`0BR;8slEK7wi~64Q_2^p*$yIdg9bB7xXaiIX=~F(8PAj@U{EI5m&y*JD@++@9MOr z-+4MzArR86wNTl{EIPDjPv)O?3rM2odv2ayj6-~M*nhO%c19$0w@am9(USfpC@4o7 z1R<;0Ti)vFyz;u~Zop{#gE5g%Pdui4vwO@lwzU5lvoDx3G1Sz_S7|Yspp8Pl|D>|S z9_#AEY8W&Wq4*X?uSM{%bt#Yr$joe5=HJBGt-xA&%d`RM?3$1`qGRW?Bj0@G8ZuQP z+X160fyS6?Z{pLgqv6>)oX$WZq!F6O4u7l5;emKR;Hx6?Ee(M>)lf#E=t@Ccz6az>A-!G=rfyuK zodAP;1X&#G$=07mTgQKVbBjqif9rnZd)=yUfj8R2Kk_a`oL8Lw3OF81i7s({(N7~+ ziLmsH*MfEVCx9*vpE^sDqkJms+LfMkb~)Gs>G$w1F&OnJNh&Tl7jUrhaRQZdeD8zd zNSfJ9h>N}~rRw_f9TaE54|FHYNzom`Z`;>(4Typ%XUY#Y!}i*C_*SiB;F?+w`|`hO zfzTNh*;d;>&bU)?87fAT#P@=1JH%DMO6S_>-!T%(d-yuKMkGgkG*AYVr{;ub+*Pa{&}Iw z!q0E8WX(!<^i|+}vV-)0E{A<9)Ey@3`0Sgp{HQOU2mFj?cRZd@ z+pao`=C{un*zFRV?ljKce)7gWJLY4n80A4LGKpa4;QkpVST&86`Cn?e>ROYnPCzvq zgKqc`UaC4d@%#<*^=h|`SJvdZ-^4?8>aY+~Y%&!sBG|3?3T6^?wr=*ip>FQxWFo$L zU-yHTqmjRero;8yd=is{|6n0QxUyJvr^F9)>o-KLMQe6=P3Nj{qP5DTJT`g9W@8qD ziIhXPLK+9^t26@Ta_&z}u%ehrUb;Ddw*FFP`J$wZ3iq#&!Y`n4&<8(c!~fSEfx_r* zkgNVZx4>-4IwfljlWNwFXrpaSpAUR9?W9%)noBcVvSWuYqIu#bQJEv{sai{UCbvfE z>zoE%4j)%TsoptJjq4RBam6se!-t?o%9+xQ21keC&6d)^ey94aROmT$>>>$)K^6qn z-0^wROajd^VHZ_3v9jX>-sLF}1VtULV_sc}0GRf@`;GXVWr^DVL+;X;HMx(e>J8Wd)w< zh+UTNGK8J;nFpzYH7bY8jzC+Zp8aCn)+7yJ`i?u<;&NEbE~SDdztC+N3>yQsR56a> zn?1Tdu0tColD@bs7{4>}VMdF6Sm#JE^xSnn$-zcB9|icozF%!2ft1gYo&M;>TNvS& z+;O=>B;|>NM5VoamQZm=iC$%TC%GjUlgTqXrq7xjY+VIhPae|lzMWDF`_*Vio*8t6 zs)>F5cIml7n10Rkl7bnx5n!dFh=S2lkH6|2>1ysmy+iUT4Fitg7q0eqhC2h^-R8pUP=yOJCi#sb(Ct^QK}^ELhr7sEfh z!8PSWVr-~pd!_bvWixp8v=qDV@0-##j=EkvOB8T@{I@U?)@DRG;>%(a)pxe;J$K7F>~Td)K0u zKceDAUU0Z{_w1p;fjWis-zr$x|_%L8RO08u)2~vy<8C zGk~kDGC&)gkhO#1zf{eMAfId4J`FHN)7yAYaO!-+jP#3omVsY!eMYTg$ z#JkOVf-q#VwhyIATwD~v(ds~iA2c@n@pfJ?p}->=-Cx^SRwD~P7J|<0XxO@5Mvh7f z`B@`Quq!tswxVgz?lS&P$2Z+FeRMu(RP+2bU4;5fzs0w-cn8m&w~<(o)L}Xjpi)i> z{lc5gL?;KCu({cA;qBs#@4fUPt(s`O1d*8j?@M7xv3 zy~w{OlEVrt10O>4aAP5TPh417f3!-ApY8A$LhB3TAIjkC|MLn$hykWb@c(i39q?R! z-{WRh=G)B57BW)y%9fo9*@T8{-uBKcDuuEtib`hLD}=I&WaMq{@wWH+pU3CBe*f3Y z>-~&-@4086bD!tj2f05lm4Ri91KrmWGQ7PPv2BeZcdsIOs5^WfY3T2a8Vl6LS&ECy z`+d@Bl>a6?e)MTcz2uaKFnl&aHQoq$5sHsDtQQ_^Ss24azqqcPSM|lKu;mP-V>I|8 zusfGt^!#ze1X21ed=JwjZ^|6Cn^J0j+xdgIOiEmWAohAQ81K^GwsKn_UUhjtHs^dA zE%^3a7^EeF_+X;#A#lcWC$=Cj#6P@#cLvzbyG}{bp)ppq3ImjJZfFzIM}Hj)nk3wIJ*|h@ooZ&x2P$N_Tj! zbl(P-0N>adZR{v#giZDE;sBB9H{{vTH{{uoy4g^{^EiAxeiGxV)-H{^+0#`G_~iH~a$=64G<@ z!<82g^vwGSx{YCb{DtLD@X|1axTq7Jc0Gc5%fH7&4S_Kk$YS$h(>0_!VFjXhr#AgAYe3A5+X6K7{qMa~_{gpXCpUb}&+%K};hA%PP_`|=FT3@?z z?&2T)yLrpm_>Xq$41#9cGAU{g=ElBzdob?q))=U`x+QNbH^%Q@*{dak&u4ziDX_Oszz4OTyrlfITBgPId9ITv70WXC&hd+G*LxdZ1;!-p z9)1IxAaQy2_P-wU)ftqX3k^33!g-cMBk8u4xttGZ$n7?+A^XLqMKh!ye3(d;JdM19 z%>3)b9-K@;F!OY0gp5|zWq-8Kl=g>q62I1=3c5QJFdFB(u=${4KOV6(LWOw`J?Jl*S&c`OUl~uOPf9UM2bsi z2D6O6XuuOW^9!#uRc@2qWL-6#w8cLpxmu%C0$;RE>>9hJ)*WEbTyF|7|{ zLDwktU7li&?`KjR@D2oibq-B&V<#E#;C3GWfLE)4yN(+Rj}d-0{s3F}$geP%agm@# zwf^rNpIV0Ggx2^gV>prpSD+rFAd5#s_MbPCn{@PxSE4sJi)hT9zG;}hf0J;fJcpsGQY7c6m;gKwy_nYY$@KkK z;VCVPkA=1w%<$@LjJ#K?x}?y0I0SKD`G!bB{A`WQ%A}|VF?$Tv$gCYticS%(@rT(g zcKAdEGo{79K2h=P?uv-lVjqFJ|Cy!&Q`6QFa~0d_Y^oA=dO;i45&Rx9iM~P)6?$?#0B_yvUv(7l&=xUM~Fn z9oPD$713a&{O|j9;R3~To>qmj@R)`R)yMy!Z)(K+I1Eo>3Muv=OEG1E7nj2$yAXiA z*}r`x5p?G0zis*+Y_dPt=36@77WU8WXd%Qyg`O(%Z-_M`^41FDuS&Pw%G1fJct!}H zg&BMLf<>B*WKr4j_aw34^rKjat&e`I1(ZDZ60MuFQSxOyQ~6{U1@kzI4Y==_5O-5~ zaO9PvzMg97d|Jo{q1dL22QT)@i*kZhyovr;{zZ+(D{;uv{+y36sxT2%ME-YWBLjYTH%-3iv zOkCUE{b`UP_on{FPC|w~_gtI zZ=29^l)qwX?ua7~T!lZ_eU_y2mPMX`AL7CG-7`O=G54RpBZmBQ z|E4~uQ~DsI9!Uz%EBJoo@X;i^)X1)9(Tpt+dhPGq2w&u6Pft8vFF0OENDyoZJ`|}t z!W?g{F4P^21Rs5sK^3l4Le(>QA z?ONIKK}+yXa^0c5!eQI-PV(HE$T7z1Xkz5(kp1{@BtMEV=N{M0?#9gAde%f?TK<_M zncx6(NyekTMh*LAX&)rmd)yOkOIB~12Psr+PInAY+2*f!UaiIMo- z?XKfWU%uvrjH&3cwO;kN2YpPV(N^P`KSewKChl~Kp6?s0q*goqcQ-ff)VGPpf8R>? z6*{fg-Ahr-H^XnCT>cPoy6V*ALEpKgzh4f$+x27ZYdd~Nq3xApm%6jFPkjq&U--sD zFBXti=0e}Mgr^u_UaIk;ci(|#ysYkdHo-{x$o6v{`8srLs&N2Irm@>!?P;SGdlKPm zjf)ocwOQr&-8}bqS-&l%^7soU^i{U}aIa}qRCC+sDRUPH?Zv-iv@%7VpWL`f zF4sjh6x3_`B_pHu>j*mUCBcY!;j&=KHva+ZH_!C-0x{pUq@r{)2||mJZL%ZLm*`LU zL6w2VcP;H|ZA@IksYF}lXNoTPcCC#V4&C#|P;AgP?v*>4o({+wT28|fedPL@6V{Ou za7f+lNSjt#W59cqx{nRCFV1MGvnxMjo!ko8nd}Izk{F;3$ci*8+aFtzjos%9Uy6#! zd}HElma7{(f#0;{vR&%ilv%p;d|G@-(J!QEY@-~nOJta6(q%#RIc#5h^2r!` zK=uC4r6cLI>4eRVg@V50n=^Cb(+e4j?QIu>f_|qeWZqU#3*6dRVRG4Ro13sYI%u;} zJl@{e%$%^wKi=GQTQ11VT}?#qZuYGo%uKnTiE1mTJIvAlIY(W=(Ped9fwQ*G>1Cc*{10J!!qJW7b-JD1Iz={BcH_~xb#K>~f86$jdNQptjgE1#d&}#6buL6KM{>bJ z3yx*Sen)xzazQ#H_FR{D&MQ|oV5pD)cFTw0cO9S-dqH!uCR?>MG-WTn)f zU_wf2?|jR{)7{?YK62(_dzV!Dtms+fC?_YPWAE(fdHd`|3DFB;BILMeDD`UpT+pF*ZKNx$|HFAtGlONylr=40q5;;`N z96w$<4(>b@=*lv0E=BKZ(j816Eg#>PJ=m+N+g({--Z8FZ8KFQ|ON|7jleus#AC>2? zx<`l{mhuPqj~zc4u9HjJEH3QC?^FUut%-{m5Jc`!#LY z?|8%7F*Ggk;BTKN1jW9CRmy^+)m3x>N5FyNri)^rE_=dWa1eZ;h z5lr6l-o#37p(`UUnSm*b7q-ra<{0I!*rkw1@u*KY=I1)d2k*A3o2 zyq{CScxtWX+Hv<0@n!<=fqudL0{y@;{g%J0nlp`?nBdhjKhFE#JD%I*KTN3em+y4W zKWwbK@nnl~lUR@C^$!JuqQl|RiQ{UAKFSprul?n@fa~dX0rGG5cSg2j7*`TDb4m|` zj{PXMu1`oa^cn zRY{()nt6VwtU3H(=!Ua}hUicBj4~#MPWfTmyE)PupmmB0L;9Oc@m2BV`csAr(G#Dfw%5+d=Wgw_)cNc-=JFnm6*xW$Qj|JZd(dSu zFjRLuWu3pei=fqS? z^14&-i&4MbskRZxd)LGtsRVrrtNe)ZQ7Cw|qvu~8$G&VXD|)k_Fs)p??ybrpmZF_cINhbTmDxGOMbRy%&OfS4Kh0l} zPdMsbSDk-IL1y{H`Qh}D{R){Y@~b5QpZg*Uma%se%oY`X{K4!8*&dVR;f*Z?rAz;? z_#}7ti(H%g_NR}Q`m=3^oGV*9?LF?*;c;w(3lF63p-j4NDq1L8<9)2(rO$E~4ZS`Z z#M%)>n^G_EcqFX=eUp(=4!26l-=P01!Hv*v;S#EpdVbeBx4d~0U4^0G%c%}C)A^WUYPH919T#}YlC+qR8GL6l4L#crq4&p zU!CI&vee73+AK&naETf9hgN+y{@9XIiITDW3=$R7zKw6DfzJA#qECq`i70R>>8{6d z2o*g;euLP*qjfd zVkhDa^$4ssr$dZNnIJ(s9>v}^^s}rpp%En`xNVl=q`A=?fxQCl#7ktTk|vVF0A7a} zg6Ee|C908wet0EHOo8~dB5jr~W3H5UUOiu|QclQ>F&z&<+Cmx!Uq+iYBuHMYFcF95URgy5;)*Kq`ffk`1W&gOfo9KKWCzrODE>3V(3*RP6oTfQ0quM1bUCJR8Gln^d2|2V!bTW&$qaobNy&1zZr*ZmqTx z89;wa;&qOcPe>WHN62j!RtccrIe4S`H7PRs`gp)Y?*~{-7{(LpgH@;Q!XF_64zSc_ zW>o!Z>ajCZX%fPnbH#HA<#`G1sAblT)UN~%p{Rug56L7S-rNE{Q8H`47eKXjpzbXd zyy4TG9W3il*i5W)Ft^7sS5*Ran}o!&qCD;1Ij%Oj4_>1{}d?jU*iJK_#NK9p%Kn@C{k)McZFX@vhC)1WYf(3_d&=TLS>)9w?;l|;7O zYG#U>Wxw0bfNxUB?P2n0hXis8M3keGH5dI@1^ZGNDkayQZ;5H#c7;#GTAPcxG}A4t zP-BLu1|Ek@^Sbc%z<>JUp4-3RA|c6y>e0!gv5z^Qgy|oz;rQJTa?|!KT2yCPX7!WT zMe|aZ5KQN`ImA~A6@4paHmhDfm0J;$!XsL0B4HQD^XTSFtPbbMFyXn#qZV1lQPm(x zAsoMLGcEoNxc5aRRFj2}q=+oK{MI>kMU~peDm%Z>nJ4dSSz8*aNR3<^(4M9%xN0ZRl ztBO_s9=EiXG+9vC%JYYv@^fx_6sQscRVE-_&&lav`ZLRn*k2$-%r4ebW3PiBFg(Lt z_oBp`E$bo3XbgALt3UPC1YR@aixi&bG?vP9jliAZ~Hvj z?hS>!k(kXIy={_#qRoO{{0WUAx%{{#^=UaO`bI-(6%(B5YJi06G({pg$?ZGi z4y72ihr(ca4`XBkG_V~*Zq#;hfHPnF5Jw>gSZ2kGduZeW%w7jLK+sIr)lohkBaQ|J zIj}t8@#c!->l^}&sLuxf*F<9`hqjCRX8^y6S!UIfZ`_X9ji-Uen%Bj5w}M&*EKk=C zu0}7vns{P8NR7Kr(jx{mE?YDeTowIqf#>hfFK|+I>Z#mV-Ywa9;S)r0kgV&cWwGKTXJ%) z?eHT3hl39g7zl0+0IwZRKf$(DGhc7tb9c7*!SgZ&ofT7|bU%IDVWqtIR&E=7*0_CF z##1AygGnx5h-tn!^|i3}MKCQ?T+3jkQ|G9geT+a7CfD|bxc6*^P}lUzqLxmrI50%27t7rBtw!v#1W;$!-C4~CM2KdzHVK86 z_@tQdP_*ZRrHl%(@iNoMRDmLfK2Za3Y2O;*)QS)R<|_vg;o8%ez$30WfFha@1*f&d zs`Wx40K-Xhmf%vN3pV(-EN8GZPWN<8b$G#ZzbG3+-akgOq9-sjFCu_U{p*i=B#=YcuO!6h*krusU^PEQRd)R>fb9mT|p4@1tmM%tZA)+Gk?EMI=RKa{W>_4 z2%><=6ZP)}n2e6#Sa3JJ`_tMc@SB-Hx2K0#D=#&c49NMXKk+lH8)on&Vwc~<^#EgW zq_WKhTuIE*SDbje8F)56m3uKe>@1!GPEQZMFyY};*8&I>PWQ*B<=EK8uKc*Aq8z+~ zOt!WJ1OMS#$r8*8+AY!gm(@aC->9_F|-_+c);Qiphi=o}gK`L5qzRzLds^%=7!}bhtiW1}v0k zYAIh8X{C<+vL|P)tBQ`-*9yjY4ih`B>|pFY4~paCM=Ug3Lf(8;~4(({zBAQu`v%~n@c7~iFROKe%4 zKKYB+0d`y_$kd``S-4>0jx=j67q|jKhn1ZU9`68C&NzF?;^>cyJ014k2gRK*+wB&H z0>zLkqkm=DH{Ea2`|hr9%l~+KXT*ZPmEmD@Qb+V`@zuv876PrwJiIr(?cRKrqLMeP zY9rh&zBQC7%($Tz!y`~xwWU}81>G<`C_5G^W(X=cuu1H{CDz5}-8W29zNOc1?$0N5 zZ#e=3o$#|_fae~yoz+~8SY*JeDp<^3&Dq8L8kFl&dSS(up2?qKk}Bw5@tXqkEEP`h z?P3wrVGweHPDua-M&bhOleV7UHt3~vS8JUoNMIBpMn>Y-Q8a)hT_~oy%N+?9bne`Cm~(B;r57G+Zh4`z;>ujS9%wc+h1O<~5+ajmJpJ zN%i~9AMouE1?(Y;JG~Ooaowk(816z}p^qyOnEzhx;IJ!#iq=cZ*`Vn%M#b_GpE7ca zv}$36p!}5?gLtEcej`>!?rWn^MqveoKIGkyIo5mmAmI`IvsT|2$>(_rOrn0@*uX-7 zk4o1BYrxh;g0x^-Z(}M_T)Q{G@A624ehU@;(KE_69^|i;1W)}E|56ocK>XN(vg;4k z-WwcsRb&cWfR(zi5<$Fb04`qIDk>uf5XJjc(a0+yzF=eefNwFs0hI)}V+G_mY|Wp< zm~uA!gB`~QB0EP`U_c`Z!KfVAVjjgO1i&y}0HLyRdvf}8hO4dI>d-?z;s48le=!8+ zQ9(}vNv?R$MTPAlySS%JwU4- zl|%<@AeFN*4gKFsjxH%q%u`><;uN<(di@sRe4}STGsrVSV8)J1paZ8s2g3O#^Ayon z5TCk$q4QC0hVb}MKzIR6WD~7yy4GVasi^yL>8Hi6=V5vcR^u?OgTbGDH9cVEB5j%r zt#=;Y z`d2Xn^`p<7odGY$u|H&2LkBj?tJd_)Zw$v&2`)F;Po*Q50oEsCou$lZ?)ZWp$6sG? z1M`Z$x7>tW7H{bdS@`oQoc*8)Yof9695?h-`c6nLC+^4kVl1?w`Ggm+O&Ble`p;#z zfUKt(Hopo*`A`r-YyHFY@(Qe;`5#P7)dE)a(Ar6!j_6&^M2{D`bdPoOYS2`8&IzGx zR5U!0M@nJ%vBFHWln1%gsEw+x0XF7V5==eJ;Z!a2`VH3>_Ezo9n9#H4=2sz#lJ z#}Fo2H;>-*Sj6*GE14@EQ&a<=5Jxst%-B zo;$iZ9h;FTA8)_si)HuOXIFT}CQtkBV!1%{ZUA2EGk=ekukX~K=!y{^j^t$U-!-aP z=he9bV9fpST7P3qRNYQmZws5~(>^~pFA_MG#80dEa5G83f2`?(2KQF~K+W+q)wgby zs0#hh726|ZJoNF*e@H(q)%A{d=h5%scD<|kiSH)2=N*v##QagVs{+^hRpU|ANXWH! zaeP{gW;(w_c_t0#Hx=0Qq&_RiB!={%XA z%738}q`s3@QTD7F{#9B7Ya%vMtwp*=V-D;0O0TkK@-BDe#>2v@9dB;Fp-088E!+>! zzq_46v&R32Z^y^rRiPq$jWr|GuJhYmMT9^hla$=_wX|o`Kc=b@J>ta}__oonJ`^U$ zC^TJ5>pw4-n%bD)p1Hx9Uv+9*O=0M-%Jl)&+2TI5rQsc;7a~<>mx{@L1r3bxFTGn# zw8@qv%sz=6)%@#4f zP=l;5vVxPNT4yJ0}3)ykf1|L?+zT#MNJwyfM_N7Hh<3m9EPcfN#f%onzpi#heZN&%CO5jE*9 z+ZEKq>ZU$+G|luz7j;N{pJ6|BF+Z8USaF8L(O116gK-pCtBn6&xlYG^_we~-tP>vd$JQ0@2bf(U4aO2<_X3)aO(nZR2RaEA^y7p0 z6=%-9mgDkVa-m8r-zsVEvwSRCn)1fxN^90d`Gf zK56wt2YN?(=6vss?%N#W?zVWcIVL2CR{ImB>{;HU@dE3)Y#Bb!ZMPgmvz6qz9F+8+ zEZcuu+0&=(-g0dh@snZF4Xg`J&AwK@*{_;?Q~KdpEQSmWp%Crz!DZT$#Bje+p2{P)ch#bouH;D%wax2vM)&4DfzSj9J&F$1~bD`#sl+46Q zEcTgmOC6GS2g!hkm7hYhKJQ=H;!i_x)pVT^Z@_kzY0z$V2$7+68v1QxBhPUlQow#V zk%B^xc*8I@>2-9DL(&6DUK=MdwZ>T_wz%sG0>Wx*6gK4?oUaxj^0ZB8{Gfp~-)OC!l zz0nk{sMl8Jedi>Jlz%+egh3mYkRgzLaHg4eS4yJMUwjDl9n-N#WV$(Z0 z=eJB9&|#ivA(^4MEKjujIbqD5?wag}LCiL2wDBmFeiOpTcU9-EU?&YLWuvs%&l+<* z-gps#kxt)uVL#S6mz_XGZe**q_wc)Pw?+NNmDm(ZXeCUygjV6%jaVvH?D$K|IaF|V z1@R~EL;g?BU-)cX49f;fgsRmrcgYObNy&r zW^!{$%uK6NyZ>%q!rc4~e-M!8NBOn}i|$XQFf*Rn5*J;7$0_$qcrKlYct+A-tl(aU zDTt@2S~>xZH%8IgOZ>So@o^P%F1>fsK>Ar5r`KjCQdiJXT#S#+AJzK@MqWNmm%F|9 zu#u4)Jj$UZCHPyK(|d?@L*kb3Fh*?+TKi)zNPAwsxB0uAG8?dp?Er_;MvZCHhQv4M&(l=`lJLB@XYW>Z0 z{?+k;YJTje1Zn;8JX~;X+nrjodA(CvQ~onT>!v7ht{eV*pff$is(;#OOhvSB)mY!E zQMy$F>r=cZn_*8j*SL!IY0Ik{3s zAegvUMj)7Y-ufb95-#6Ms#;Fhly!L?>@?JyJdqM}`C!cLjOKlwy8ccb^@nGRe(IgC z(S~e>ZuXnOc6sXnf{>56ftcv_g&U#O&JY*RLSV>Uh}3xB*CEfj5eG7u4Wg#@X1HD# z{iDI++94-!nP4l(h+VADA>n62|My9@r%UxGJePolj9k)YL=OWg?*F%5|9rYts``1|Kd0!7nhafF9o1fG3SvF>B@0sffkA5_y8_P?aAk}Z4 zd7Za|FkP}hX{IBluy>jJM$?9W!5`Bib6b5U>RLaxxzoOvWIsHq2& zvrfxX?1gH(>u*MiqCshfi=fqhGoA-rP(4}*ZLP`%?iTxn+6FDdsc%1~r!n~!B76Tm z54*i2SE9+gs@rkVpu?>})X)FX;XO4UT91+N9Ouo~^3EQ@$sQ9%H|zv#ulFC6KW8>7 z+lx9^S%0BE#-H5oWs=+sUlXI?FEMq_fKGinyX<1AnVeX$D+tofvvSRjkh>_IpW{$4 z3;n<&-|WbP1Xk_6O9~6kp1gCNcDkOZ+!$UPv}K=aiO`U*1&RblCcSL63!vB93|ln? zYFixN1GPJOw5-@aJ9+Dj_Nri$m!3rN+Yx@?U1PL=1`6$|JK4vdHD|iL9(Tnys%!g@K;X#-BMhIpS49DBkKTx_CB=RjR%<9$r@IuxV!oRlozie=UF2vwXenXU30fVKho!G-oesMb!8{f0bRlGJQSlYAl6|jh4ZU zcc^EYl?>^xxEruxR}8M2mXirwKBxAbm6zY59+yosUwu@KqaG)L^mm*xTtAH{dJtqt zynsW=AiDApW+cjpDU@aPc~|V3gWq)(LicI8s*q4e?q0G}|EI;X+zh`fYd|BBUkl!-(=7zQKWD<9fvKbe?b~7$og?#PIxqto*TdECqVuK!iaoBzE#H z!I^qu+~1_v@EOHI1Q6O!iRR;8`=?En$N)h^=`DgtE)Z^ppDPU8l(f(<%^y8$*@fJ2 zpZt3qJf?ae`=9uB2ir*$k$AEEOo(eYNu!wg??$m)q3XFY#;c$GW&6e$u@T=LaXz5Z z0@Nd_)BV<%o)7$e&zGt7YwUh{zzwF)HcFKYw;MtFdSx~seQ8W2iJ^PhXB$49NBFLn za6-#b@0zc_!gJ%(dz6R>`7G8vr@2DhdY=?%8SK;QxA?iV0CD7US;0w24V339El|o= ze-)S>flD9 z@}-x!i4WMW)xrlsL|aCI18Eya-66r|@RVmJjRrN028E3V-3;3&fxqzmIW1R3#lm9( zVEdjv#JftF>P5wl3sp!g@jOPRWc?Z3J$e@hS_{imwlf_}ePlh4wUAJ`k?CHqfb)2s z$Clli#+$*D-5R+2Y99v@zPNkrXGJ*nsv~CCY2I`(zUiWR)1@7)pc1WM7pu)a12Vf~zc5>crgB5Kyuh@sxMWA?HVZHs!4g#KJ&WO-X9D|!kC zkhR4D=Bc#c0F|L9K;`K+ca_1X=FK!zvY0wt1{8~T;i z23Pqp%zFOdSKpYCa(1UXoy*M|`kthW_>RvS!K0rwPVf&SuIlMwL!9xQ1O$>ce-GWo9}c%d>t;GepRUw-B%zI#ler2ONT5PjJ+&m(q$TXDosm8ga+ zEs9n9Eeyp>A-<}8yM>U>n7B#7_lUEiMk?*%m53o}`8&^kEOyRmWnKMT<*|@$xa`_b z3CPUiN-=I3h0fzjv21Z6E|4w6Eb7pQ!KPpE>HJiLO##5Y)@TVts$E*V4h)#Nu-Gg6 z(2)xwM{Rnzk2m25ml@HF^T^QJbhC+pVf)*5m%sr^cq8cyvn=G*f9~fYI(o21=8vkas=r1|(v>O&=9xcUy_TeS+gR!?6-YNI@vQPp`@*>g*BsE6`sbb@uET|f zEh`4G?x}4m-8`i)2XKkR4d>m%GrAjW8s2B$Te{vN0@-VL8-VP&WV2^o%i-@^_fkKVgO3gk|7z#1Nr;arlo#;n^pwh^N=^ z-k~ar#|M|;HN?FrJTK!6CYrk-#c}3c)72J27THh;R2sa9q`bpGQf#suh&Wm!DAn}; z61iS_m9vDhaZ%I#n^U}U=3a^LYF)2(6mZ|kb%A5>=h7} zz(}bAf}F4c#gC6N1Tt1dk#Wt90TJKt;N+irCBkCkev|Nn2#cHhOK!-l_Z!^O)26xf z^k5v`CspW0mwSVAeDb0e=x`a$Nn^ae($$*L9Rg7P1bsyLTlh48jXASs8oY4k;S9ib zY8(u)Qg6LeL~GcO=>}uQ%`wFOJw`J~414c^sCc{7E-I&!1E`R~ za8F`?Lt8smPu@!p)_+A!b9!kqQQ3Z9-+KTN88QG;Pd`2JO(RCeEB`_?XNHu-YZ^F+ zO1#FSQI*$ArVQl^}Y?Dcf&S{L+iHktTBXvRF=@r58x z6{YlcR?2aKz#!A@G#)sQXch;?aD&iT76+DaWT`RRY7=zf)N2ZfZeI~(`MUiw0>hKO z{SsO2R3}4fvG#IXKq?Lep`p5nKINNfsGr?=sW>C>{y$yv?9;!^EfBr9CjaJZFHSXD zw_*5A&@zlYKfirK$lCDrq*ZErCU!$O5VmO0GX8VctU=4dZkX{ffnQs-T!?zCST%x7 zJ%UU%qK$@Hn2K7Mky`kks#I=@gTZQhVcr_O_4BfjkJS(CpO@i$tR^&>IxlB7b^dqJ zWmBg0%3#Y-Y$oc3V;M_HY zz&F+2dhk%5*&zB_n-c)L^U}ms zRVx$aWdsD##TtANp1e8@>??Wyypj!l=|i*SJ^K<;zA}}*Cgo?<=PwmCrf|Sitl|*V zJlh|G!;5D+S#J z4bR#((pVtIe)4b+Ymt@)A;C3pv+Fycnlm$rNS{hlC+UV&6ziKTJ~KO?dCgG=X{SIw4XGR!G<=i>r2%gr1oBSL&V5ig)e(3)lZYA^;aPrLxirXwqAuQx5q zJK1JKoyTwE6t#D9?<_e;*YwfwNgg!&$l%yez7U=m)bBTOPcEIB5424hNJSpCjPOAg z{WtVJJmA?L^bc0obLs=e^HsrWM! z2y3=zqT2yCNrJ5HpF{a)CbqW~vNjSFz@6JXdMS^LLhtf8yr>~T9w$DR>Kl-{T&Fc# z7VQz!lTMW*E2f7QcB@2O`bpaM&!Iem9_%T+;tUcH zkK}Fg)d@cw$-Cu8A^~w>#3TJ9wX1JINSpry`;!Bq$*`bMn?G_GU9*JzlDsySVDzq1 z%U;amvh2E8Rr{@^4dW+>aWF1Ww&7g|<7f{iG=C*fk9Xb1^yGlcklO%{?4kX3S|gD1D(}s4`%1N)N$ zp*aC!I$s}>pGzv=`%xJY zI^44)lxHn?Fev&r#d-b>gwy57gmPM;(!zAPa#~-dg^_HjGx3>MyfzCNYmqeQN2S-< z3z%;&zcXB7c|K?GG@|rD&nJA)kj5Pb#A6+Eg2y_DLp)Y6tg@XS1%I=D!Uf}Gj_BN; zWD&=)z%_DEGoK^|_VBdkKw|rA*At#rUEB2pv&;FB15c}j&+l&Rv(gU|AyWpP1&^D| zjW}ZwEyNEN21b_?8#Sq=j2E9AIE5N$lhsm?gBvxk+?DlGp@sa|$%j7`mCB9H^6{5pB$I ze^!`^D~ySmIg;k0lkV0$7e^I+v%fL}GsKehVo zhYL9qtE)cnPhNu8UvFWG>oWIb-1msLt!no(B+l6-vN-buySNXh4h7#yRegPRgfGiK zB3b{EYce)``+jGsZrX*Z;U9J7`@gfP>_)i1=srzyL*t{`FpQsdW7o`_>&l|`Irpx0 z)_(g{>XV!GZU6ejFxKc$ro%UrNm7zLp(v1rsD?b}Z{N}(b?1b0L@GO3u$%tbMQW$cStWuKeCTB)s;W2KsSy2l|ta zxgYNbiptcNv&F<~Y1C$h8WPXf2VEgjeA`u#p!j3x{j~ud|DMfhkwzM3spxx$LF^LgZ&s1D$VkOKQFz!k{_J5nGn3UGk@4(Rm%q36T0nR zqwF}N)2w&5t#7|#XJ@2fv*F@Si}B2U zP+hP*(SAnfN4e`!a@XB5&gjof8_Bz5%9q_qGn>iGDB9Xr3O&9QzwUc1ZiUVKC31v% z@tUvXFy7JenedCm{Ast;N6N{fA`B(*<+6hnl-oTQ?=DQkhJ-sVSOqlpIQFy^dai6! z#Km(2*^veNLWjNo@stMv zO$lFC{dSKOm_+J!x|OZp2j8mrR5CsOVg*_|*mZ=9NuDYYG>mqupi)x29pw6hm;&y-;K&?MC@scN-gd6+jl z4x=$p>93E9KIAJT{rt7w_Smp=+0sR1dEa2GG??hB^+M?!U*W0zHph&z3DzNrLp!VS zYF%r2x5FYDJlG9zmH8Gg0dFDc#;*q0jsRN@t_Cn(KLr(<+A+lVSx!Up+X)BjM^M`z zs9Fr05CndzlgAw*Q+C~3X;gta@yV}^o$*V51>I+G^YG;7I8K21jv{*-l=PieFd8ss z#*d5$)lYb{hl5b2kdzkV*5@%@>FM5 z-sYh$i3oRi5M$b)GLwM->}h}sL`h*Nqbic*^R&{lrk8ph3cWRdb|Cf323Amy&u?Od zD!Ni0RV`@ty;kr~A5!B<$IDE{P}ZQ&kNON-uhtmJ_W2MJl}ogytl-LkV@oFW8F+7y9M>al<0rojk8V83 z;6uvWJE5}Q=kSb5y%1GlI)`mibU$(@t;Y1VtjE9MDQC8PN=zw2n)#s_DmYtiU!O%b z6iA(naow?0f=c{(z>|b>6SftE{`}}z$pwY_s(A%a{jKLCl7iGLA#_A+UIL8RzKD+` z?`j3s^sUeK^*lbmyN*^={@NTFy-C|lRQnq#mxl}3a?uP#g)r-q$zKPqurV_O1RRk| zs1!m@2?@9}UlA`$=_RMpqnv;Ounou{&IxUDI7gttZUbvOm0K!rB+q;5(}-y+38X;* z<4I&A1KHWY>{ogi_2L7~l=BF*0BL~c(2hWJL<)LMJpkIu z%|r>*j7C_yG#FLnkTg`_J9I&pv%z}69?N@c4y1>zDJsZ#A*8f;`WG@jvGZh?!Td{D?8fHXS%hI&`hcR6hiew9LVbH%9{`I%Z$teT!svD*FHUQ*X0>7v(wu2C|N zu7!8cZ+k7HWXwe`)BkN^&@oEpyE9*Nq;aQ!7&b{%hreFZ_{!ox&|Z|x(_$&%vAAvJ znWbW_q9iE;8k}N>V8((}Yftwhn6&_A$|p^a?GU{F+jO=?4+^EEy@BYOm@(Os#Y-~S zdh?T!gUCqu2)9ru)Y<|=zlaY!{`m+g$e+xEs^hbcy2!|T(9~**>Zc0v+wX5Tt-|;C z0|rL{zko-H1K^Q{)H_H2*1oIR^h_~Wu}QkUOk6DUa%&k>n_JhWL*?W;Qs?{F<%DCh zNGbChq@LOrjm%mFb;v&O3!5T_Px@k!8s?7GRA2NA$1)&~~&^c;neG;;Z=AAZ*hF?Id4$xACUtr0}jn+D#M(HRWQMYA;nqWSt zT0S{V2}Y!GaKh6O1gB#}8Z*f0*<-zW0ax3j6T<#A4DdQYm~h(@cCU!0b^!hZ$R>?; z2ZRR_slcz20pP)?{n${uLlvrc0NKO^zhEjI4r@!SPfBXe2Ylh88M&;%eOVwQWS78J z09+iN(JCU6SOl4CatPt$FPt>%Q}qUQzEu&t_W>sAd_$&y&eu6rV4x`u3;|~U`VQX) zPZp!=LRjeosQkMhl;ZBWl7VsXjw8fS>w`2ZoDgZ)1AA!O?UOsqy-nQ*>?M;elFYpa zI_#5qk}bSF2JFAvCu9D*togox)M`1hI-F9yvY30k&6%@SC}yWPHCiMk zS|kCagoubxxo^=|a>W{r1affPiQ8ECIYl?8WwE(je%=buwi=gpj z%kmBjX(leeB0VFUUcaP~&(6d=yM?7$%qllj1>x0rOpF$K&90C8h3DCe1A)Rrc`J0*2gfNv`0zmT? zA*_$-0MM4SogLhziX1VBnQEO7XA8Sr;#&uXX=?|meTl4eH%Tt65ajWR+MLQbVaXkF z{AJY1grfKe)0j>;TaU0rS8uSbem~;mPHR2FlYb+VN5ceA5Se^WW%9`s`#&Q=&He@3 z7hsFuI-xuUVfP6}nzo2sX;Q%|^lU+Z&v;@iyc7HFwQQ3y+}@^7`|TxTERwjr2Xt*2 zbZnFPv=CjlDEeM((w`+ zI1B?eI~0L@awQ27yS0TjC3-|biu)0V^34Hk>E4}lMb}-T@YfNYNohgkBZsJa)I%sQ zi*J?PiN7l)O48NjN6N}O2C$T}CL|J9zFww5FiAYYBm$5O;YKj|-ySwJh>HEUM?Lom z8MEaz+yN^o{~g0UhUgdxqGM-RA$8GdL`dL8T%q^?g41^dCmjjkK{|38q9Xxu8*U)f zA@+MV5z(6$PP`+-)T@!Mfbz4uhwp!mM|7|R5dV)dgQ|kYA=CS@Z+#Ey4z=PVIu zEENa*Lcl}(!_RR@z5X%bk`wwKAVLs2;U>a?`c&ni_J%0p6MF}1{-^Wx@d#DKrSKLb zOsWZV<}GfF`M0G)7fysA6yn=GYXY%6|8CU0h1%J&Y~Ag3sf$RS7|o`*-2@`PdOpI<~#lB^*vFy+5JCQn$3^iZA|gZ$*ezlVS} z`<_@zBUp-oFXFJkoBuz)-U6zsFL)Rwr9+UCZj~+pX`~y2?pCC`y95CN=@3vrX{0X= z64EW*4VUhE`}q6b_x;~n>%Fz^J+=3qGka$C%7LgIb0={g)TpC-zt`uKZRjj1Y%rNr1*0vA~o$YE%wIw zbNqi?t6*5{wMA-T{Z~B(PpJi>A`<9xuxC4zB!>cZlmQxpG>8ymFd)WUF$O?1{6`Ld zh#dcFt(Sow!gaKF=M~QMvzs6ZndJkFScgnMryHc(>#U)U>OXHx=LMer@_CT8+B-=wp!H|Q%Fbhfg668oiiH+6KRR6MT73fjEFUT>rW-9E+u{*6km(1sHABD!qBZy-=8U}KAF6;s2iM!K`+7d zRvDD2-#Nr{VO(oh*M78f*34+{_Dui&yc)*tySV3fp*Ah-uq6MbROjrxM76a{Ep9(G zr-+r0QzU9G`w4~m!YWq2K_B(cbGXg5HckAXHx~X!>K}hJ+45yQai?QG+TE3~i;8RC zbR({pK8C$i&pZo0mu&N*U22S7G?2S8kaOo?@PU5cn9n6cy=dDTV-F3w!F78Mh6a+j zCX$LKlB1eAES}9N!*8j3#Z5@c3$y|Kq?=rp`?aQH;aza=Ow)mRhj(L)&|$8QsON(k zc+)Ae1+h;i5|b)*L9Xh^k}fKUToxU*l!FDZ6l70hnAI&HNOe+566D?>#=P23Ss9K$ z97zY^FI-t!wC(!tPF=LK4j%R7!Lv9RuKD08ViiR>6nER=;Tw%@ciB(G(cs|WNgmvQ zgK?G@W8yQ7%ayXRd&eIX*(Gt@0c$Dex4ZcoAuNKWN%WjPvMae~R7`OS)ph;T zvM%`+-j|uHdYx=t{3fKaW!WLBqjG2e=IxU9&(y3bE<4#-PY`P2Tu3k9eEvQ`x>Be@ z7~Uwq-pJ3mIUkgpyx$l!vbb^5+z=JMFrylE(+DD_%#y@jcJ7NTNIn`&eKNQpgnm0u z+uE#2{e2u+cF;@_3aS!F5`7s8gOx`fy|@1#eVeTdb7oS|WNV}p^b7sw5bhlw-GVYQ zPBS{5;C~dh=VjKn>TqkOaqP7;-0q;`Bb;K(Gwj7ts;eKN8RPOw9b$0z|%O%W! zQ9T#_{PkW~@}JSH+PONBFwk$W?JoFi=F7fSGNw#v(#tyPQPzw*5doVFTJZC>#_gB|aE--RWuSA$eiaWO=g2F~0i#oAAJ3?4jcR^zYuVsNUlw zT*+oU*Fwm4Hw+$nVUpC ztp2XLXja;zHqER)jbIfw+N4Plsrl)N5Tme{%OZ@?ow5N5gg&%u#zigcJT)2jD-A;@ zet6Yr@ViWOQT=Kh{eZg=TG;Kwvdpbh@Dpo(d%j%n`WVi9rWAC zn-XQMpGaPYo24@~R$n6Nag{sRxtKnvi|tQgvpc*bYRJZ%S2M4Jwy3rR6|>MbkpGRg zUBO?m2Q+;k!WRR6gS`dc#++3bp8p@TPl0cfO~4s`7{C(^#gGDHVF?Y6Ng!(jy^fq< zSB3gJY$r(KTm6vk zC{KN{NqPX5IDGq7qEp$4`sJCXw8uPeP+yvb!jLkuEY||>2C^sJhQ;HvuNdBAT?-i_ zZt1*|=6V;$J+VZh8>SVR0$WgonAic>;E=*Ge~>r)yuDcPa|;N zT70tCsi0W>gl#IP(kzm|B9g!?awLvTA(l-cnN7jEdUKPIu1fGWRa&uO&w2f?+8Er3tnYO|}l1);k!TJEWU#Z&TMuR?^NUTHk~27?7)vV1(U=kIamXY8h= z_&xh*_2q`!ar_wNWENRy2_jf38_;kan)(w4{}6F>Q{{<3E`LyZTg~-Bc0G9hqHd7e zd-+`E0|%6S;YHhh@mr#XBuCiKVQBAn!lEHXGn@DTq08WwAK4L&uU%V-C|E<@+{WVe zwHwj*QO|7V-zvFFSX@Y(D7j01!ZJrxB)h}B;3D#@+g{UIY~S`ajC?UL*Yh0Vxx35FT4Fhf225w>7PwkS~;Peg3p{qpw&# zH*f_JD;kZp*S!Tgiu!ki^xw4|ck$Q#Z;()8{;ZSu;BpyzG<5E&7>oXy+VT6?rd*cG zi7YVM@k{l}o>JGI*Q9kg+??!_7B~v{@5t!CYm}edo2?hg(E(N5ksq3Yyaya9Am%v> z;&~`AmR|C3FABALXzB2@nW0}Fwc;*m&G!jiJC3}P8(4H6c!?7U*8e8U;;`Ke#>*;% z=RDrF$DzQE6>+RR=qOd=;cgW(>HPXNSzMbucmc&{J6iqh8dLO|42sQq_A<_4>6e0e_ff-v_IGZ%Kn`z%S7h+mc1-iFpNv*Ij9W}b zT1#MQkV-?2K<)0UK4twOq@c+;KbnU%|Hg? zz1f+1M>Afx|CS4!yELy&-jX2xRdM~gQb>7*k`r@SB;$L(YKz0R49GsUmx>1 z;T2RtQB*pLvA+G=UyZe`BaUh<;`^+hGj67~s!#K59=JfE7rc462Aa>*KK*E)B%)gd z$I$9|5HLC z2mA)sN`wwegqBK#l3?&)7`y`pzsaj?cEZ@!INyzzUVb`y9&x8nHe)Dpg{L@lhfCx4 zZe(vCxE*I@zRVUSF}6c+Jy-s`lEE658o@7fmzNmdWann=eDQnw<#$R>O$*!BSzR|M z`!Pseo_*d(nh^@ugk^r=L^#VH)Kj8S=(h}< z8MNYfzne2?fqNCvwKCAo88iI#AdSQX;T3qrv1ab0rt0P%o?t5<*jQ|;uHRB#074->S(|aUruJXM}K2SA9_tgTs`)(u>6oXno)1EQuqYmtJ13Xd%!*wGGd}}=L=<9%k z;B#4zdiy_(hhNn6dI(2wAYkK3N4HMi3Rq z@Gf6Sfw9oZybJ=+jsy0Hps1fxlr6aJ*J&1YDmYULJP)M~xZ_zN@y(Z<^O1x7s94*$ z#j4`Jq$B<^c7~Bst&E?|>Xx=-T)eRNy>wYrx{!iM%KR$UVNT^%>f=#^ZN4vEK8j&Y zrRZl2G!uwK)jX}@MVN19QtWAn0ry(PSwWK4hS38?C|)b*RUAkYAxi)XPLMAs4miZu zd1MLf!>P!(7V=)!__dEt8qhGJFntzB(ogt%&u%>!3zrtBMl`&e^P@_e#kYx`U0ktr z*IH;d-+{YBI~9y33v-`aWr0VS^5;lD>?KALG=3ZezswFtcY8quMh%FHY#dZP5#<=Z zjvBtk9=>jn+UEg3nf>GVO&^U7wnC>whqBKMqruVL78D<(g7vmqWq#ct>a|MAGK_;) zZA8aKIjxUL$!cf9(^EI)2)qYwxQENRGfMk8{}v#1Pg;TY?+s`O4-3|7-z`8W>t5~(gT(`wswfz$Zdm0OSnhblY>d4P%2rg8l>60+6N6i1vG9P^dJJFumvQSQaE3H$ZFm?R_iSv3a~SZ=jr6Gf;Zo;> zjPkFw&IlpBv~ndU>Dlg^<7dQ<1bRClEyoRV$bwl_-CmGL5bWCaOJAU=@JWIIzCt(o zP$7|Vxx{?14QKc}_hP(&o3d4Aq;V6yn&F*7FM2g-r7m42FInG?UJddC7$IFO$N|Wg z&jyh%pA8~kKHJ<})LIiuua9Qpb;+WS=HkC&uytSfV)rNDaz(<_;7Z7!A?^>NGqQ@!YxSK+nzDngAo@C=M>~>cHx+#)cQQO7U?Wa2Wh;IkQek) zli_vX9OZ(>X8|4LJWV89JLTl7stD1EiWtnx!;qfP4vKEkZSM0A%A_R`vlxT*4>a$M z@_i?OCnvmZsh_YR7;~ka1qR;WskU2k0*IMhUV0b!P3cSG{wRdmH*EPb7~fN#P@nfs z@1ry_zU6jV$;aiDQRFg${!-;i6YSbh=JM^+K#7P>*7b=eoFfHDZxuZ$-btC&A9IdC zpV+y>=ywX-63OGHKJE;9p@&PUmfp-7=0)iStlYKqKHiIi0V46uL(MUNne4 z<-f5a26BuxNhq4SmV0NF2zYmus|}o+i5QEy(%`=!Wd3nLqGIe)$!4M=KnWiVvgRB1SuEp?D9bC@*PC1)IoF~3;`4(@D;`c)DtGe5T$w>;K>BeKXyAOEv~3T ziBDZlfMLUAT#&BGRD^U*W+bF*GJBa_1{qzN87T%Cdw8>TOM@YhEFziKiDLdNeWT#| z8e#NCoLM^0|7mxTUc6H0jY+x*S%3f)iBQ;A_AzAI+~!Y zKvxs^PdT>wVBRV;Il;GdzyK7Or$7Khdj?e|1MsY=GNph@q|96;EMWwBp(u{V7!z?n z#MjygN*G@P%csNbp0Liof9h`kJMu;8sM2H3K*TzGj!*EQRL=+blDhh$rHydlW z{f09e>z~n#(W(P5XS6L2;lX_*0f;945bC^|6x4aOV5swI-?$6ZxqSm`2*A!eum{_`fQ2#p$ z07qT+3CyMf3N5Z!P@0@>V64!%Z3H*$_1*-)-q@z*4|ixTtEm9ATO^G}`tPWPG&&F* z#e?=uG^ijIa5)7WybbthNqiId=;6@=!&qqEC2&pzM50m$b-n2-XQSy4WNVwi)KGV$ zNh5Fc1L}kn2A&?FbR2KU+tlL4)F)D*Byq{}2T#Uz-K7fLKr->Br)J#P_uQXu=5^E{ zTt2dX{x^71r7hU|2iZ4GHV!O6^z#Hbe{b%8NuZ{2YAaxm4`pu5#VL#oPGzIfb{_#P zE`iPnTh zxFbl1rBI@gPi?D6j9=SQhKkOrp&~yY1dtEcEDFj-j&_hCLm-VQ2P|wU9!l7jCqoSh z*vi)n<&U0L2+s;;lrUpBZcI4)n7?2LIY@{2N%0KI@5qt>(19Pd6!K+4%^hojk@%O8 zMW;6eGjVn4CNq!v$Y)2uez3EDE?uPY!Ub~|OF0IzdFL~|#C-k?5oUml#bA2{g8=Bd z2n)wz+#+Hk3SRGjyIKYT@R;TpZ}SHbnnCmc(UJ$6Dbe1vU~0Ci2u;ma zAuVz%O$gcUBO>okA@&u@u&ll$GxuKmt|jJU5CR|NHha}`v*<932>O>19}m2N62+NaUtylsM2H=4N*n+6GW8= z!iw>?I#qJZ3W;Gg@_9AjK_tlbAZPD_^4L9HYbmV#*RFN6>9!e2^8YTw|wVBW(^@r z{BLLfR0$$XV_sBaUc*T$_gO0UN$Syv^`9Z@KYy+NsCp{*=A;7k@s%Sg^8Ev?H$1HW z?G|%VA;ajD2Fhr*vuJC`Dh6yI4e68y8UI;}Cuo&;(5o}9Y2?l|nosFx(A25snNsHS zP&|U5XId-U;y;u89b6V6U{mGK$f={i`V2rGN`7IXFb`s~HE85&w-2NMQ7oOPV((8*8cR_=u>!tQm(W^<- zu9cOQ)5(R~{;+FNSd61#AI$bV=6DGtAKc9|R4PYTM-+bQIz;Din{hTggE85rbyUm0 zPn+f7-&lg@uf3++UYT{^H?hf`eSY+^Yr$)wak@*F^?OII-K%LPj}MMlvJL!~C$-cp z_wG?P(UWR(V>pBFu0Jo^Tp!q-3%N8=x0V~vbz)ebXSh#F#JKAoyM^6}O1~eyd%5!0 zIX$rJ_F%0AZ9h#e&9q(hbd4k35%z5$T`0$^GHYdUxza=gR6Tuj_gC?=*peg3v>AA%ONAL3~%q8#SJx7kEZ&Wa~;B!w3oW8^3|imH515A6&`4-c~pkGsSguDZGw z8bc2b@5h>NPx$7-8t#vdwzsLfE@s3U>Q4@f@AhD6r}};k_leg{VvUiqb9+!81J$Wr z`Q7l{nJTqmI;#_HnVt*ZKb|kzs}6Jf1IW`~NSI zfni2<3HkpckKy4Jl*e$z|NqWo=n{~~zEfZSap-I-I(~dM<>VFRv~x4cGw~b+^-hz2 zVB>bsyUtIh`9jrF;OHf?xQ;YNHTc%yW%NlOHEd-UXay)pHYDCMg|`2Q!VZ=mwcy?vAF6=(%yCG zFWsMe&~-GQYc)4h6UDPH+B`);A|!3sgB33Kclzw}eu;b6HOvel>TmJOFcVxu{FZ_w?)2TEl?+pGuxX$lL|nB{&Py5}4=6}0&WX*l)NAdp{RE|!y%#r?ER&iwdJqJ{zc z`J*?wZ7oIkvO5xP^x%c_Kgb_}+k9JSCru`*C`q%NYVaGjGr=yxgwxt}YE`G%>BFq6p}oOhYn1s-v`LNsS1q=b=}k3!pL!?{pOa;ihT%*9HEcL| z=(Q9GzABe{K#sXh6asD`o+jB+gitO5Q2bRx>nsNHF#Hdwkbebw)19-Mgk}aTVDC{j zZ9X?oEWQrwvXb0X0m%*j)d<2BL;MvOR#RO@wpu8(Sr0=0X;12t;T_;R4EP785PD&L ziT&5i1!?UT-KFra+w0oT_r*-Ty~RW$ul7zkroUHy6TG|0h*ERzyZIj2J}}9eBJwr1024=(FUI9m}r|^J0>qj%l)N!l2`BLuL47&(iU%w9u1@EKXwJ9ZvjI?o>k+0IHGR!R#ljOsZ63 zBn#9GSRP<98R|EoBj}=f4I8)vb#CB>?VAIode=+^wUV4v$@fi{vn;{oS&2;JS3{LJ3SO<#!P#-SBW(pCyjN}h z7SlLZc?IN2fDkdmeU;?>O7AKePiR1_skm=ifOd9^HC6x)>Rj!&euneUTqP-PE2)>H zHW(suAfRZ(h?f@-r&gK&viE`bsy{yBqlgX)~te0O`zkg_a7Lk+#5RW zS6KH{ScjeNuwdF-YUXZRG|-QY@}VGy;%H55$=jlDT%iXZcUPBC`!~;%sm7TO=t#3; z{2ibAOTpLkJ1Qy)4UHb%`W~5-wY%s0;|M!V7A1BxHC=Id8h&v^C~cbs&co+uh4;t> zZ0=gDyw*`=9;EqrU#tDS9eIv=a9#%YKc@SD;fe^FbUV^dMm=ovwGJTtj%QSc@WIim zi)kkD@nG)_sxln$3GI*(?3KvQNn}FbN{IAtzE2-CBbR9;L zeca%hoa9aS``af>DfES>@#$vZqa9kt{kMFSEk@#fP#Xj?75{0;FR!r?-(!h~5q_;& zbhSS?k+sAoaYg0o0^ksqB$3958~!y#FiA(K3L&Bt_8FOK3z=sW>;)BK>#Enh?6so@ zA!y}F0GfU~*Xi%~6kjRTdQq&{+|fx1jLK-bHbBqC8)5+fm!h>3>HGEc$am#jh8v|M zjLAKdZ!1Q55+;>!o<$xqf!mKQR{E{6iKU8uB+n+I#tV|vI{8{P351OT4+dkif` z5-RNT-7#Kxttv>B#BHK`j!k(+!uQL_QbHJNy0NlG(M1zzz5rd+dCH*g9HBn&wUggQ z!Wb(-*dzcXo~$t-1%d@sA)FY(ug*bojEP21&VNEOAtCQUNFS;QUHP=2aXXI)3&h=_EJoJ<(Ryk>W;kLUG0do z=`#0zpz)7MIKp!d$nTNu4MIT|vGFae{W+OQ(|#S+Mh%K{5&|(n4$K#`uny1kWeRhS>VUuQ!6_k7iQH3^~iR zivs#92D*p3%!GJXSU8sfA-iAlfcqm;135&Jc~Hp5t#$q|Wt6<|a44#jl%i;2(J164 z52z<6^A8}7hV_TCkDnV;=jk4x7V~9*)zh!Q$S=V2(to-Q>x(yj6$Uou zb8EG-)@(8$zl(7c&~^+Gb2;W3e&-6C?BRV+^$srIplbr3_HK(`GSAb5kDbh_L}!ly zj6h*NC$sOqwXtZ-QZ`7@{rEscp0fcoS~A3-?GFg5D}$4ta&UoiODlB7J^8$-vJLh8 z4h#yK!G4HOLH=VTpNw1WTS0|NVv2)BsHw;c6jIjko)Ex!N?c)|VKU_4R;a=lF^!ZQ zAi`_`;5!m^HW0OirIu0V3@&lfbm12OwI*ylAiE1j-maZaJo*yRg9CDmXnw6YnZe$k zKg#FVWEFAhz3v9}-=p9O10E3vUoe6GA~KQO!-odLh-q5nfj~73#{=T@gj0i2aHtIK zimAjs@9xXwPBt%Gq0`*jpBYT5)GgRaetCdTGawHT`o|{mB53F$xcLy|JV$JmM8YQS z5cLP5)$6v*vKD1EAiS`Fkb3N z!aG-ZXxoT{Ac|ZP)h@(_YN&nO?BiUeoFiPJA;@E@LR%oaNkbu!AF^}hL7Sxok7k4>vtfaC(d z58!$*gPs3PGh|7SJf=SwyS42DHt{;9snhe!6b!NgbHL<3xHy?$%%Eb~U`5?MCQ|>j zuxK!(w%CCO_|YL}SuXP;vd9_&$GHN)NqKN=B4R&Sojs~<=m#A7qaCHL!up7?=!=PD z0F5Qr13}eyq*n=1vKEqvuEJV{zfo982#Zclkcgu&CO&dyn|v$Np$~y6^lim-R&Zq_ z2~icfmg3Z1wOqDr5Xbx4Xk zQ7uUVeh>!NFX#-N$Rek_O{oJw(lKU|3`wyn;v~!n(v`sAN?znq{69dX3OETr5n0dy zs1u+vV=d7?AOf-g$R>>dB#nAM35!9EH^~v5m^_D%60+|u*afU~ETSfVJV`$zpT&4A zBD7D)w&svY-Rr{)Fs=|*;Z5v{(4u12>0Rk~jkDn`GjSy_jEqIKkl1xOge1j_!KoEX z7+KY)bb|kv0jT|!jIYBw@0dJ$f@Mv!Q^G?ma;k=uf+YbNte75zV-o-^JkXtv`>u$W z5V>q|SjURVBs;~5jhC=|NU4%IH3HEj2*?OSEg`QCOMeH#k_062f0Zf|QzMSvrW(+9 zpypPMDb0R2FW{Jt?(aZ1{;$G6Th1VB{Uas(JGkYTlJFOE6+>@bYrr^ngAEQ_<3g)IKmhjs!KI6BhrrpaT~sKst}%(Ssr60-To5pznNy^yS zwF9ZV-z3V$)S{asg}^fB8RM5{D;Nq2os#BWM_3 zwXDS25+-ZinxaKhuN^h4%*sz#yk=ptcG&tp0x$C?cRm2$*MTYQUYVE@p#_N2+b6}! zLs)EXVe%W@xJm|HRX=5vr1*=4$roowUcgW_E2hU-pi{hr#UU0ZA)7{gGH9xA$+lxU zgSg8j-OC=g2WdfF1Yo!ci=_dDQX(ekcn-%B1RD=+zL3pGn!drgvd{kP8}B7<+P(>_ z7Js>nO65d%gcd!sj`gZk!Dqrxe2ykwOYOzdjya^s%0b+TNf8rA+~qyw0ntTcs#mW zR2=cA7{sj+3zr$J-=+t@b%3tDkhUMNG-Hd5ZxCjPpMU%NQjMA}4UCiSHUM9X$=Dd& zn>F5*HszR$jHQq&X?Rz5y&%(%*_cB zzsOHiaAW-W!(ghN@`&a+P!m9xCf0)rpVFZU318$pL51Ew4A$ByF0aZgkIyZxuQhju zB`$p2T1nqXp>mfuzDjfVz^)3Z_E>mma(_K(u^KR=Fsl1ymm0aVp|Kj-ir(X5nE%1p z^g!9nRc92eI)24MwAZvHnQhYIf+fahC)YMIw2J5|6?<5XUzz0^`}fVvgh}rXg0vpT z0vX<$S|4A!!IT2svI(8037uu4nrl!Nd+G z4K0}P8#A!aRWY5+CE~q?d@4T&<`LVIFKXdWejeBrV)23hA z&Eb1yX*LW{ zLN^Dybk(Hr&f-cTjKA?7J4{her`SgnOkE4D^sRQWH;+j>6ReVm8)N5Em*YR%*+=AE z2(B@%82sH^U7>JouFRu{C7cl()daD%b`R@HVRX<@av*eLtG3 z$Hq%F9#S3#Jp)aY^xtmJ=gAhiZHgzqS@&bOGDo#} zgQl(q=C;xg_=70HAGXY~dG+<*`EtkhP(}o$bVlXp6sU3XWgj2Q>uZndHn|q%YcV&( ziz;xmkzTt91vsBGnM(c;y3F-*FJnrmk4N!LJejCebE^M0T#c$LM&z4)0$+umfSSt5g%u^=`f*&$2%LQ(d!~wP&8tRQL%+=Z(~)RTr#D-8wMG z+Byt2FyTTtA+rBRE^19U%wZ5lNHFPxITy$!J$y=QyjNCVza=upGgM3z&L=-y^=oU6 z&8SG%J&xc!@??Tn+E1_!Cg49GD7G@Ihwo{fnj+W~08geH(lRHI(yK})+Ql|qfN?XaC@RZx}0nWPmgery8 z9@beF1iOB|6XvRe69wyvY_Yl!n5tGh&h5aC(1Q;izIWeFGgQo#PmbYIy_!-zy2qzC z3WGw3jQ8w@`!A7M+HJaI8~N7yVXhjc@!||p)+YJ289g()@$)zGYC@&$sTJ#PAE)6D zI}`Z!gOrMB#BFFZ$Na}>iv%rw^OG~e%D$&x#v8ke+F1{zoUa{RJ4GFK!p<79!Ynoa ze$_40uim(w{*fgJi>F=mTVb}lSc2%%MEpHN(l z83$`=69bvLTX0?J~Rh)o9v(oZ$17qzNSclU)K z$FN-_S7|&6y;hn@kb6im4xVOCnKnk7>0?ub9H-1Eo5_zpJix#zw47FcvzyYB9117g z-N5_G7h6i0oWg}FS;SPJJEc4n>RZ(zF~$@aMNeo{Rz~8^W91&3Rit<{TlOo3I@XJ3 zswRuZY2D91A9=KIaFy@a&TQ~zrX%HYskFfIPS0?9?!^Xpjn?!ft@#XD^PLx2c+Uhz zjeGbQ@O;YKR(IA*ZQDo%&dvK31>w?f$_L(<6U;J~TOoTQOFbW~W|b+KB9SAc7q`wf zXi)=AXrDKXFZ<2Sa=+&9q`I?C4ku+OmZ`pM{utrdR5YIT)1~W=(rz_pT0t74KGybo zrLm*E=?#L3nyC*pPcGNLzUE&kcVD=P{#k5cWmi#TWn$&DZA^$vb1vS%AttfjF~stX zL6s0WezK$Nvk2D*LQ50>=A2AY9nl_}!k#EiqDu{x-2LY~>#ss0k$$#g0ACnMKq7ov zD)?z!tZK5>pmEh=x-hN-LKT=eJpiR6Q@zEm_A*y&wNc7jQI{O8<2(X(gcFX{D(gN} z+J*b{Ckl4hi70;VY340jlH(+TnGeCloy11AdZ)C;h!4Mk!Vvg|?w6HfhPHRYp^fw2 zq6xctrw>gyX|G>%&U;Ts7WT4INmeq^F<^M-jCjmucwXXv`b}=yM)LR*+F*SfCQCf( z>xi-^p6wgkAF_yVq%v#-Wn`^~J6^|J@wQk#d$aF9<4i~PtJO>TT}rWh_;g3Z&vleX zqWVjh(_!wdjt753U&y?d$SPUndC zZS0KDj8#|&pHiBkR#@{hnl@IysR@VhVW|~K<}ddnxEIHlgsFI3$z-tt1UTZDo^N2$ z2CJCK@vfl!{9s+|ae6O`Nd67W_6Dm;sEDX~DSwNHo#Z_KRFQdasuI%q6AiBj5e!+2 z_)~_r)yzvr?<+p-GR-il#J3s_^OMQwEs#u_;|Vtl-*phwp%J{l#HgUEyRD`0GmAT? z=U5d!;+BYEy;tyC)sIf}Kl2e8EQ&z!G z$cssu6VM)Fc+9+qO)yqH25RUPtC)mLp-T(VW0E@Iv_+c2FVPWm?=Lh@iZxbuFPq?u zUds=Za6mSK4H4F;a`81j%ZoxI%-LhUUJoBt?lWf(nmzT) zQ~3VZSb9Yof4HYxo_8KuVvXUPpv}N&#LzK4YQmbP;OCM-txwJXZLli3`@;Ps4o=ZM zGSmh4(7w9`p8E@u!PW75{)+4S=MGn5H$*P?=gCP|5vidqHdB$88CZDHgcB_IbTA}i zALOj3o6KmLih!)RN5C(d?J}h?%<&Vqw21ku~KIEEK0?iU%WFZaHpl&5+M1E)g_{`l z%IKHwf!BW(KdUpfAGPYqvbK{2tBw!HcD#5y@FJ4PiLF?P^~Mw5i|7YBiDW}5 zqV%s-1q1V63^eCT^G(yLv4V=Ce&12670ixO8Tl(Ldu*2b;tn*gSji@}9pD*K@PLbS zzrb%c_0PK+=smn@Vprz4CFXm8Mrh}m$Fk(GdfU)9Ll4Z-a_G)pkIgpG_ZBL`&t5c+ zF+HEB;CL$%?AicV!KFh;+^n zPMj=1n->ZNlIgKeD!U$8cr?$&UP_|5)@a(*;o)%VbRK<5z{Dw}X^p!3F>?OB{s}ye zcWgJSSpAoN*;9xCM;M3!;Q5bO`d{!;+@s$j=Clq^{6YJ}&DEi4yP_kI;m7&&2 z_{POc4!%ciHT$-cs_w3JTOL_U*3`ePJ*ZYV?s@-6pJmk^65hANR!c8Vy~J47N)y)Y zMlO^eH*X~|hp^O@-m*`4ujyUb{kc#UlUuu4nK{qTF14i1nxtk~k+mUvACql)iPZdK zH%3I&^~*)=;jPEU<)O!YcQIOSmgxQ6MP}RNzUKYT;AWX0S?TGq&9C}ZsQWKE*5>tvmeH(|e~j_!}II+oLZZ?n_XCS#%a|%zWI2WBkYmm zYHNrO?RoY zo?LIap5zjLT&`=*Kdv(q6mEFSa*g5BQ2jab^z+#L=4k(LV@Iahea86A;{LZJG(nq- zv!u^e1FCH101{8$b5nU$J$H-KE|6-7o8=y!CAM zJ-!vQy4_;&lFH==dKXxSZ}eR1zw=zAA%-*|tQr2=yix<8sZ7P&dR z7sjb*0hopTIHzt}3%MPAr#b&7T1;d^JyuufqxIm=+{h(}$ z!MT_(mU&aGpRbFBa2JeNq*Teh>fSc~o*)|S+We|8|Kg-NW?+p^<;K+R`o4t!`T%Ze zbH9+O=`1#4czu5(aC>Gq7k0=UYO!Boe%E{a=sP*a?$ahXv#Yt-;l-Z)vY6ZJ_CNP? z_s4!pA-7kZ`%PJSH<}AMLbt}?O_V!_G4uCBxBLs<_cU$qd+$3$8@axoM6T$uG}maZ+c^M&`DK%&R(!Iw-~Ch zVE=vNyuq&a1{6+dUhHic_}4G})U7N1ukgoBrH;Xk&*Kt!!^-h2p&I|}i!G@K#0Qt5 zk%Po=&jtHt3B;At*~^bRKf_OF$uC^mKdmTD?RnW$3tMd&TE}E@?J=@cZMeuN`5-IY zIt&E-;Lt9fYkxZR$$fPw6S#dY$y3g^6+aK+Ir?uOP+Cw?ntrNAG%xJ$FwAR4{C?Na z9kgX9{zL3FPV(J@v8$D9`|J92VEuHyETc;0Ox0DG9B25Ny-L#VbO! zZGJ)d58C;2?9lGV-b8v?{p{y2+Xe#u zlwA?@<4>m}om6O$2Y3~074JNH7tT1<@pG#1C;IF$ktwCDY1_;s!Y3qkej#hiwu_;{`eOSldx>_LP zkVXfrXW&a#5+kwx#TeEJ=ZwJ5siDb#2(FBz^1Ipz`%j36rUc^`haj=Ifs4}&|1W<5^4}-z-D^yU0Z*L|F5Yt;ZfQO@9?8ce!u68+u9g(xL zcz0l|(M;zlI+8dd6#IsfnIr4m2J-xos3hJ_7vIGCnMd|pGhH1QJh?V{DH%Q@S!*vN z7(Nl$PPPVa;oDDrP5;7w9zp2|+OQ6K84oR>!E%%%KrZ+njH7gMm9SZVjpjw@BI==Z z>b&vqe@$^L6M~+wby)XP!|18Rty`9Yp$ajIw?Uh1E#2M#0s{TSRMB z_C5pmGRBOmUT@UwnB$DohMcYmELe8bg;Y068n{dcr#P@vskbphU>UUHln`sS@Hioo z_Vwf``s$8+MC*t6S+Br6H76jVA~bAbNHUpF6CTNOh1wg#1y_gy3RR~vl|(uA-xK)S zs{vKK{5m+yQ}~ms-~vX8H*hI69yRv$sg??D%6LHz?YK0(}2zN z0U*q9SLblLe$;_z7bm22Q$`$|-40cqOzO3nAKLbiBTb55*xtBtsA0M&eBqjIk>F}D zUaRu)GktCfmJH^q4XwA!cZtE{Du)80faQ9HD1C8gFV)FdqIhW@qZufD#d5~?7VsN^Un zfIRh=5jbto{{Ih82-j<+fR^zKNY)RjXCQ?W7l13_X8hnP#K4e=O;E*M^?3!_1Uii_ z#xr-wHRb~U9>SRmzll4IK*p%w*qO3jF=SpC|-hAh6<{FQgPaW6DEd=PqRO3=A${=m77|+}r1V9c&9t8GwKQ zXDa}&fJiXC2YCgWEeWx=Ts;&sbC}xyI|PjJvMgrz>{aywU~EJaUjQ-OK7b2e`smCU zPJ52GPCU4MqoXDlC%r%cqwQ78j{xxo^UM27VqY^U|kSPc!&al|P zhK>tJ+YbkXAiym*1C*hDz6Oi|J`W4X0}Q?Wgi1jv`o3;@52xVwP6=kZD`dJ74EQP# z@MlaRfUv>51q}n)pd5g`+jG9nx{vdp39q{l^^`iTvIFXUoh#W}4*CsAD1rI)HzXGfw@*!89P*cmc;>?NEX#zefCu-e>pp<)Z-7fu zs8U~`p`L_s4$MHLA5M7Bf2(WKo zLJouUtAl$911z*S04%p_&;Pp?_}^*J5CW_!f7$hpGiND1-sCOjd(KjGyh#dfHHf5O z+K7ERt%+g7BAH%=p!Z+bLs4*mC%m5NBYYSAUmM|UA-J2s;Eui~(D=pY49y81#M z%wfSd$Eh7L|EtBn^!`U7&Qg4`Ns7pi&2gVzp_V}qfw{g!!VMynB!xO4335k;*o*(V z9t;5;eSBf}(gRHVU$4X29zw+p1fcdilHNR~t&@)l063dHhpiJ&b?LhYfHOkqzSu<8**0eQP(FbnxX%hgyE8;UGV74?5@S$dS_U*Z zi8_`Zs9MR@-TzK*)xp`wDteVAGE9|;b`Das8W!XK9WEl+zRHi;js3EcizTI|NnBe2jlcaI?B^W#JL{t#6@hKt|+2uY;qG)kr7s$(;9q zC%~Fo;2~6$i&9L@TFv15ARwE=>TDm3v%yd=@O9xd@xFH8Arx;C2Z-7Zp#_Qep;QCI z*Llu;J_TU=XKPLrx*BzJekOKP4~wi(QiF`Xj(zb zeIVs2K)14B_+a0XzLgAjaa7K;fvCHM1kFK+QLk_9?7x@kS|^a-3c%|kJ_Cl=1%mny zwhXXF1@sMoqz@oS{AXxr1j`7x6)1=QX(<3YegsPcNVFlt@En*0<4jnEg$+BQN*V_n zuD+@AMaL2}LlA4J-L5VM z+NoR7zLUarL!tS9Ef6%+i-$EakhEGHNHVMi`nM@CpvxFxhQ$)c^F!BO!@vTDR(T^d zRrf1aV%OJGrewGq->!2SLLaT1n;Q##kFJx9W_WQcuIj0=mS@}dEU7;mB#L~RX@@@ZXp<-sb;lG z^s9GX_^vAp7d#xqANDa8KK(=_Y}K4i>m(#AVK0>(@uQUFqp1qoGNnYz5p?Iqmw^AJ4PCG>-kCJ1^0WZ>o3!@EKx6C@1?Nr6G;tCIS;D>52&H z>=#)}h--Lz*yH5qPEq~E4_P1A3*+@RuJ-ZqjXY*wl4jTP!p0<;jl=QeQO;%H$Q(J6 zw%%Q3W_~C&S_q7(aKDZo;&VA@M%F|6ajC4be~JeZ%cnLgb1$TX&DPnw0uJDJI-#FL z@He6DmKJ%oCdsUWlo#(yucqeIqo?Ly+BZA5mz+b}EPgHZl4h2Nc(!*jo=d>ZBjU7B zV~sdeeaMc@43M#XE6AB;?aNZz%dwnHJRW-E`91DeIQZHs`&oRttHcaN<>+lCV2^sb zANU)@PS?Di8%khKIUEsbS-PN~X{WPkInTK0%TT|y4aZs6+d_=YgC#1hDhjgw4l0^j zx2~I7W3;lSDj}B!B6G0m)n57TrRXnU92M70*|;rI-rm+^$wRMU;X%Y`r9x-NnXt`n zJ9HDR-X)jcLY=B{f&SW8_noh{0FlK0r0PBa9X_I^K!7{T8zj<&te#2m)m69efj{>* zAMzIRW3Oe0^zW(;kejN;Zr|4N{^TBdizrv7?QYJaQk&-t&99P3C|5noD ztkZEeSz&ohJ)cLM1e>TSxgV)bigNIPk5RYd8=nF<`;vwb;t;nn-I_sJBY`46_hO-P zo5pn;&6>{RkPWBc4X3^hr_|v!q~W!jHU4M}@!Jn?)cHRB zYFS@lb-a3}%HyzX$Fc=ymWs3oKfo0QzoxNQ7eABU+cPtUIiOs^qy9JAIhpJk&60E~ z*)tSYq8=3I!ET23AoJhUlyRG;=}q*25DM$hJ8g@sP&{gb%vX;h0_Wcf<5}=nOn(NM z5IFyt%UC$2*F7d;xRka2jS|EJ89zH=M3FuRBZ_OX|1tqnb{S4cQs+}Rk`S{_*Rn`r za=bK+S3S$=!g!;2zl1)^8rAH=Y2DwZ4_4Nq?%66%J6aT3k$?69zW}!1WxHLZc95}K z`Dpb?vM&9Ik6fg(?qRD?mu!LQ3ZCjpjfz)TzU~rYo6$++_t=L|6^s140~fi{g~LTHKM*U zkQt`?r0}O2uIFsw6_rYlHVG%`?{Oy9zM-BOHOy_cuK?N(OwC)y;w8JAh+5xdQRh1U zjG}(ZvpmV+O9sCS<>eaSH0FPKlRy!glio-g33K@FL$}EAy?);c<{?U#J=bY7bfC`Z z=~GUs;|xALA0^x=GhB$N^KZF4f=3*$`1HakznHYP{&PsSwhnrFef9K8Iy_=r+t^Jy zbaq#;Z&O%n5}F$0ZzkDX@oSCle$j_$^*QDw^TWehO`csosx9eTx2SH`&Dm4CDP}=o zJ^os|$D{gsL`+$Nel-gv-vh8Gw0v9&5dP%b{XNzpA^^4FF9^B&_}SOTq$wGV%}nr3 zXl{&0>{p^O(@W1UDXXWKoQ#{O&pZ?f*}vRUXrU%}{gn4z!9{Gw*y~R@_Q@5{m>NhP z?(9932Lwj##yDho$$S(JaoJg3fM`w_2Q5D8fImT+h306X=5xE z@^KwO0WwUxxu>Xix(%d%9ZukE5b-ZnCJ^W~H9_}2jM=lAmW(QfLv-dPB_{s8brDSC)i&au^MP`*0wO)hODJH7_Nor%? zBq%9b25*6Amk!lieQRmDRTwB=KrvFW5Hdvr2qynRT&0gg_bV|}(YMDGqRI83hfh3Empf5V z!%&Yp`%*LHS36O(P{+B$!Xgz%j9V0ET^NHJRCobIjT=13EqYW=m>hu&W*M3pr=%2UTDIns@EZ9)N3h`I{S z!FbLAl_ZRUDA7cj>qrgeXZcC#fYZZ^k0ocJCZa+{x^MLA`mNUEW9+OF&`|10;*s~>jgTcgl% zWGQ=ON#a=(-Kvw?s*}*FE(H`t8^ z&f_=ObKt)sKK8g&w4@aJGHeCG*0@{~9FFCh>zWmvnib2M6$2Hz33_!$)vq-C))=af zos@p~nOGG0W%o*XDI;F1Jw1jm@@+hRGC)PJ9*2G;k9<);dsz^Cqn-deyf)%|OTS~V zoODOFRSg+x=MoYA4V69XX7*VbzH~QoOrimPaaLik8f0=#>gw4@nm5O98f2=>#C#?H ziO5{|rA9`sl~kwf~1yT?EyZ6C0G(4K8Eep9NhWKa{c__69C;gAOBKeDcAy zCfYn={Iw>EQgQxt1Gke9L2r9XDG&I#J|{^G&h9nKmSt4NH+k?dCZ#_cD|fQ^7{3Lz zO~|CnTP?{18)|q=uu-D5Cd{YJ2LHa|dvs>}n|g0=f>ZgE$$RauykAgWn<^JY@G0TF z;a2`M$ou8&J>!|uABke#j~b*uo;=)6X52{*b5%%!9X`^nc%3kI7ef_l?&T1y&T<7 zG6Wenc7nEh$Q>sb_j~j#*&}+mK4YyOG7U_kLe=JX2x3hJf{~x2(Wb8fh1Z1oTH zYn|?q+4O6xPS7hv!CkZzfjc4EA6<-v83=cvY?T$(0%U^z*&P`q>$A#@PFDr}-60^W zaW(~JkZ_ZAJUWjcVjmTUDasPJOHnvUR%wVe$@3fJKP<5&VF>#w-S_jo;4$^`%qsz< z7dG!)+S7MOy7g(a?)hIx(8^JbF^974LCvQRX(V%}w#8DdwaAt7o zGSHZu5Og)rE9gK}kV&kejowUN@B>~Cb=MNOAWJN;y96N^l&FDrlQJmn~6tm;LfDB#0CWpG7eEQVafhLoe<_8Tcbp zxa~^hBU3?6VHX@PE`9y|=j*+WfW*fzb(jFV$76(2*Qhm*5TV0YtHCz@`L1PM+R%Q+ znbj2Z>k(hVL7&gqM_UAu@B6t^lh!GhAX z(dqa*L1&1Ks958lJ%=z~c|T7v50;m)z_4p1e1l;!lG+`2gNzmfs^5WF$V&cX7H(1}9KDXuP#+ zhW1Bx!iYs0>b4UZjaiYVnPZ?$zx#N7=Z+vgLHE^K%rxA~MO!4Z&lY!pTSmtl|>mZsGkH0=KgIp9rH>}ZTu!$!hrqM?Z z+jt3YY*2JU1=Rx%zM z@WxlvV`{*44E7rkbmoV?LM@s?qAVhSoAEfPW(rxdYoM)hB8-8hLAfW?ea}}|s1KA! znKq>6B@>}S0H%zi{`7(7(+93kA1t(=N^3tg(|$T!<(+DBdPA!D?G+^pd~VD4^)I+s zBSh!6WS&Hioi1fM9rF*(81#}kR2EB^H~K>m1j?K{l`}=PUJs8H_PL}q3Wv`XAP_OZ za~j061k!S-{pL1;$8VH~KpaMEM_|fnk=Xh20KVqP`#H;~7P9pHzYeK;*|0l|u)8SC zTOyJx4hN}wh?8@Zx;cCu`|*Zc5Q5FWV!@DP z_R$wx$9Y1QzTZ{daYE6Oov%xoD1jVtbCSyC)UlLae$jVq^6LvpsAqW*1YfX2mBB%f zE|`-9+u=kORUW~8g0fSnDiX0OZwRppB4WfUz~H;;A>CR~ZWS0Ng;q9?$hV<{R{oP) zUXBh#`Vzef0=IcxqiJv_TfvzeLY!1D=Y0ozPjgo{6+tU9PDQB{M#I4A7jNRtQ8S8QF8nrqQ^ermp)h9wcw(@xyA>_akDj z)BS#!pFK~SdA!SaO>gL!i3M@@!C27V%e0w;F=)RA+eEkyMKp(j62khM)ER7qWDLH7 zZ4i0o8(0k)EO&*xY>OzwDH^Y}W1Hbc|M|xX41@|;AZCx;H#&WtXcfkKH5^O4c_Gkn#W))ao(|ZOZmhaS!lDPHJzxaV%yXQN9$2P%RKARZQVLn?A#}lZ0cst!9y&P*F?=Qk^$S#~3Nc6n7D7ma z3Nffm>G?H6ougwpHdtnTd1t*s%wRL5I7H9y-y~}aJYURwR*LRdHX!z@N|j)yxa_Y+ zB|})jJ8mOL+@Ksev5J@aW>nO~6OJKY(0MBqQ=^hWfPQwsjoLEo`|Kb-M&g0eQn=f#q2#cV$;43*DMCY+4;F%8VCNYS4b-EeI4+|d2z6X$cuxb?j>OqWhU=zzURIFtM*XjWfDc%Al9k(N6s+CtSP8oIT>amE`-Xj zZ`Cy@v2%gvB4DWp>}=51JSB1SuD0x~;LGn~j6Yw|*rSyJIF9i{NwT?u$?la&V zY|`nNH-KgdZFLxlAs>|t8GM0yIRh@lFw|Fjk!d5MWu{sqP!ZL7T zvMA|`@qN)Z0bI|)K4eb+WJ#KE+y;x4$g|cP>|_WlKz-(pLo&mV@PKEQa5U!Cz$c(? z6!eSCM?eC4+cFNsBLH#B@x()TPOg8)Rq(qnu#Xnxk zVkZ8?@y~(tiGy3)h*R6hysCY`*v|{^6GyxjV&{pZN{8&`B!GVh@{x^TRqOJEgV$(z zge;{y6t1Q`mer~^M7?33J599yMcF1F+l^s|#K-o5XMSDJ{1OtbXz5Njl)?GjUg7-H zz_~pT!T5#+hm0nA`<5*z%I~u_Av#cT!6c^S6&hvB@cP-q+y7H?p3)?AKAgarPIDke zjYePyz3CClx||Mdbf_FUA3InIww7wB>px#ud{9ff{P}`LH5_pmL#*!SlxUuI!f45W zj`)g%Nn(af;pDr~fbdsrVTI{t-`tjF3Gsh40UK|7oUeqSM)h_>*;pWHhB z`)JULWD?avVurl3ud6b>Yslq_dPu%11UVi~#J;FE`P+Cz#j48qet=f-IX+7kDTFAc zgk>-*TbA(-ynLNr`op|PAt{4-mrtWm_5uI%+?IIi=^p5j2vR0^BtmN}m>^U2I-)v* z8z~b!DUv|RB<9Q>qMh#P*?39V#R%A82Oo$Ufr+BlC>;Ec^o-IUi{@pu=srkju2iId zAA$SIOyfGieFQ#8;J&?=&D2kz2HtdJUBaVm*mh)n^@8qS%>+S{bi%zI@T&2R6A8;a zw~Jg4dXsQ?KhZNrIFRew#~^d#pD`{2Ow!|l=Gz~>xaU1l;Er@Tc$%AC<~s_?+{=wO zhOnX)GGYe-4-OkOOhd)o-o;6HLuQj7qCAB#j6x7or4H~sZoqK`ag4R~Ip7rtn^AIni~_fS+K3kdwp>n+Q9#qZs)7lw?EUPxy9#*GeI|Z${pU}> z#TLi?MHo`rDwf5)z3 zye|=x_8aWFyiDTtfALE-_2_(&PqE!OL!9|9_9>ey`>nj{mi;$8(WS!+bqev{0Y5hW z#PNR=e))kYT}tWn%iQR%H@9}@Z0_Z^@4UpV&^OSH7HaI-O0SN;-jRLN-}OjKi61gM z(&25{j=FelioIC#Sn3|r%%RtJa*C?x)chNB-&3}er(%Clwko>=p3E87ZA_qy7siv{ zTM+PTl=!9XeCSO&zaG5xZZfa#e?(aTKQ~ahbU@TJuV0yUYkSwQdyfD4rq)9Btc2@u zsrU4aZw`le@+jVmf!CrZ6W}k}s;U-;?y9$`Kh&vszLwX@iOahE91**d)AdxgmRNI5 z#+$3$&f7)@z2(tY#e3k{NmJkR&mtP{-{6WT?Ak4h-cp~( z-w|>`_paPZ>BNE6GOgYx;WV?kz1Gw4)zH-C`V@!rteUXh0VXvzzwpAb-A^lRT&hct z`$oJ!mtH^#~W!ve$u6oGuE9`jxro6-Va?0o~U^qcX8y(%k-rU92*}}vQ z8abHSpmT9ib5cVCQBe*h3wtY9Yie$8Awhl)x!1O?7S7Zha<(R}7BUuQ4(1kOV(9<6 z*)waj&7hL8#fidKyu%c+DTBhe{{7O&N39a%#3;eU;k$_IQfHyGI#P*ZDy$4#@kaOj zGpyA%r#voYn{tSfE=9k1r!+=4w`iko(p2{HA-=#>N%=Y!JVjnA;bpaJUW7df#!gGZFKSH`ijG)nRfnjy#U8uOY|(?xcJv z;JMM~cZ>d4x5Y;HEo*|{V^9IN;`;X;AB2D0_?Wu4-x=L?aO^BC+>a)IUUQqZ6Z4t* z?7A#4b$|co*+HE6ZNF;3>4d+c(Zsvsz0r4v?qdEuHhxW+YoommZF3IkOF@@+nQ8Wg zH|iW73QkmGbq(5aajReFhyrdI3eQeH`8K+KBt@x>R?%1*I?Y+lu=4UcyA*FDI=}2_ zoBDQtLmB(+{)BRED`4XOjA(zu<#&LW&-pF3!2OxWe!K78cEI&c_ufZwqkwXc*^Wk~ zsicj&e$UUR9Tc~5UFX<2OVSrN=lkpdce_3TyDVgD8^@|0Ev=WMKH&|ICn5$l2`%(D z#arXnjpVL4w8SVFsO~l|GtZ~ltB3Q%+gjZ34|A?nu^#t}-^7h^-R0dYXwSc{q8t!h z^r63*I{&>-b&+#>xm4l%NA&(~f#Lr0-jIa5OT7KsvH1F{&xh%K&Gw^D&Z6bC7RuUQ z$Aw#STF3m~T2EIjVq-e&P%fr~kB_gmZkz6%+YWP5c|x;D_79omryeUF^!~Z3yOm#C z8aI-ikFf=xm+-wGb6lNQaP zycx%m|Bk2JZ6PK3v+wgKXRQ%b?;K{njWqpPsATWEKNlm5@9?`$Q`NHjHZ{?*>qs?v z-N3P-T`?PQ+2C+5nibm3hT(#q_zk#J|ZvXR$=XGX7K$C9t z-A&qE4ynkNwYvZHaj~=S&o!Gy_Vc0B5b=(UoAD!*v4)O->$#O#n=hNHcQ3xW@%5j2 zE;u&5I*FrN-DtaiP*I(h(|LP@9_%R6h{kw8(Uca4O|>*ME@tYR?Q_~c*ytF?G3~Py zD7wShT0mB`qDi#=nUAVOw$tU^K4W_4xs`sY5ruUR)#Eki z-4M~U*{_;bdV^F`aGsAlcK5&4l8Z_CXTQGdAFL%6voUw@o9oDWy+>yty|yV|ma{ZK zd4IX_vps+$)q8g6r2wo>O?LdR-F_bId3iS^r?ollPTUh;SV3+EUvCrLYQ2TN+#m2##a{juhAXjOrFFdaBu|!%sMRg{% zUdHUGVG#NP5Z3mWaX_=U-3K}KW?b2q<#zj>&e3ZY4S8!jqFkjM%Qaz)#p;wn9^QHk zwc-vkt<=RIv-JoSyWmciTJT2FqbJ9j%9!~I=5?f!Z`)T_u{m+ez{uAy*-W+&cq7ky*$L3@Kl-s zl2tH~?u3SHoM*t$oK824w6S&gQXv1+Qm+=y_V4GmUn37m_}-8N+b^N`6Rc81A2d+jP zZUkN=1qd{L?F~PB^6|W4H9ZD>`Ly-#OCUdBJ7A{degk2b8(b^7v&g(ko3jnkQn#&_ z6I#>VmrKUnpt&a~xbbi+_|D7$B&xwhsl&6H)OVM2vah%F6HPVTgu2CZwLcK=yvPr? zd5P&(BKmgN6rcTi6H^@(T45lymq{;`y9K9A7UMf^u8odunZ;|t=Q`mZ;G2_8^*Y>7 zX^b=re7y)JS`c;ItbuFa1?t2gSUwcg0CObWnI~)C@BWrX`6NeDRn&r=_v2YTzmQGf zWD)#X44L!C4jcfs1j)LHK)*j>Feh}%?gG%wN~74yksNqqg_$g7A36mT`D!WxS*r>7>*H#9kYDg_oj|6jD>K`n88Sv3OvFn2FHT@)MyqFiMoE3(!|lRCa3tf>freDi}6 zM0=TUa1}>VwU|su_A220e~W^)33SDv!FILKuB<(jZdulVz=0@-`#Qk&c430&wD!X#*z%W0AIzDHu0 zn1Ti1oLGR({e^o#ahd0sVWz}P+M$sqRkD>AaLmgfEx3FkKLncv8z;e6O2ru{R3U#k z+1lWStb#Gy&F0B*tBv;|g6@D3xK?DPsBqSPYg!b2KJ>jKX``_3$%^kAD#t_~s@ zYWml7OHb9+G&C^%Rr2Hnz)Qx$xfFJ)RIU=Ppmz)2Vmp~ zDAxkb`O`Dns4`E9Zp_0R_%Or(__Wi-7JBuB9LoKc-EO@_p5)eyxi*Sw`K9y{r@j^4 zEM`yPo~7Pzdr#7D00=mT)u1RllGAS5%*?J6?^S~ml~o1_?>~ZG4iPZrMW#&{*cB_dA)>3NnkR4TzC=?Fe#)T6K9oFcmJP z3z)Fp7yv96MYIC1;Q@eOp0fKofb8pD25OlsQ`sJJ&~(xWf>t4p_!hGE6S;$gV&KrS z+zBSebtKQY{zoW4|$xiP}L-I^U)0MC&pdvf|ka48J{69Ch&-rQGXs!CUS2&2} z>X;w(bW1pA?d{M`^N=(PaG4bI3yC%V6`y}3dZMoFvgL^(b=u&=Q3*66tr4*2t#S#1 zjzpr|wzZFeS6iTdVGVay8r4>gqDt}rVwXcC$T{W)RSR3Vx^JnAVtmi1O?~A?vuU9Q zBIJ8EGN6Jl^LDKXjJ%>Aqw zUl6x=afeI07tEztb^tNs9OLf2ilS;w^AITZAW)<=6&yyUdE$F%ZlRnYRm(^8kr}QA zF~brBU4?h?5ce=P&AMfcK^WD_4WtUSaEf)yI)gAiJiuxoon!uPV%oL@f8*gvpFxL|8|e%w)d z^ptf(185saW|O}g_I_Kv1CXRU%WHRwRZj48pOzR(p**)(FcnheU&M&-EdtGaAii>C+2$ibkH0#!F1~GQ; zh`uO8)6Q*(q#PqeNIAd_q0kMSR}7^4-~_vS29$zXtF>$nu7T54>y{%1xu1~9oz&@I z+A=K3*!^N`+2F$V?Avo@NtLUo_Trt(r z<2&FY0*Y9iI_J3OwPLb#z;M;Q(;r3N#VcH@hIW~?3JxxLFXt@)o< z8~3zRW-YNM%*=24T$1SFG_u~hs-#C7bX3o5uTCMAu!_AK=33r#%CYH5^7Qo|DD~?m&oPHK&@+FReMi= z9mlxmuHq-+Yp7D_p8-XTO#L2&Ofq4vE&za^D}M518iNYUHLjgUM-Td+zH!e}#ZM(@ znwg9jjTa0+X2fXMrx?&kNBcry){G-MS}2H`MZI1kH~2`k{&#Ge^1UUG&HK1FZy@T! z^Mjx{0MekIv7VN$ia(bj-s1alqMo)MX`_ixh0_Hu{(j&lM25Ut}QVoE1SeVH`aNq;Z6;ZRYy zXs=;7|M>$YEbyti4{L@fFAq@VqoKJ>CPOs{vm1!l~(aXeWb z7a$wwQd`bxA!-Wn=aEAg>c8Hf`zY=C;gM3@31*zuckbG!$$yZywi+zS=IZK7=6n)a znqDWQ^%jq;bJVu*eN6vC-^5`-^;HWki^96D9Yx>SA?HeeG1P*mM*Ln6YyEoZi4c$Y z?pDBk>4GqYivofbs;+Hi&|K+Bg2KFtor`c?kng<+gH@5Mjdj4tW0RbPu}hXtN1A{O zLVFcUo;3dW{ea?i<3#y4oM#n3I8WR4>RVdtcLMCn{2DAh7z9cK_R@8i^q*f|+R@mA z>HRG~@5#qY|0(XFRN=5E^c$&9G3UvPkBeU?GFQf#D$zGA_50bG!m|)d+x?MAHX0DQ zc6EDqudiL`zda78#Y4VNF*Ki#CRtg0zE1uua)V{yWREnL;9Kh)zgI(oXbyFx68?== zE%GddVnYG#DgM#)RLQD=#fK?ut&Xty%2#4#W^So)cOS@_mRvL(uaj=jJv!0Om1wsl zsvV3ZH?^#(#AG-3>IYk5)-RFN&GVN#^6$`NPsD9V`13z$;UB#qTUfWl40f{r9nh=3 zwrm@jTacUfd&}={9}}@ah@r23lQHNTS?B?-qw*J<7jY0S-?3?F`no~ zr$MHrF9u6Ppnl=clsLMrN@|a$Hr$O(_a=)o)&@+Hja2pd4MKm5pJgN>U%~g??JAaT zbI`<=6qwaT&a5xU4T$7xFCH2-wUu-JkXk1XCx7E)?yc2p9W}RZK(NN9k`NJmAK5&1 z&E`DzW7Dp>*bJWgeEKJewB>wsd}%@bY&ZC#&*A0MMaC&KTa2~Xe6!!Ti`iX-9BY=I zN~13JE4GK+;LW`+(OjB+>gFSDk-m7^J&X+qW|}@Gm?=&yoR&PT+IUOKW0)Z(lPK{n z)TNuigt{G@NHb-u8ml^!XCG8?WEs)#SPEWThkbn_F&5P67)dkH!uU>OgmM2pxe6DE zkzkhdiY8BnM_?A>VRe(`z|rTU&G$2NEkl`a5QLQ`_8z}nnC`{ za~B5{t14L*p-AQTWVON}b{0#aJ~u|I&un!kJ@8X_8+u(4=BnE>7pN}nFMUNwU%MAq zt|qxFddgEB{-zCdf#XZ7q^_ygKaTFxCAHMBoB6MC?B6;WH_55DB#eIy$IrF+3vlP0 zaQk@o$BX8~CmCK4xEaLyh;-kOj@L_eed%N}tqN6WBKCTN^H2(-7r&yYlh}Nn>0=51 zdqt9vX!20}QDt`!1?WBNJ;Ghg`U>RROLo=WGuHR@gpG{?xFhHkc6u1|SWoh~jc0Y2 zf1p2kzax;V7&lwP(?={s_(%qm!}P6t4ewfj_9W^$`Gb*WVrQ*e44fKv%Wq}hAf;;9 zfl`x3hw|mWN$3*iBgJPi>-`?ETZnNy_ikFM=qxDgA(l> zr)6OXlKv6Oc&dmcedHU=#I1f{q@G4jxWua%%e6X~(j;zD*W6ock{3sSxZbpztE|O* zcGoMosrN;;{GL~itck>k_ZX)j#yz66L3c<2lX@#1LGTObXhKWRN%+U^SyIbyxL@Pd zO^JIAOqaEOGFbL=j}OoC&Nnxd;0D=El$qrz^%!H=JF_N75ZiVs$A)s-p-gn+VOY?H z5xrn%5o%BxR*aPy3#z3HK+a%z9PqKT4|Aj_vF1Mvcfw#r)hsl(b+t;Ya@I#MRR$;2 z@A&Xn88P=#<4_&5LUDfMn z@6|sSR+ZOrjglaKArCc3QFxldg%ickf8<-0E%n=Sep2_SzSpElQ`1UB7vqFF>1-l+{0?cF394pvx1&{oXfT; zO}`4Q^8@Xm&4=MXi^O`HPm-faQ5~Y#j^#sxNaPJCn;2X8;Ktww>|^L^e)5i2IAtm* z<1LUD56A>9yw7=LF(L%W?yYWn@ciQGn^KD7*qI3t0R4Z}5%vkJLhIPp3sRnos1B!K zG&lM6x9{nWW0KOecdxyN~iwMM{2r`8AoSo zw7*=A8p_7)I&7+6$b#HFIiP&IgcVM?Sa2{5VjKUoH2}TiF1BfP3@z6uQ5?&tJy>b! z$0^1q8LmvqVh`h7#^egH7=5wklX!|K%l^?Z?NxfIF@2y(lXRtC17=!XRbPnyRy z0``I)@DMK=Kq)fVgi*5-lbO{5qZB@m2$!gC8=ic-Z^3aaQue6{*610>kN8YtTL+Ga zbIX%DQ`)#pwff^lzE<+)mz$l9IEF=ITH$+yeXWdUq?7vu2P%~WvT-<_jXHd~@}jH` zJaO+47E54U9F4ax=J=XfIHglKrAas?mGsF2>638jlZ$NWlg7Bn>`9(kthn88!!ZHm zUaw~N7KlZ^(f@EM@fUoO&1t?l!$-XG1Fh!CH-6`>nWA(r#sJwItA}KV)^m$16YwH6 zg860#7Ym8XUAy0w5(2%7>iTf^N>6uFTPg|ReVVv?}Dh<2wZ_G$iFAV zprZdh@$J441FSS~Ar`B&Z|+OgFepN@)c=HA-B;B&=Npz!k8RZ0vCz=MF4(daQ#eBeNeG_nA_s9Zi6yxR9tcwCijIhhleLeVS<9x#ZgdD?Ke4jAOV4IKW1MsE|HHla!@c7-#vc3Kx%OIX&iTx__WR7WhZ3e%^b#|e@*qT_ zFlfT#XZT3azRzF9=~^{tvr_Qw7N% zY_*MXpzONFxS5rV*|}bZ&o1*dja;=J-;yP5D-upbYe~wT*bHn}%#0j8#oNAC>WqZh znXbq-8>F65B9@06_w>+9wOaoSLnK&%CxBar1M8Q&QLZpgKM-H*U_R7M2V)RcJEY+L z9jK1|JH#n-y{pckB@T5NDyF$DtEUTg51?Ln!%XtXPv|@N!SEAs@Ia9;yiQomAX^j~ z5I{{wcwj8k5woFl^~Or3!}`#gs+~{D{tCG{w={k3>mbGZCSUox&EY6b)6Gd##e(^t zl4tsVz{vHtmTD!};c$DA^VPy$56NvWwF3tAZL?v_rzZAKU{b3Gbh=JL)7P-wo*2oyi`r3MkkE>Y!> zjZyzFro;2@H4xRvxZbK*RTL4 zn<`!;aLYJ)$;E9u8zd4zF5ye37~X*maZDj0vrRpCl9BwmYfK>k9nv+Qt>E?x={|d; zqXkt;sA9rB*k5{E5HbGQ|xHZ;E!F$aUjLb3Kj|s@OuH& z$mwG_oe7%z>#%k!V^vvUIl}_u!DRDZ_h;2xf z^$ReE-7~EyUQ!GWeyW;xgIRuHI8Tgm%xL)xceZYebgu7EPt-)}fLr0;NCRoShb+H? z&v)-1=rcNPI~U`Gpbf^hsJDIeN<_|5@FOCv8DM_CrrwO0S=#xPA!!8;FOS{uM*_Wu zEKuZR$Py_xAN%0<67cAf<@iwK)T&Kkk?w`yfPrW}|0re7OyJ6#*DYyvI}MD!T?d*R zTc`LS9X=fdIvi7J3v~F!P!pu5d#E%I>lSsbDf-;CG5AmXsMt0)8h8R$iNNJ6b>hTz zN89k{b>g#`Ze3vbgSigBSQgHvEu6>)f;4eAph-jhhh0{O&>F=5!hJdiBW$l0P7yC@ zf|%zen>)65(*7m^Kfc33#tfS=fbP2L2bGB4VXN$|C!aBpiut(o^A=y&>tT!|xq}MU z%g-){$1DH}z#0N2KD@vW^}N6{!8?}1*YgUIujwMWSUZ3Sb|t+;*u^?Xc`+Op!b2`) ze$K{{rEpwuuUdLc8{|-ji5PMgVqnBd-yKe}ui)0I0^z(ag|5S%*AnEK+c^cTr@N`8 z+2}V4KZu60X}=ZFjG;;h^F=a27vKM6X$Z`pDFFDpSW! zh&HVt$g$`&S(YbVmM2;Ed$(?Jt8Ve4ZgFF>tjKPJ#L6j>RE_I|@lyCG`Y$vpB#?V;DOHc5&r1z|tUQ8y+$dnbSNS;`wmzQ!Ag?lU~TVIxD4I4SqpA^MUn(u*e`p5&g0#pWvO5kN$7di^iYWixsZqu za)F3|6;woGV1$IS?LN`DadtvAuY;_#Qa5toOx`%L-`ahi+Pn^OT0;)Y%cPvZMG_X{ z9gtQ$IE(J=2K4k@iZIv5M4-F$Vs3ch{=}i(@V+F*I`U2f?hfmQw*bP}W)hNJ)n}mA zx={-~#|pcui@@=^6x)H}cr7WG$S&%$mBY^EOiTcL@8#L_Em{ZTJ$O)xMX{3m}G_0k%V3=n+Tn3wsPH#jexoILL%6WUF|uH z+>2d3J%!e|WA*E-Q<1%ylr1q@91Ag8#P*WR?xDUf&FxoC(IW@i4C=f}%Afm!XVyJ$ ziP_M@V?qQ%FV>`3fP&CK@*reKddS2CZ~;ij599#(@o)q$fs>?;g{}+dh|&E?O$0KL zuOTzq8(CV$F@L>B$k||mTjR3NRO5nS!2pIBEzE)7MPMg$;M7V+TqUm5w+4>^<=iB{ zZn$)WXuocNyKY#n1J;LwVJ#+*wjo5Bbo?QP8v9cv;14kgW?n%^y}-TOImXSZ7g%aI z3iBX%rn4RL3txbd{3a=YMV08}=Kz22uiT@v8NSW$k;ADw0A9+o0J)<*%L+FN{ z$2M{}>U$Z`ByqMx@q%sNzn$2d@x;AHs8eD21qyEH$T?Zk*@#^MGGKZoTV>Q0-V53U zamX1k`f;?DqCvhu4-aw_dU%kdC`E(n>!Q{XP|t`70MkqJgB~8x7R@$r6;x_){(5O> zvLcEkG=Mcib!x!~5oON7=z#{XUYeIpdUzaaAr)&q57j7^Nsyo>3&;csp$U?&(G%^_ zFF=SSAmcr!gt;DQFe?=N)noo0jgCu@++MoXpA`8yfvF!{K%1j}i=b%YNPfD)Hj@^bwubd+~4v&P>xzsD37)*TTJwYm8?<;OsEOci%69ASSet6|}o}ati|c1%2=j zP^i5deb;IZA%SZ6!+$mu!yhtstp*zF?#sYHPq)mLwj{u3Xb2*8^@1LgA`!zdUtr?wQ#LN)Xxp!l|{N;HP3G9oY1OyIl z!6h!=5DAr}7l`4)=?OW#9y)-3mk(Kbu#g~7CRD$HYAAufJ^ zMRi^n89=w(53n-B5OEJoIXT*f-oB)MEx|pAg07 z^*j_OP?xBxcNBA?E_99O~+2xn2Mk4hH#wSHf z?z~XhrK02O?#`aGEJ47=l3kYm7-Q|?heg$QQqHpAAJ}j}i2fnJ)Uc>M41=H3i%D^F zKNkVu3}XC`z52i8zrDV;5}QmA5RhzhIQyqnLvs3R0X785wTFZFtnDF(vo)2;XWe;9 z*k0XDSS`|3j^164-c`QC5oFCCWX&IB%?1vQPX<|9c@%yF8_54`{JKAq(^Y-iQ->^& z6p7#fqO^KsfeBK93CSV*&_$A4nKRbGFz;#?$e5NTBWu$H!|W;V{YmEQ5PM3L5FV|#GuQO;)sglye6}4vndB}bSQ=6z{PE2We?`9+&q4k0TD~6uyxTxWAd%v|TY9X}`doO|Rs`RpjO~Q5q%H3}_PIPx67$-u zj}NUkZ@4i?v_CN@()cM#_GIc{Y&gsN0#8|B52fmBc4hUzSiZ+-n6PdVLnrBFWG_jr_-0C$KSt4mpwnvPnt-ss3&`S z6C)EvtRZWEqevD&nty(Ub(VScSa0~^;+^RCQaoL^_vp3S+1*_@nb%GFfB7-U=9;P& zRgI(aZznk_3w03+X6JOXZ1e_QTGvOf#|a(kG@FhaH754z2S}N3o(+VTJnFEM?9MD< zdvL|6x^Hb>(%ih4TQBNxz#5#%)TEDa+?DBgBXAi#(M&Q?(Bv%^Kc~CXEmg{Wj!|;F zy>9F?H0C%VopYLGm*hB9*)3T*U~4bJdu)0~PUBL>@QZ~2qzkd>%SBsI0%DW|lMwkNTR9BRz z98<;yl^t|>ZZ7q13H!11t+n}|ug>w@Vl&hb%lParfDumZuLm^$#4`g;ol@ox@e$FaoR%~bzZB}^wjUwH3_Z)u2-434`@omYXz-b zS-)yT{DRYsG>D_5mfISe6Z1U5+mPl7|LjV{;BzcG|6U+Ib;-cz_Vr$;*RAc|$&pxd z@bZyZWB2*R{BiS5r$?Rs*=4`Zy4O}S`|bZ3)jr|2yF24;j>pSMF;DNui%0X#_170Q zX9NwY3H`$dw9Rgh4^B-5Ii@V{s7}PLFK7OPXkT(#Us5Ep_VVWcnrL5%_oC}yj%u;F zNyF!^#yf%4S^q`TGM2fo(FaotaXCk6$g8h zXB%}fJ3s4$X95>H49&nZGAJdW&!7gM zddf?Bzh%~4+5S1C9-k#358d%k zt!d$Hb+K7YMDtt{eRK&HKh;FMT>Z6-_~4#WZzN5_EC9I8%bcO!wMLr;sd9;v$2lIP zbEBIY#lcswCP!i+H_b#qqp$e6S+O#v{&~pcPb>`};opi{M*vQH%I)0N?CUY&_a0N5 zD|!0cS z#XXz8`%eS&MO8x49$uW<5@6AL8|bxqXMo$UCOHAU9CzoS`Lruu%_^M0wEWzk6y?$yt*GTRhR z8&42Uo1P-#A08!8X`Vx?ss#6zRchrMYh(?6d22dy`DBDI7+I{Pr;g_@34V4zj|;Jj zkN5^4%Pz(4cZz|FC^S@0!G4t8a zB1;sc8K?mV?MA@orsemHx*#fjvNd}`JCf&~VXnnuO%Rw&R4m?3v`x_$&bpK)nHexM z;7EF*D$_=SXU9+3D~@aVCT1^X8v^DvGENUfKC^g!Pp9Y73Q07Q303v~@XFW;#trf6 z^ZIJRBLZO0Tp1&pqe%s04OMn@r7LH$V{749V2m!H$ZY2ta7pL0XXP6%fZMM4LB7?| z54T>8&>A~4tZ)$!&=%~{0c+bo__si6yfA@MA4JHns31iD`bv@qkm->}jsRsh>zjNe zul(=}+!N41a=a)RBTtI0DP+8xhf;%^omoD1SW5A;A-s2riL)WG6eJ@>)N$M!vF!?g zSRYg*rOYBj`@TX9!%L=OBaYQi9HLr=0J{Chcve3du;U&}Q}l!;O<^i4_|_D#591*! zec@!zCjy66J|e~Q8BpfyoTxtIYE+*KifgmHeLAMfd`gQbl0MLPh1X_jhe@y2^OTb# z+6=rO_)O7XuLkcYfgM(U>K>_8kfhgarFwgad#TP)^`9kZD4sL%E|&2V6XNC_YA9YX z@vfGgPr<8b>9)8$W-cvrRk~Sfp}dAe2>VcM_N^#!HAfpi&r%B;<6)>$HS^=C3PQ8~ z=ae+#dB&h)()XN7&Monyt_U2>^1GHH+Vq zb3Z0ja$1Ya!fmbs%TNLw>_m#tUzgSU?)dj?`O$50bG&IlhCS&A#-P{?aTjZ7Afk~_ z0yrRjptCwc3v)-ohDg6k@X%>qdO&X1cZR6+a=lS#d0el2=W-As1^y6o3+$>^%O21t zrx*c?Ry>s~;e`bbnAZ&pqANkPM$`TB8(WB#KC=q4Cnnp{ySKT}nReOE``bfL*U8j% z*+RWSYZ#K}{69bnHCqn~MvzGc4~sT@rPecpJ8&y}Ob@aNvOhrl*lj(i@4$H_&H#x3 zNfw}$5rbQ@(2#QghJ#P@S;h|bsL?1zvT2ANtlF*>a<1I?{ zgS-<^QJJ8g7cDc&1sxR6s)~F?KcLluim)L>0cM)`f3?G`#o8BQoTd?5GiFD9x=`W> zXOk44Sy;M_pMRq3%KvF)n71~h(9lLQ%?FQ`0VLThV{}0%kc2G{|M@kwhO(Lr@69OP z2phn}$Cr?F>`|5>4rUH@n(qcqZ-Qz>tbFq}UAVYUtkq@y>p}yN6yWPY2rMdk{^uc9 zNw^{;w@=MT^keJ6$4L>R23;9p5K^2bSx*~aaEiVK=@Wln;{!UnG@#1E)&i^@0K@(w z2WFm!oc!t_Z!|dq+tB-;bHRwvj?D-wPPUwZB8-_AshpoEugY(aRQtG}vFWSMw#oSI zfJE4bO<+Swt2z4kdG1<e5Z#``T**tR4Zzet@_^kvmtpGv^KNFkLgw1O0y@2LN2G&qrm1b`bT5)O57 zu=2g-0IUL5g@@E)i37JK0ry1;R^Ce51yQ0)8ZcSfajy%RdDGw~N#PB-(0tL6TFi0a zp4uP)ja|%vFsX0&zN#aA?xgpXOP? zL{Rcf?R&`h{wg)dH$Te!B~vUhM{9r_b+`&n(cdeO4p1PA=teYP9iP-nf0*L1`J)^- zfGWZ|ARh4YX(!ZPI6#kWe4q;INp2Wi0TRCME4P5$1x_jg6v%uQzzk5u7Y$+@7DAOB zDfhzQMP-+ahJ$>(Y0oHV#eHJP{UtCR$l4VVfi(Q6#TbJR0+HW5HR$k08DV?O?(MtG zCm{)Qq?*2#0Bg`6ZBT#ECj*S^v4$i*VpV$n#f=@8n=W?}U)P1WAOr7q z1f+8z3_M0>f6CJme&0X7yihJ0H9`Vp^62a{+%4DtTvU!?2Oj+xi~Z?~mRZT{(TZjd z!=KGdY*9>r{mCyOP%fku!g;hGnPdoP+_+IUuQqtf(0926(rHaz$SYO|1I@T5$k zu8B;6FHEVKndlPd-h}cG;1kI4C7E{?mUrU~8-!_aRoTMi8$D+;vBM_{0xqNBN|fNg z=u0txUI*D?5fg>S>qa34AmwaXD#5TpndVn8q9(B5K}vG|0Plrh_*lMOKo%zDZ@0VDH8rtDp+T0xR_S>3kvMRCo&_9?Wd{IZz%_ z3n(vNj4k(GTsLe_$_zeYoHT<++u;~;>o;SQJb>WemQ(*NFrM04(GIpKW^dni{=8aV z+9#zEA4wA+=a)|WSaRk&$Im<`;8-N03rssTCb~T1;J`^>sE;7qpKT(Ha4DC3JPN^e zm@o^|6I;WNr1AX#g!=EzuiT4cde`7144D2KqR-PWUvMP^?0kIft9D;*vK2+Wd zHhtU2jZm~meX69zJ=cnjQ0N0H`0|7eDsP{NB@1)4`AvfxO;FM4SLHX#cgFMm6lp7v z1>Kj#2N|62p#k??!)O)(h0N3QU98R%ny}}k=dj3y@Te`5+=I(xLZu&|w<#om!a_-FXZqI51X~5pbuta})1iYaXjC}@C z{D-4iLRZ19#Z%qzz4Ly5kl{o=luWi{#tRZE{N$?i$j8WnS@Q|U`Y+D}+= zzKND%i!Hp;Zye7?c2+LAEW!+8W$jRf*s|?I z`3)m%&7I`CMjwMbG)pba(joMsho1%qPAK5j^B!m-I5U8lLs(V(zQ}u3Y?VOdo@>Wu z3iTbQg%`Ck`q-tTY5W4Od|I_d+w9YSmSFgChXS5A??DLAn;8=3Zz8HK=Blu=^%wD@ z$W0!0N*?i}d?*APC;}l|qNULvyO>OkJ?N7M3l0BsPXe`aihAI^!6UU#8U#I_apL&T zWDiQ9OivJsu}guTZcOgG_e^xJdu6)nHAemJ+2e(Vv_L{PZc{lRHwx1%xB>`D`P!U8 z4v1kC_8;+_T-Q_0%cEQgC{xGMx7YPfMldx*NxPb}P68E**y7>h?sdW{4gytlb|PED zSFAmR`M{QQtzrSvN5LC%&b7pvs+Irp?;d38bv=@CP}$E@{+kJ({Z{&Cv%zh(evEfC z0{__ZXtHSo_kS?s_fh_dynIu_C%TT;U-&{oDKwy6MrZEL^M(RD8$+m~vHu`Dsp)qs zYX?=fxC7+Gm1mGM7O^srtG?2ReTf9(HRK<*fuXrOKzaF(=~`*wKKsH$eyP@v1FA0! z4`S=*3Uj=J;vuaM@^ErqF2VG&P)K&#Y1-hIKU)xgVsdEv!C0tTPIS&^zWM?ya~^Re zCUx-u%`#|BooV{+>gXu~_ufdgG2d8o^#1P!L*%URm^Te%=BF3VgOgF|S*JY5jng4p z8?&=BbZ>`(efoDM`4g(TDx2?qb-nsMgJYvFMhr-CnWxvQ?-1R_Q(uqHMq1V19e3QaV-uQ()jBqreDw=GRSDEd$kQ4@H1O0~lwE$0?|X$Fw%k&RqYC5E`?oK0xg4uZo(Up-X^Z;kT1t1U zw+1xJscfO%rm)I4$5Y%}uX^TQ1i~7v*hSeblr|J?pMftw)auc5G{Y5opJIkDRY#4@ zidq{AKJy&lo_H;`=W}#MzI!-3V-rvxI{lSpC+cNLYU@19hsUY`s7hRN_8%_{Wb z$Mf6Etk`?yhlX?fY_~|P{E^o8ZmWieJuJO!-9_rnPrQ`*l+)HOA_K`V{jC{BPflgS zr3DUi(XMo&r|_fzc|@6+4X&8o3qy$ad=4*YK+T8{Gi|}-b6p#vvb~h%<*I9Wui(u^ z{ac-R!AU0)g3qDL?N+w_^1tnIKZEHgrckZyAMU0)oi6H6JnOqb`^kChXvD~W6#iSm zaLnoQ$mD_Ro@6~Lvq=m4Yt1>W{iU8&JzWWsyh=S?8aoW~%WL@TCHJY9(>p>bCAFN8 zoaFR%|2$H|RN%3IF4Gj;0iEvb1NUlNh6RMFVqh z$HxQz61@qZp1(0?k5IyiFfW{W%@)KrPd$l^vby~6rwPG?NAopnX`5(pM#pusua+>| z(dKU#`;1f8(nlfk`+jd3N>iMoP0p=U!QVq8oYZ|=#^qXF6&s(~yPd0s%S>jMcR6={ zXz}pOoG$WLGo^WgIH^*$rxDd73DYR6JrVs0OqDX#YUJ~vj5H4VlVyZ4<>!+_dl!ja zjSHpxme>~W6y@l&_^S^*@bQ<`?YgVwaQv-tzB9Qs9eIDW8VLM>T<-WtJR~uPbdsG* zvU{PtLw!aaujY(3?%|NC?N;Vm910ulZT-+M59KDN2*e?nYYqvPxWro1PyU^^bSWjj z*|Rlpy1M0#qU+3KWP|F|2TP1n5ymZ5Q7m7e*ECH=w{jA#pW^+qtevV2?Jy1Pl%&sS z2-K9#3)I+Fb(@%}RqkBcS%<+Yg?aOYM@SFFx%v=xngaijaSPafemA98U*ozxF8}=a zkqYU9U)(%t!XrzTBn*$OEK+|sm%y50g-5Io;dbsw+LH;={9KH(guGmgl3E0OlV=|K zqFtGhS(gn&*P#g^7~^;jR1uv1c;dlWJpSw2qgwXNhM>WIzEmt%nxr|lccMA`LpdiA z;DYb;u=%F+{!uXMW$XVWw=8b;Au2^U?uKJ+V1UjhtG%?Y0j?*|Noh~*K}Cw}(|b9d zZ{PMfw7!LH+E(vL6zrKdQ2hCdBSP1T?6hHjhWOIy5ez?DAlGDaQOad!u_p|BdzWa7 zl?9M6F)iI-il|N7?O#Rhft9e|Tgf}FpJP9NU9ht4b`GR8u8VLQ?lFLRjZYA?xDQ`q zsZ8z(4BliyPv%hh^~*bJcCk(co*zZg(gVg^Fx~AXIpt)TI#Yz+L3^J3cF41tZlp5( zl0aoMuwU`6Hw|xf>wlwEz4aUm`b5s}(yZ+=(92-WQnU5_Q=sLHHx(5y^0kkn)mxfE& zEe-oN6f=-9uI3aO9+h%B`p0lQhN}3>^o-(qxBEA?_ZF(Pd{W!tu|PyEd_S3eIg5uM zozkY7m4+LO4-)}p`pG*eUpT%FZxuW?Ss!sT(!xT;@7oaTU^+NE4Qo6i*yFIgHjA6Tx2OML%RLU{^ z*^fq6aY}dXBs-%?oE09q#f%F`o1p=fd7h#TXLbTUqGFlCR6=wQ{sJYHZ}<*1)N+Vd zZwcTouc+(p%wStcRP%Qg12-RH_IwsS2XN)Rk=5w^8RM1k`jqkdveC>`11s*A!?U92 zb%s${))t57v%i~abt?b#Y(=@0>3j>v1`-8t`wYDrN_rW-I4L-;|3Ze04wtNqpC}O4 zA^?XK{0+`wv*P8KPN&d;Ror`%j92K5U>X$-X8G+#P_DPI)nNKCX;P4F9Y9%b-*f?I zTD|df?UHQAZS$nU`2kX!E#ZEya3ZtIISlX$w)b^fE{{|8_I1{V)(2e9?M2N~b^0sL z+D1I4ox%8F)d9>B{^)9!+_*f0dSwfvHDxt_`h!DhruATDNNe>?heiy_`2Ov9nZQh= z9rRwUqwd}Jj1SB2+Gx`$1cSa0y+Hh|V&|E`IZisLKEpEDG{nLsYgJk;!rc_>TO}5t zq-;sg@ZI*63_4AIP^_}Vt0KQozdn8XrKoJFe7~?!=Q{__vx7;fF|tv4l6_a>?|N*a z!g@fG;k~6hs{E$hmR=0m-OB&2X6Jne;(X38BH(4D9hubMr-Oy58&1#XNwJkZC@8*i z5=NT%SemC(i7JKMKFl7T{`6PO`ZVP!!Hob}@)47ZbRj$3Eb9Y2b6Dly_i07!{h!Dd zTbw==v735hE4UT4K}3u~_J^7ZZl!I^jzX(-Xzdrt3>jz+@{pz&%Ui<8;sCN6In<&J6GtaF$xVZ_hYF9gGiht9IEDzp+2?u zbGVezB1AO__?pKRmYC(~GP#z~bs1pIE^01QAYKa(ED^I5zdRkgZJe`4<$3Lr=Rmwd zgri|H1OORFOuo8>WKBC5zE*3akggeOYh%8y4=9YA3#r(3d+ebIk_8@=i?_xQe0SM3 zo6%wcc>vE#HQ~H&NlR;1L(Raqv+mJ->F5ekJ`{0C=(7$t10r)l>>FhuBATC{?(4yM zT#a4p72U`JI*8d_2UJAsxEf&FXc6t%4ZPi)U%lu29(_5q1&c&N7s2T<24hsbqZ#okRJ=pgRKQcZ>z#$xL;!z~=t-5| z8n%QrL}4(N0axAACkxlO);Y|?ma@e|G%_Csz~VMl2QhV3c-k}vv)}>u%*c>oT;Ov# zOo~=4692z%SX{n!zsE7C41`ZnyTD_u#;L zW}p=*XY$M&vH%n{M-AZWMml0er@)lnNyk8u6T^p5LNtlpVos)>QL*}MeXj_XN{8#a z^!|p`@6I{l!I|AmxNP#d=aTrvaZ%NiMI;m z{XJiY`h@%*#pr-ZjYE1^I0x}K_VRp+gd6xDB`2WpqhdhKKzD#`y?AKgue;{0WKT-G zZu0r>F?7418b#sqAay^@PO49-*Hh>b3vw>^P)lTo!n{Q~FbVw(0A1+_PZazuh ze9HD#{&c@&UVhv(NuaK=;8+-cmwT?Hcui05jf*K3iYtZ|O7`M@S-o=J2^clBkEi;9 z{nPxqopC(i4bi6XOotld?{VkpSA{C1TI)N^D<|v4`qgtFd}PtFg4ALaV}&l1&-sRYvpKC;YOOZt)wlL5S}jx>!&DkWY!a-ftP4Xi zu08zZ6%$O*$P8s|AP3rgo7Ik=U=3UG3rC<#bE97Jhm+hG%B_}0n(T!2O+;gUVf6|r{w9QQl8)!!#HjGR5avZjp5 zlk*mq*UXMrs&$+l0C^epYBjEERDfS!xTtyuu;ra)U4b45bgZ*IT0y*#;h@}%2tWY* z=_0P6$2-QBRF`gi4_Bi_^t_KD^O+QG0HO&QY&Ydff}a;2xM-6HSq}VKl&RZs^EKHVzn}HYJZdFeB(`2o0 zf?7maME|VTc-X+-^#yWFda1)-5g+XAGQ$8DKS99;=^t%<|?t~^m_Sfxp1g}9bad;a2s(l!Z%b= zc8$pPE*PLjh7hg8t8-vJMMu!lzCGiB$oeePhqZ8=kF%hnzR`CTrQf{GEo|%*$Jnz`W<3PY7AWr2gI@{TY z^2XFAtAQ|^L)5(QaZ<-<1_V6$^#FKYG5?7f)Rpnvh&=LpThznQ@Ba}5C{O74M^PYX zdFu*eTJDSy?Vq(}h&%?76?ctBQQwZxBSmyU>`as%EE0rGEdX}oc7!$o?RHe8K~GnW zYOyfdBU}k>;)55Z+z4$v!NGMfGdB&L|2rY_5AO)X$?ht&>~=V7UPq!#IEb2uYST^I z{&cp8zp047;q37yGHYhOU#_EXRFOFLO4=+qdb;}CxsXNdSJa*{I^aR09Ai8;*jA-k zQ)t6LhDu5qr6XwDa1ffI6cT$LeDX8cfHG{L5YD^^TGj~u^SBahAp8EHDqQ9La-;%N z#Vdw~={{1#EBfFO21Yq8?6i>$^zkqBEvR>x3?AxQRQaZS1ACIELw_ktxt2T)QxEIf zF#6sI`||(xFUb5Ic3lK>GJxa@GS^gb+0wR}OiPLX(e<@l&9jd@$FcK*?X>Fr?Z}|! z6%>VskJ4<8g0kC)c!}?=oEs7EG!Ie(UPQIsmm9pc4;Z&!F8*UI4E&mqEF4NTS6c=D ztT}d~p={aRM_(JbGWmG9@U!_U*)qI}G*63T<%?s{ReOVqP2=ttkHXk*tr!Fl%Xj=EtxK&_TA2d(Nd)>fx(fr~#Lm*{EYw+Fp5XbpoYKDf+6mtk=?eKvqCUjGm3oKqw~ekd%it)cTjM5 z-m9ngE5^jNep)iCZT!vcasAfE+N{4`w#A~2dI^hmw@w`dr(5ZmsBpsyPqRta-0iF>>YH;xm-7qhov2S6@9N!Gr+sLz+6x@SeqQ1vWb&7G ztx;~UktxfZQSFMH&DUifE!WLalkHw66C|ANGTt72J5ccUAdz65C^3lAD_hkwAI`tk zP1eG7|9#9vQTC{?l-83~zG=j>K|7vp!vBC#?q>N5imcB_qfc+UhR?pno)L4AzWm=L z`x;x+KpLx?#p~P7x=Di(l4D8{vma<*d8p`^;A-? zCbrwHFzPJU_HBE!pP?*!?)Tl5lIvjLh;}UQDih}3clViR(^Xz0Edl5kPDo#2vpYf0D&*05d z1olU)%IFW`0`HoVzbO|G!0T#k3S7wp?@70BVbGL}a@^_cF?7pglkrBe}*JQI33bpNSO^>Ph9NnVORbiq1 zuFh60Sl18m!NY+cUh^u5wOOioUELfy+)1UHB5V0dFtCyU+rONu; zuA`0DmibVGo+e3=Lxb9dLts{2)y||;HveE`0n0Qgx-v89CT>pKd?SH%V|9-df z{M)VnZ)mH)f9qBbUOx8!2?hRR+IS9fPF{ZQ|8wY&A1axnp1!Vj+1nM?zi6l3_Q5PFoA+8yn;GvcLT$K$ zGr`~eGj)0B)79K8L9Ops=Jgok^63rfsf$t6pP9Nlag_~=a;ix#ThE=-MBaoH{~P$z zg`wa6e~!a{pj@d;w(h36IQyKf&5C^tr=VQLFXEoQiq{`0%T_Olc~e`;Y&tH-7#EZ> zBscavakQxF^IsY5l-=6F-=AyOMJ z*vJbn-LSOz@n`YbcXh|=%EIK^a-)w~YoeZS(89lCxh0)SQ}vo~AgjLk^0{O}kmqWg z$kyC!_-fJPZ^_B6{Cwzl^Q9*5?uqXc6=g-QzZXo3aw;~%NO;F%Ni*sc>IJquO1J)M ze-#w?X}R^}(Y$}6a|sWhfD#vR|9h5#D0B)IBh$cmN)I6?=6=)+LB5l%=aCmYvUXgw zNM$Eb=V^iX%i8opr`WOJ+7py`+Y zu=U-!M5U>&urPE$Xp~XAl*+7618e@5V-T&JgbE2wrG`vGXi+@FSDEi`UI}Por)EB7 zewvz-KU!4M09Xu}*)QZ$Cqtw9zEi5BqW&KNiX>q=zB+uRa^< zG`O7eUAo!(>6&G$Trz&m%;cK3WP0P-z1_g>nLMMpSNA6o=UL^r4zHs9(==-p4D91X7#K1RvK0BRzL5 z;E6HaH!7Nzt+q}neTYT$2lF#czuDWAwwBfi34fd9C(#MZEZ0G-^WWtdL}ohj)sU)| zKiQMW!BmFvg5Jl}1eAXC)c^Y~I;-0fJ$ooA>)f@D|5L{faT5}3nw!*BwD-haeDee? z{&>XBpf>ry?ckjIAb;W&`O}K{Jpar)ABJZr@9h0ZFT}IXhj91h$$uFWYrwOZvUYMX zM7sM1n;Wju3#d=82Xo}wasQQS{klV*tHCRkca$JKHQiA8Dz9r7#qU+APag_? z&^=W`lcXNvu5BH9Bu#5?x$s2jeYEZp?gFh4I;NPtc`M3f3W7a$0qSmr%7;g^3J)9F zhJ-^B_#ZB~IZu;2FEM{0n9@R{>a5g>=s`_rvwZ?)=HSyWM094MXProFuH`Tw`eP;O zEzMSs+-8_kLycC=Zc%6ZXGh212owER9vlZ__Ufhg9@4oY;Yb7Ld`M(KUc?)I&rgru zCy^Gtgex)G-GmcD#C_^J%Hius zyf6gUfCJ})&pv_}zYgcmBA)-JlOa-ECOALcl;MbZ6<1bZPoB5#@u~AlZpgub$#6=*gb7HOGll%BiS=((xN5K zJFiiG_Faib6+x}*MB6j(DA?2UT}hQV-`g~AIUi+s;fH-9s}q*d9b6m6hw^{B(aue> zn@Eqwy|gvw;ik8qUdikkN$#mGsk>QJV*hL(9QO)rD#v1oIcyy4{wh!`mMH?`_kM)= z8}_mQ4rkd{8xJ!aF7lDm4J!H=)|1WOKWY*)4PU?_s68LuAs3@&b=Z!(wiRs9%hNPG zqZr2#mFV8kY)j*orNf^4j6c|UeGst~;{G1p&J4-!Em3*ZgW7U9eiwYZOWXz1;K0GL zSDVyv={aLgjEn0V#2NDEFRtO3sT*WvtCIKoojxYwG|6bZp;?^x%lMVXlfP|-fAM}NS6!u{!oFEM9|??Uu)#1pqtacad+0uRy;9tGnD zjPSovm5v!wq>`{!{s}MX$Ebyjt);zAP7})Mnah{CtU^`NLRU;*71yDBc=E1#mIr_G z7h>fple4vYb-TF0K(~qbLDhHKb9{xlI&J;oAtUp8F@IaB?H?!O)m5)0AE)L3g z2aY(E5!N?1N9`%isn*zU@KIGe8CfqRXEM$~^F=V? z2bt~UFWW7+-XvcBszk(3U2~ItDJplqgv4c4(k4o{FCzOtN$N@uC2W4%^pzqpZ5)5G zRWk^yrkjGFtl)V+f$3dmqGCF*O{Xz^(YfI|uvUFEQ{92o^Z23Nm)cO14w~}=1e_)M zm|h7}i^q$`Sbs&Hwe8>XWcnKB!#KLggkH{fG)A~~6phpS&PZeCoCZ)+l875TN{jwB zN5w!{VJj(<*VKzbEiZY1`<5QRsIv3axLzA~^#)eTy6w{&BBX#ip^YzJIln)qhQTL`va3_GKrinyJZ_ zyI6ATiQwwWNafyT(8{J4~3PP%9-70j%H_vBYYKjKk{R+ZE%5+mdeB^B7NMB + +
+ + + + +
+
+ + TeaHRT Bicalutamide 50mg
+ TeaHRT +
+
+ +
+ + 100 pills + +
+ +
+ + $100.00
+ + $1.00 + per pill + +
+
+ +
+ + + + + Delisted from store +
@@ -402,52 +443,11 @@ - 2 days ago + 5 days ago - - -
- -
- - -
-
- - TeaHRT Bicalutamide 50mg
- TeaHRT -
-
- -
- - 100 pills - -
- -
- - $100.00
- - $1.00 - per pill - -
-
- -
- - - - - Delisted from store -
@@ -701,7 +701,7 @@ - 215 days ago + 222 days ago @@ -886,5 +886,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/groups/combination-minoxidil.html b/diyhrt.market/meds/groups/combination-minoxidil.html index 6e1956660..e0223e3c9 100644 --- a/diyhrt.market/meds/groups/combination-minoxidil.html +++ b/diyhrt.market/meds/groups/combination-minoxidil.html @@ -484,5 +484,5 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/groups/cyproterone.html b/diyhrt.market/meds/groups/cyproterone.html index c44a104a9..e7ce52e73 100644 --- a/diyhrt.market/meds/groups/cyproterone.html +++ b/diyhrt.market/meds/groups/cyproterone.html @@ -503,7 +503,7 @@ Cyproterone has a statistically associated risk of Meningiomas, prolactin levels - 215 days ago + 222 days ago @@ -773,7 +773,7 @@ Cyproterone has a statistically associated risk of Meningiomas, prolactin levels - 123 days ago + 130 days ago @@ -869,7 +869,7 @@ Cyproterone has a statistically associated risk of Meningiomas, prolactin levels - 30 days ago + 37 days ago @@ -927,5 +927,5 @@ Cyproterone has a statistically associated risk of Meningiomas, prolactin levels const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/groups/dutasteride.html b/diyhrt.market/meds/groups/dutasteride.html index 913d8e7dc..aa1497d74 100644 --- a/diyhrt.market/meds/groups/dutasteride.html +++ b/diyhrt.market/meds/groups/dutasteride.html @@ -557,7 +557,7 @@ Though the exact mechanism is unknown 5-Alpha Reductase Inhibitors as a class ar - 215 days ago + 222 days ago @@ -727,7 +727,7 @@ Though the exact mechanism is unknown 5-Alpha Reductase Inhibitors as a class ar - 215 days ago + 222 days ago @@ -815,7 +815,7 @@ Though the exact mechanism is unknown 5-Alpha Reductase Inhibitors as a class ar - 215 days ago + 222 days ago @@ -909,7 +909,7 @@ Though the exact mechanism is unknown 5-Alpha Reductase Inhibitors as a class ar - 57 days ago + 64 days ago @@ -1175,7 +1175,7 @@ Though the exact mechanism is unknown 5-Alpha Reductase Inhibitors as a class ar
+ style="border-left-width: 0.2rem; border-left-color: #044E7F; border-right-width: 0.2rem; border-right-color: var(--bs-danger);">
@@ -1203,9 +1203,15 @@ Though the exact mechanism is unknown 5-Alpha Reductase Inhibitors as a class ar
- + - In Stock + + + + 8 days ago + + + @@ -1244,47 +1250,6 @@ Though the exact mechanism is unknown 5-Alpha Reductase Inhibitors as a class ar
- - - In Stock - - - -
-
-
- - -
-
- - Dutasteride (Dutas) 0.5mg
- Aipctshop -
-
- -
- - 30 pills - -
- -
- - $41.30
- - $1.38 - per pill - -
-
- -
- - In Stock @@ -1298,7 +1263,7 @@ Though the exact mechanism is unknown 5-Alpha Reductase Inhibitors as a class ar + style="border-left-width: 0.2rem; border-left-color: #044E7F; border-right-width: 0.2rem; border-right-color: var(--bs-danger);">
@@ -1326,9 +1291,15 @@ Though the exact mechanism is unknown 5-Alpha Reductase Inhibitors as a class ar
- + - In Stock + + + + 8 days ago + + + @@ -1414,6 +1385,47 @@ Though the exact mechanism is unknown 5-Alpha Reductase Inhibitors as a class ar
+ + + In Stock + + + +
+
+
+ + +
+
+ + Dutasteride (Dutas) 0.5mg
+ Aipctshop +
+
+ +
+ + 30 pills + +
+ +
+ + $51.25
+ + $1.71 + per pill + +
+
+ +
+ + In Stock @@ -1510,5 +1522,5 @@ Though the exact mechanism is unknown 5-Alpha Reductase Inhibitors as a class ar const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/groups/estradiol-droppers.html b/diyhrt.market/meds/groups/estradiol-droppers.html index 40601e779..43fdc6327 100644 --- a/diyhrt.market/meds/groups/estradiol-droppers.html +++ b/diyhrt.market/meds/groups/estradiol-droppers.html @@ -399,5 +399,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/groups/estradiol-gels.html b/diyhrt.market/meds/groups/estradiol-gels.html index d13764940..c18f2d348 100644 --- a/diyhrt.market/meds/groups/estradiol-gels.html +++ b/diyhrt.market/meds/groups/estradiol-gels.html @@ -311,7 +311,7 @@ The main downsides of transdermal gel are that some users may have issues with a - 294 days ago + 301 days ago @@ -358,7 +358,7 @@ The main downsides of transdermal gel are that some users may have issues with a - 307 days ago + 314 days ago @@ -446,7 +446,7 @@ The main downsides of transdermal gel are that some users may have issues with a - 28 days ago + 35 days ago @@ -460,7 +460,7 @@ The main downsides of transdermal gel are that some users may have issues with a + style="border-left-width: 0.2rem; border-left-color: #18B2CB; border-right-width: 0.2rem; border-right-color: var(--bs-success);">
@@ -488,15 +488,9 @@ The main downsides of transdermal gel are that some users may have issues with a
- + - - - - 11 days ago - - - + In Stock @@ -631,5 +625,5 @@ The main downsides of transdermal gel are that some users may have issues with a const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/groups/estradiol-injections.html b/diyhrt.market/meds/groups/estradiol-injections.html index 04f8e15ff..1a8f2e421 100644 --- a/diyhrt.market/meds/groups/estradiol-injections.html +++ b/diyhrt.market/meds/groups/estradiol-injections.html @@ -313,7 +313,7 @@ The main downside to Injections besides practical difficulties with injecting an - 318 days ago + 325 days ago @@ -503,13 +503,13 @@ The main downside to Injections besides practical difficulties with injecting an
- Voix Céleste Estradiol Enanthate in MCT Oil
+ Voix Céleste Estradiol Enanthate in Grapeseed Oil
Voix Céleste
@@ -544,13 +544,13 @@ The main downside to Injections besides practical difficulties with injecting an
- Voix Céleste Estradiol Enanthate in Grapeseed Oil
+ Voix Céleste Estradiol Enanthate in MCT Oil
Voix Céleste
@@ -702,7 +702,7 @@ The main downside to Injections besides practical difficulties with injecting an - 287 days ago + 294 days ago @@ -785,47 +785,6 @@ The main downside to Injections besides practical difficulties with injecting an
- - - Delisted from store - - - -
-
-
- - -
-
- - TeaHRT Estradiol Enanthate 10mL
- TeaHRT -
-
- -
- - 400mg - -
- -
- - $75.00
- - $0.19 - per mg - -
-
- -
- - Delisted from store @@ -871,6 +830,47 @@ The main downside to Injections besides practical difficulties with injecting an In Stock + + +
+
+
+ + +
+
+ + TeaHRT Estradiol Enanthate 10mL
+ TeaHRT +
+
+ +
+ + 400mg + +
+ +
+ + $75.00
+ + $0.19 + per mg + +
+
+ +
+ + + + + Delisted from store +
@@ -897,9 +897,9 @@ The main downside to Injections besides practical difficulties with injecting an
- $80.00
+ $75.00
- $0.20 + $0.19 per mg
@@ -1002,47 +1002,6 @@ The main downside to Injections besides practical difficulties with injecting an In Stock - - -
-
-
- - -
-
- - TeaHRT Estradiol Undecylate 80mg/mL 10mL
- TeaHRT -
-
- -
- - 800mg - -
- -
- - $120.00
- - $0.15 - per mg - -
-
- -
- - - - - Delisted from store -
@@ -1084,6 +1043,47 @@ The main downside to Injections besides practical difficulties with injecting an In Stock + + +
+
+ + + +
+
+ + TeaHRT Estradiol Undecylate 80mg/mL 10mL
+ TeaHRT +
+
+ +
+ + 800mg + +
+ +
+ + $120.00
+ + $0.15 + per mg + +
+
+ +
+ + + + + Delisted from store +
@@ -1249,7 +1249,7 @@ The main downside to Injections besides practical difficulties with injecting an - 276 days ago + 283 days ago @@ -1427,7 +1427,7 @@ The main downside to Injections besides practical difficulties with injecting an - 316 days ago + 323 days ago @@ -1514,47 +1514,6 @@ The main downside to Injections besides practical difficulties with injecting an In Stock - - -
-
- - - -
-
- - TeaHRT Estradiol Valerate 10mL
- TeaHRT -
-
- -
- - 400mg - -
- -
- - $70.00
- - $0.18 - per mg - -
-
- -
- - - - - Delisted from store -
@@ -1596,6 +1555,47 @@ The main downside to Injections besides practical difficulties with injecting an In Stock + + +
+
+ + + +
+
+ + TeaHRT Estradiol Valerate 10mL
+ TeaHRT +
+
+ +
+ + 400mg + +
+ +
+ + $70.00
+ + $0.18 + per mg + +
+
+ +
+ + + + + Delisted from store +
@@ -1649,5 +1649,5 @@ The main downside to Injections besides practical difficulties with injecting an const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/groups/estradiol-patches.html b/diyhrt.market/meds/groups/estradiol-patches.html index 32d044f33..ef95a308d 100644 --- a/diyhrt.market/meds/groups/estradiol-patches.html +++ b/diyhrt.market/meds/groups/estradiol-patches.html @@ -1315,5 +1315,5 @@ The main downsides with transdermal patches can be difficulty maintaining higher const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/groups/estradiol-pills.html b/diyhrt.market/meds/groups/estradiol-pills.html index 39536ec28..e23a64172 100644 --- a/diyhrt.market/meds/groups/estradiol-pills.html +++ b/diyhrt.market/meds/groups/estradiol-pills.html @@ -436,7 +436,7 @@ The main downside to oral pills is that much of the Estradiol is metabolised in - 215 days ago + 222 days ago @@ -491,7 +491,7 @@ The main downside to oral pills is that much of the Estradiol is metabolised in
+ style="border-left-width: 0.2rem; border-left-color: #EC008B; border-right-width: 0.2rem; border-right-color: var(--bs-danger);">
@@ -519,9 +519,15 @@ The main downside to oral pills is that much of the Estradiol is metabolised in
- + - In Stock + + + + 7 days ago + + + @@ -540,7 +546,7 @@ The main downside to oral pills is that much of the Estradiol is metabolised in + style="border-left-width: 0.2rem; border-left-color: #18B2CB; border-right-width: 0.2rem; border-right-color: var(--bs-danger);">
@@ -568,9 +574,15 @@ The main downside to oral pills is that much of the Estradiol is metabolised in
- + - In Stock + + + + 6 days ago + + + @@ -622,7 +634,7 @@ The main downside to oral pills is that much of the Estradiol is metabolised in + style="border-left-width: 0.2rem; border-left-color: #0D7581; border-right-width: 0.2rem; border-right-color: var(--bs-danger);">
@@ -650,9 +662,15 @@ The main downside to oral pills is that much of the Estradiol is metabolised in
- + - In Stock + + + + 4 days ago + + + @@ -704,7 +722,7 @@ The main downside to oral pills is that much of the Estradiol is metabolised in + style="border-left-width: 0.2rem; border-left-color: #EC008B; border-right-width: 0.2rem; border-right-color: var(--bs-success);">
@@ -732,15 +750,9 @@ The main downside to oral pills is that much of the Estradiol is metabolised in
- + - - - - 6 days ago - - - + In Stock @@ -954,7 +966,7 @@ The main downside to oral pills is that much of the Estradiol is metabolised in - 4 days ago + 11 days ago @@ -1015,7 +1027,7 @@ The main downside to oral pills is that much of the Estradiol is metabolised in + style="border-left-width: 0.2rem; border-left-color: #EC008B; border-right-width: 0.2rem; border-right-color: var(--bs-success);">
@@ -1043,15 +1055,9 @@ The main downside to oral pills is that much of the Estradiol is metabolised in
- + - - - - 4 days ago - - - + In Stock @@ -1218,7 +1224,7 @@ The main downside to oral pills is that much of the Estradiol is metabolised in - 141 days ago + 148 days ago @@ -1358,5 +1364,5 @@ The main downside to oral pills is that much of the Estradiol is metabolised in const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/groups/estradiol-sprays.html b/diyhrt.market/meds/groups/estradiol-sprays.html index d5c1ad641..8a675bded 100644 --- a/diyhrt.market/meds/groups/estradiol-sprays.html +++ b/diyhrt.market/meds/groups/estradiol-sprays.html @@ -402,5 +402,5 @@ The main downsides of transdermal sprays are that some users may have issues wit const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/groups/finasteride.html b/diyhrt.market/meds/groups/finasteride.html index 8f46a2974..ba245d2d5 100644 --- a/diyhrt.market/meds/groups/finasteride.html +++ b/diyhrt.market/meds/groups/finasteride.html @@ -518,7 +518,7 @@ Though the exact mechanism is unknown Finasteride is also associated with signif - 215 days ago + 222 days ago @@ -647,7 +647,7 @@ Though the exact mechanism is unknown Finasteride is also associated with signif - 271 days ago + 278 days ago @@ -735,7 +735,7 @@ Though the exact mechanism is unknown Finasteride is also associated with signif - 266 days ago + 273 days ago @@ -864,7 +864,7 @@ Though the exact mechanism is unknown Finasteride is also associated with signif - 215 days ago + 222 days ago @@ -1206,7 +1206,7 @@ Though the exact mechanism is unknown Finasteride is also associated with signif - 215 days ago + 222 days ago @@ -1412,47 +1412,6 @@ Though the exact mechanism is unknown Finasteride is also associated with signif
- - - In Stock - - - -
-
-
- - -
-
- - Finasteride (Fincar) 5mg
- Inhouse Pharmacy -
-
- -
- - 10 pills - -
- -
- - $9.90
- - $0.99 - per pill - -
-
- -
- - In Stock @@ -1499,7 +1458,7 @@ Though the exact mechanism is unknown Finasteride is also associated with signif - 215 days ago + 222 days ago @@ -1623,6 +1582,47 @@ Though the exact mechanism is unknown Finasteride is also associated with signif
+ + + In Stock + + + +
+
+
+ + +
+
+ + Finasteride (Fincar) 5mg
+ Inhouse Pharmacy +
+
+ +
+ + 10 pills + +
+ +
+ + $13.10
+ + $1.31 + per pill + +
+
+ +
+ + In Stock @@ -1721,5 +1721,5 @@ Though the exact mechanism is unknown Finasteride is also associated with signif const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/groups/gnrh-agonists.html b/diyhrt.market/meds/groups/gnrh-agonists.html index 1b6298ff8..bbe2e2ad5 100644 --- a/diyhrt.market/meds/groups/gnrh-agonists.html +++ b/diyhrt.market/meds/groups/gnrh-agonists.html @@ -367,5 +367,5 @@ Recently we've seen cheaper formulations come to market such as Buserelin i const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/groups/minoxidil-10.html b/diyhrt.market/meds/groups/minoxidil-10.html index ceaceeca0..f8eb68bef 100644 --- a/diyhrt.market/meds/groups/minoxidil-10.html +++ b/diyhrt.market/meds/groups/minoxidil-10.html @@ -319,12 +319,12 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi + style="border-left-width: 0.2rem; border-left-color: #18B2CB; border-right-width: 0.2rem; border-right-color: var(--bs-success);">
Minoxidil 10% Solution (Hair4U 10%) 60mL
- 4NRX Pharmacy UK + United Pharmacies UK
@@ -360,12 +360,12 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi
+ style="border-left-width: 0.2rem; border-left-color: #31D4FF; border-right-width: 0.2rem; border-right-color: var(--bs-success);">
Minoxidil 10% Solution (Hair4U 10%) 60mL
- United Pharmacies UK + 4NRX Pharmacy UK
@@ -648,5 +648,5 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/groups/minoxidil-2.html b/diyhrt.market/meds/groups/minoxidil-2.html index 6f2587f20..b435bd88f 100644 --- a/diyhrt.market/meds/groups/minoxidil-2.html +++ b/diyhrt.market/meds/groups/minoxidil-2.html @@ -434,7 +434,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - 39 days ago + 46 days ago @@ -572,5 +572,5 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/groups/minoxidil-5.html b/diyhrt.market/meds/groups/minoxidil-5.html index b04c1e51d..bfa58b3a5 100644 --- a/diyhrt.market/meds/groups/minoxidil-5.html +++ b/diyhrt.market/meds/groups/minoxidil-5.html @@ -557,7 +557,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - 215 days ago + 222 days ago @@ -727,7 +727,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - 21 days ago + 28 days ago @@ -1012,5 +1012,5 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/groups/progesterone.html b/diyhrt.market/meds/groups/progesterone.html index 715cc6102..5de139219 100644 --- a/diyhrt.market/meds/groups/progesterone.html +++ b/diyhrt.market/meds/groups/progesterone.html @@ -398,7 +398,7 @@ Progesterone is best taken as a rectal suppository to avoid processing in the li - 215 days ago + 222 days ago @@ -740,7 +740,7 @@ Progesterone is best taken as a rectal suppository to avoid processing in the li - 3 days ago + 7 days ago @@ -1181,5 +1181,5 @@ Progesterone is best taken as a rectal suppository to avoid processing in the li const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/groups/spironolactone.html b/diyhrt.market/meds/groups/spironolactone.html index 9bcffa090..de11b4f1e 100644 --- a/diyhrt.market/meds/groups/spironolactone.html +++ b/diyhrt.market/meds/groups/spironolactone.html @@ -1160,5 +1160,5 @@ Spironolactone has been widely used particularly in the United States in transfe const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/astrovials-estradiol-enanthate.html b/diyhrt.market/meds/products/astrovials-estradiol-enanthate.html index d6e1a5610..db4475a76 100644 --- a/diyhrt.market/meds/products/astrovials-estradiol-enanthate.html +++ b/diyhrt.market/meds/products/astrovials-estradiol-enanthate.html @@ -428,7 +428,7 @@ Unlike many other medications on this site, these products are produced by priva
- + @@ -471,55 +471,6 @@ Unlike many other medications on this site, these products are produced by priva - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1336,13 +1336,29 @@ Unlike many other medications on this site, these products are produced by priva - March 2, 2025, 12:03 p.m. + March 7, 2025, 8:13 p.m. €50.00 In Stock + + March 3, 2025, 10:08 p.m. + + + Out of Stock + + + + + March 2, 2025, 12:03 p.m. + + + In Stock + + + March 1, 2025, 8:15 p.m. @@ -1750,7 +1766,7 @@ Unlike many other medications on this site, these products are produced by priva - + @@ -1761,5 +1777,5 @@ Unlike many other medications on this site, these products are produced by priva const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/astrovials-estradiol-undecylate.html b/diyhrt.market/meds/products/astrovials-estradiol-undecylate.html index bd8e026c3..0410377e4 100644 --- a/diyhrt.market/meds/products/astrovials-estradiol-undecylate.html +++ b/diyhrt.market/meds/products/astrovials-estradiol-undecylate.html @@ -343,7 +343,7 @@ Unlike many other medications on this site, these products are produced by priva
- + @@ -386,55 +386,6 @@ Unlike many other medications on this site, these products are produced by priva - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1251,13 +1251,29 @@ Unlike many other medications on this site, these products are produced by priva - Feb. 1, 2025, 1:02 p.m. + March 7, 2025, 8:13 p.m. €120.00 In Stock + + March 3, 2025, 10:08 p.m. + + + Out of Stock + + + + + Feb. 1, 2025, 1:02 p.m. + + + In Stock + + + Jan. 30, 2025, 5:03 p.m. @@ -1417,7 +1433,7 @@ Unlike many other medications on this site, these products are produced by priva - + @@ -1428,5 +1444,5 @@ Unlike many other medications on this site, these products are produced by priva const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/astrovials-estradiol-valerate.html b/diyhrt.market/meds/products/astrovials-estradiol-valerate.html index 193882e69..dc02fb437 100644 --- a/diyhrt.market/meds/products/astrovials-estradiol-valerate.html +++ b/diyhrt.market/meds/products/astrovials-estradiol-valerate.html @@ -343,7 +343,7 @@ Unlike many other medications on this site, these products are produced by priva
- + @@ -386,55 +386,6 @@ Unlike many other medications on this site, these products are produced by priva - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1251,13 +1251,29 @@ Unlike many other medications on this site, these products are produced by priva - March 2, 2025, 2:22 p.m. + March 7, 2025, 8:13 p.m. €40.00 In Stock + + March 3, 2025, 2:33 p.m. + + + Out of Stock + + + + + March 2, 2025, 2:22 p.m. + + + In Stock + + + March 2, 2025, 9:12 a.m. @@ -1609,7 +1625,7 @@ Unlike many other medications on this site, these products are produced by priva - + @@ -1620,5 +1636,5 @@ Unlike many other medications on this site, these products are produced by priva const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/bicalutamide-binarex-50mg-x28.html b/diyhrt.market/meds/products/bicalutamide-binarex-50mg-x28.html index ba99fd8ed..91b6a4123 100644 --- a/diyhrt.market/meds/products/bicalutamide-binarex-50mg-x28.html +++ b/diyhrt.market/meds/products/bicalutamide-binarex-50mg-x28.html @@ -318,7 +318,7 @@
- + @@ -361,55 +361,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1760,7 +1760,7 @@ - + @@ -1771,5 +1771,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/bicalutamide-calutide-50mg-x10.html b/diyhrt.market/meds/products/bicalutamide-calutide-50mg-x10.html index 92a9452c5..d73681c6f 100644 --- a/diyhrt.market/meds/products/bicalutamide-calutide-50mg-x10.html +++ b/diyhrt.market/meds/products/bicalutamide-calutide-50mg-x10.html @@ -362,7 +362,7 @@
- + @@ -405,55 +405,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1563,7 +1563,7 @@
- + @@ -1606,55 +1606,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -2828,7 +2828,7 @@
- + @@ -2847,7 +2847,7 @@ - 215 days ago + 222 days ago @@ -2877,55 +2877,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -4011,7 +4011,7 @@
- + @@ -4054,55 +4054,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -5756,7 +5756,7 @@
- + @@ -5799,55 +5799,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -6718,7 +6718,7 @@ - + @@ -6729,5 +6729,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/bicalutamide-casodex-50mg-x28.html b/diyhrt.market/meds/products/bicalutamide-casodex-50mg-x28.html index 27bbcc6c7..32c3458b4 100644 --- a/diyhrt.market/meds/products/bicalutamide-casodex-50mg-x28.html +++ b/diyhrt.market/meds/products/bicalutamide-casodex-50mg-x28.html @@ -318,7 +318,7 @@
- + @@ -367,55 +367,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1297,5 +1297,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/bicalutamide-castramid-50mg-x10.html b/diyhrt.market/meds/products/bicalutamide-castramid-50mg-x10.html index d0ca3ff4c..4c9e5eb02 100644 --- a/diyhrt.market/meds/products/bicalutamide-castramid-50mg-x10.html +++ b/diyhrt.market/meds/products/bicalutamide-castramid-50mg-x10.html @@ -318,7 +318,7 @@
- + @@ -361,55 +361,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1280,7 +1280,7 @@ - + @@ -1291,5 +1291,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/bicalutamide-procalut-50mg-x28.html b/diyhrt.market/meds/products/bicalutamide-procalut-50mg-x28.html index 2b8558bf8..175990e3f 100644 --- a/diyhrt.market/meds/products/bicalutamide-procalut-50mg-x28.html +++ b/diyhrt.market/meds/products/bicalutamide-procalut-50mg-x28.html @@ -340,7 +340,7 @@
- + @@ -389,55 +389,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1299,7 +1299,7 @@
- + @@ -1348,55 +1348,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -2242,7 +2242,7 @@
- + @@ -2291,55 +2291,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -3210,7 +3210,7 @@ - + @@ -3221,5 +3221,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/climara-100mcg-x4.html b/diyhrt.market/meds/products/climara-100mcg-x4.html index 909df3fde..a7e3aaf1c 100644 --- a/diyhrt.market/meds/products/climara-100mcg-x4.html +++ b/diyhrt.market/meds/products/climara-100mcg-x4.html @@ -386,7 +386,7 @@
- + @@ -435,55 +435,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1345,7 +1345,7 @@
- + @@ -1394,55 +1394,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -3160,7 +3160,7 @@
- + @@ -3203,55 +3203,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -4105,7 +4105,7 @@
- + @@ -4154,55 +4154,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -5048,7 +5048,7 @@
- + @@ -5097,55 +5097,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -5991,7 +5991,7 @@
- + @@ -6040,55 +6040,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -6959,7 +6959,7 @@ - + @@ -6970,5 +6970,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/climara-50mcg-x4.html b/diyhrt.market/meds/products/climara-50mcg-x4.html index f04ba86d1..f17240088 100644 --- a/diyhrt.market/meds/products/climara-50mcg-x4.html +++ b/diyhrt.market/meds/products/climara-50mcg-x4.html @@ -386,7 +386,7 @@
- + @@ -435,55 +435,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1345,7 +1345,7 @@
- + @@ -1394,55 +1394,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -2259,13 +2259,29 @@ - Dec. 6, 2024, 9:51 a.m. + March 3, 2025, 5:50 a.m. $24.00 Out of Stock + + March 3, 2025, 3:50 a.m. + + + In Stock + + + + + Dec. 6, 2024, 9:51 a.m. + + + Out of Stock + + + Dec. 6, 2024, 7:50 a.m. @@ -2920,7 +2936,7 @@
- + @@ -2963,55 +2979,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -3857,7 +3873,7 @@
- + @@ -3906,55 +3922,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -4800,7 +4816,7 @@
- + @@ -4849,55 +4865,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -5743,7 +5759,7 @@
- + @@ -5792,55 +5808,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -6711,7 +6727,7 @@ - + @@ -6722,5 +6738,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/combination-minoxidil-finasteride-3-solution-morr-f-60ml.html b/diyhrt.market/meds/products/combination-minoxidil-finasteride-3-solution-morr-f-60ml.html index 44f81d71a..65ea9baff 100644 --- a/diyhrt.market/meds/products/combination-minoxidil-finasteride-3-solution-morr-f-60ml.html +++ b/diyhrt.market/meds/products/combination-minoxidil-finasteride-3-solution-morr-f-60ml.html @@ -343,7 +343,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi
- + @@ -386,55 +386,6 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1344,7 +1344,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi
- + @@ -1387,55 +1387,6 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -2321,7 +2321,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi
- + @@ -2364,55 +2364,6 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -3291,7 +3291,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - + @@ -3302,5 +3302,5 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/combination-minoxidil-finasteride-brintop-f-solution-100ml.html b/diyhrt.market/meds/products/combination-minoxidil-finasteride-brintop-f-solution-100ml.html index 1cf815a63..9c16f05fc 100644 --- a/diyhrt.market/meds/products/combination-minoxidil-finasteride-brintop-f-solution-100ml.html +++ b/diyhrt.market/meds/products/combination-minoxidil-finasteride-brintop-f-solution-100ml.html @@ -330,7 +330,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi
- + @@ -373,55 +373,6 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1404,7 +1404,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - + @@ -1415,5 +1415,5 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/cyproterone-androcur-50mg-x50.html b/diyhrt.market/meds/products/cyproterone-androcur-50mg-x50.html index 6d37d59b3..c53d8bcda 100644 --- a/diyhrt.market/meds/products/cyproterone-androcur-50mg-x50.html +++ b/diyhrt.market/meds/products/cyproterone-androcur-50mg-x50.html @@ -343,7 +343,7 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If
- + @@ -392,55 +392,6 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1302,7 +1302,7 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If
- + @@ -1351,55 +1351,6 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -2245,7 +2245,7 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If
- + @@ -2294,55 +2294,6 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -3213,7 +3213,7 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If - + @@ -3224,5 +3224,5 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/cyproterone-procur-50mg-x50.html b/diyhrt.market/meds/products/cyproterone-procur-50mg-x50.html index 23cec2cb4..e441fa645 100644 --- a/diyhrt.market/meds/products/cyproterone-procur-50mg-x50.html +++ b/diyhrt.market/meds/products/cyproterone-procur-50mg-x50.html @@ -343,7 +343,7 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If
- + @@ -392,55 +392,6 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1302,7 +1302,7 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If
- + @@ -1351,55 +1351,6 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -2245,7 +2245,7 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If
- + @@ -2294,55 +2294,6 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -3213,7 +3213,7 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If - + @@ -3224,5 +3224,5 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/cyproterone-siterone-100mg-x50.html b/diyhrt.market/meds/products/cyproterone-siterone-100mg-x50.html index c455be72e..24acf1ebe 100644 --- a/diyhrt.market/meds/products/cyproterone-siterone-100mg-x50.html +++ b/diyhrt.market/meds/products/cyproterone-siterone-100mg-x50.html @@ -321,7 +321,7 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If
- + @@ -340,7 +340,7 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If - 30 days ago + 37 days ago @@ -370,55 +370,6 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -2084,5 +2084,5 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/cyproterone-siterone-50mg-x50.html b/diyhrt.market/meds/products/cyproterone-siterone-50mg-x50.html index 8bc361023..d4372bcc1 100644 --- a/diyhrt.market/meds/products/cyproterone-siterone-50mg-x50.html +++ b/diyhrt.market/meds/products/cyproterone-siterone-50mg-x50.html @@ -365,7 +365,7 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If
- + @@ -408,55 +408,6 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1774,7 +1774,7 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If
- + @@ -1793,7 +1793,7 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If - 123 days ago + 130 days ago @@ -1823,55 +1823,6 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -3085,7 +3085,7 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If
- + @@ -3104,7 +3104,7 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If - 215 days ago + 222 days ago @@ -3134,55 +3134,6 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -4180,7 +4180,7 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If
- + @@ -4223,55 +4223,6 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -5749,7 +5749,7 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If
- + @@ -5792,55 +5792,6 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -6887,7 +6887,7 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If - + @@ -6898,5 +6898,5 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/dutasteride-avodart-0-5mg-x30.html b/diyhrt.market/meds/products/dutasteride-avodart-0-5mg-x30.html index a42113dec..55c533e2d 100644 --- a/diyhrt.market/meds/products/dutasteride-avodart-0-5mg-x30.html +++ b/diyhrt.market/meds/products/dutasteride-avodart-0-5mg-x30.html @@ -351,7 +351,7 @@
- + @@ -400,55 +400,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1318,7 +1318,7 @@
- + @@ -1337,7 +1337,7 @@ - 57 days ago + 64 days ago @@ -1367,55 +1367,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -2637,7 +2637,7 @@
- + @@ -2686,55 +2686,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -3636,7 +3636,7 @@
- + @@ -3685,55 +3685,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -4604,7 +4604,7 @@ - + @@ -4615,5 +4615,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/dutasteride-duprost-0-5mg-x10.html b/diyhrt.market/meds/products/dutasteride-duprost-0-5mg-x10.html index 25d9e318e..291a234b9 100644 --- a/diyhrt.market/meds/products/dutasteride-duprost-0-5mg-x10.html +++ b/diyhrt.market/meds/products/dutasteride-duprost-0-5mg-x10.html @@ -373,7 +373,7 @@
- + @@ -416,55 +416,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1406,7 +1406,7 @@
- + @@ -1449,55 +1449,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -2359,7 +2359,7 @@
- + @@ -2402,55 +2402,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -3496,7 +3496,7 @@
- + @@ -3515,7 +3515,7 @@ - 215 days ago + 222 days ago @@ -3545,55 +3545,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -4495,7 +4495,7 @@
- + @@ -4538,55 +4538,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -5672,7 +5672,7 @@
- + @@ -5715,55 +5715,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -6634,7 +6634,7 @@ - + @@ -6645,5 +6645,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/dutasteride-dutagen-0-5mg-x10.html b/diyhrt.market/meds/products/dutasteride-dutagen-0-5mg-x10.html index 5bc61b9e1..c7584f722 100644 --- a/diyhrt.market/meds/products/dutasteride-dutagen-0-5mg-x10.html +++ b/diyhrt.market/meds/products/dutasteride-dutagen-0-5mg-x10.html @@ -362,7 +362,7 @@
- + @@ -405,55 +405,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1523,7 +1523,7 @@
- + @@ -1566,55 +1566,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -2708,7 +2708,7 @@
- + @@ -2727,7 +2727,7 @@ - 215 days ago + 222 days ago @@ -2757,55 +2757,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -3691,7 +3691,7 @@
- + @@ -3734,55 +3734,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -4996,7 +4996,7 @@
- + @@ -5039,55 +5039,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -5974,7 +5974,7 @@ - + @@ -5985,5 +5985,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/dutasteride-dutagen-0-5mg-x30.html b/diyhrt.market/meds/products/dutasteride-dutagen-0-5mg-x30.html index 9b3e5e59f..fa7fec822 100644 --- a/diyhrt.market/meds/products/dutasteride-dutagen-0-5mg-x30.html +++ b/diyhrt.market/meds/products/dutasteride-dutagen-0-5mg-x30.html @@ -141,7 +141,7 @@ + style="border-left-width: 0.2rem; border-left-color: #044E7F; border-right-width: 0.2rem; border-right-color: var(--bs-danger);"> Aipctshop @@ -307,7 +307,7 @@
+ style="border-left-width: 0.2rem; border-left-color: #044E7F; border-right-width: 0.2rem; border-right-color: var(--bs-danger);">
@@ -318,7 +318,7 @@
- + @@ -326,15 +326,21 @@
- - - - - - + + + +
+ +
+
@@ -337,7 +414,7 @@ Unlike many other medications on this site, these products are produced by priva
- + @@ -429,6 +506,55 @@ Unlike many other medications on this site, these products are produced by priva data-bs-title="March 3, 2025"> + + + + + + + + + + + + + + + + + + + + + @@ -454,13 +580,29 @@ Unlike many other medications on this site, these products are produced by priva - March 1, 2025, 4:49 a.m. + March 9, 2025, 8:27 a.m. $70.00 In Stock + + March 6, 2025, 7:05 p.m. + $65.00 + + + + + + + March 1, 2025, 4:49 a.m. + $70.00 + + + + + Feb. 25, 2025, 1:07 p.m. @@ -516,7 +658,7 @@ Unlike many other medications on this site, these products are produced by priva - + @@ -527,5 +669,5 @@ Unlike many other medications on this site, these products are produced by priva const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/open-gate-labs-progesterone-suppository-200mg-x60.html b/diyhrt.market/meds/products/open-gate-labs-progesterone-suppository-200mg-x60.html index b2afe4cb4..c85529cfe 100644 --- a/diyhrt.market/meds/products/open-gate-labs-progesterone-suppository-200mg-x60.html +++ b/diyhrt.market/meds/products/open-gate-labs-progesterone-suppository-200mg-x60.html @@ -283,7 +283,7 @@ Unlike many other medications on this site, these products are produced by priva
- + @@ -381,6 +381,55 @@ Unlike many other medications on this site, these products are produced by priva data-bs-title="March 3, 2025"> + + + + + + + + + + + + + + + + + + + + + @@ -471,5 +520,5 @@ Unlike many other medications on this site, these products are produced by priva const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/open-gate-labs-relugolix-x100.html b/diyhrt.market/meds/products/open-gate-labs-relugolix-x100.html index 4103b72fa..a7429448d 100644 --- a/diyhrt.market/meds/products/open-gate-labs-relugolix-x100.html +++ b/diyhrt.market/meds/products/open-gate-labs-relugolix-x100.html @@ -307,7 +307,7 @@ Unlike many other medications on this site, these products are produced by priva
- + @@ -399,6 +399,55 @@ Unlike many other medications on this site, these products are produced by priva data-bs-title="March 3, 2025"> + + + + + + + + + + + + + + + + + + + + + @@ -494,7 +543,7 @@ Unlike many other medications on this site, these products are produced by priva - + @@ -505,5 +554,5 @@ Unlike many other medications on this site, these products are produced by priva const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/otokonoko-estradiol-cypionate-10ml-40mg-ml.html b/diyhrt.market/meds/products/otokonoko-estradiol-cypionate-10ml-40mg-ml.html index 3d99faa07..56a7fb388 100644 --- a/diyhrt.market/meds/products/otokonoko-estradiol-cypionate-10ml-40mg-ml.html +++ b/diyhrt.market/meds/products/otokonoko-estradiol-cypionate-10ml-40mg-ml.html @@ -422,7 +422,7 @@ Unlike many other medications on this site, these products are produced by priva
- + @@ -465,55 +465,6 @@ Unlike many other medications on this site, these products are produced by priva - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1768,7 +1768,7 @@ Unlike many other medications on this site, these products are produced by priva - + @@ -1779,5 +1779,5 @@ Unlike many other medications on this site, these products are produced by priva const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/otokonoko-estradiol-enanthate-10ml-40mg-ml.html b/diyhrt.market/meds/products/otokonoko-estradiol-enanthate-10ml-40mg-ml.html index 5e0a7ef0e..8119c54a3 100644 --- a/diyhrt.market/meds/products/otokonoko-estradiol-enanthate-10ml-40mg-ml.html +++ b/diyhrt.market/meds/products/otokonoko-estradiol-enanthate-10ml-40mg-ml.html @@ -420,7 +420,7 @@ Unlike many other medications on this site, these products are produced by priva
- + @@ -463,55 +463,6 @@ Unlike many other medications on this site, these products are produced by priva - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -3574,7 +3574,7 @@ Unlike many other medications on this site, these products are produced by priva - + @@ -3585,5 +3585,5 @@ Unlike many other medications on this site, these products are produced by priva const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/otokonoko-estradiol-gel-55ml.html b/diyhrt.market/meds/products/otokonoko-estradiol-gel-55ml.html index 6ae4ba598..419e78d7e 100644 --- a/diyhrt.market/meds/products/otokonoko-estradiol-gel-55ml.html +++ b/diyhrt.market/meds/products/otokonoko-estradiol-gel-55ml.html @@ -326,7 +326,7 @@ Unlike many other medications on this site, these products are produced by priva
- + @@ -369,55 +369,6 @@ Unlike many other medications on this site, these products are produced by priva - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1848,7 +1848,7 @@ Unlike many other medications on this site, these products are produced by priva - + @@ -1859,5 +1859,5 @@ Unlike many other medications on this site, these products are produced by priva const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/otokonoko-estradiol-valerate-10ml-40mg-ml.html b/diyhrt.market/meds/products/otokonoko-estradiol-valerate-10ml-40mg-ml.html index 2301525ef..4fb9a80c2 100644 --- a/diyhrt.market/meds/products/otokonoko-estradiol-valerate-10ml-40mg-ml.html +++ b/diyhrt.market/meds/products/otokonoko-estradiol-valerate-10ml-40mg-ml.html @@ -337,7 +337,7 @@ Unlike many other medications on this site, these products are produced by priva
- + @@ -380,55 +380,6 @@ Unlike many other medications on this site, these products are produced by priva - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1245,13 +1245,29 @@ Unlike many other medications on this site, these products are produced by priva - Jan. 29, 2025, 2:39 a.m. + March 4, 2025, 8:04 p.m. $65.00 In Stock + + March 4, 2025, 6:14 p.m. + + + Out of Stock + + + + + Jan. 29, 2025, 2:39 a.m. + + + In Stock + + + Jan. 29, 2025, 12:54 a.m. @@ -2243,7 +2259,7 @@ Unlike many other medications on this site, these products are produced by priva - + @@ -2254,5 +2270,5 @@ Unlike many other medications on this site, these products are produced by priva const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/panacea-pharma-estradiol-enanthate.html b/diyhrt.market/meds/products/panacea-pharma-estradiol-enanthate.html index 2942bb92b..c364acaee 100644 --- a/diyhrt.market/meds/products/panacea-pharma-estradiol-enanthate.html +++ b/diyhrt.market/meds/products/panacea-pharma-estradiol-enanthate.html @@ -337,7 +337,7 @@ Unlike many other medications on this site, these products are produced by priva
- + @@ -380,55 +380,6 @@ Unlike many other medications on this site, these products are produced by priva - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1347,7 +1347,7 @@ Unlike many other medications on this site, these products are produced by priva - + @@ -1358,5 +1358,5 @@ Unlike many other medications on this site, these products are produced by priva const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/panacea-pharma-estradiol-undecylate.html b/diyhrt.market/meds/products/panacea-pharma-estradiol-undecylate.html index 998dd0fd5..8b2742c32 100644 --- a/diyhrt.market/meds/products/panacea-pharma-estradiol-undecylate.html +++ b/diyhrt.market/meds/products/panacea-pharma-estradiol-undecylate.html @@ -329,7 +329,7 @@ Unlike many other medications on this site, these products are produced by priva
- + @@ -372,55 +372,6 @@ Unlike many other medications on this site, these products are produced by priva - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1323,7 +1323,7 @@ Unlike many other medications on this site, these products are produced by priva - + @@ -1334,5 +1334,5 @@ Unlike many other medications on this site, these products are produced by priva const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/panacea-pharma-estradiol-valerate.html b/diyhrt.market/meds/products/panacea-pharma-estradiol-valerate.html index 166bb3308..2b928674b 100644 --- a/diyhrt.market/meds/products/panacea-pharma-estradiol-valerate.html +++ b/diyhrt.market/meds/products/panacea-pharma-estradiol-valerate.html @@ -337,7 +337,7 @@ Unlike many other medications on this site, these products are produced by priva
- + @@ -961,6 +961,55 @@ Unlike many other medications on this site, these products are produced by priva data-bs-title="March 3, 2025"> + + + + + + + + + + + + + + + + + + + + + @@ -1096,7 +1145,7 @@ Unlike many other medications on this site, these products are produced by priva - + @@ -1107,5 +1156,5 @@ Unlike many other medications on this site, these products are produced by priva const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/progesterone-endogest-100mg-x10.html b/diyhrt.market/meds/products/progesterone-endogest-100mg-x10.html index 905303d2d..c624a3a3c 100644 --- a/diyhrt.market/meds/products/progesterone-endogest-100mg-x10.html +++ b/diyhrt.market/meds/products/progesterone-endogest-100mg-x10.html @@ -346,7 +346,7 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v
- + @@ -389,55 +389,6 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1299,7 +1299,7 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v
- + @@ -1342,55 +1342,6 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -2236,7 +2236,7 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v
- + @@ -2279,55 +2279,6 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -3598,7 +3598,7 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v - + @@ -3609,5 +3609,5 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/progesterone-endogest-200mg-x10.html b/diyhrt.market/meds/products/progesterone-endogest-200mg-x10.html index 590aae259..27979a782 100644 --- a/diyhrt.market/meds/products/progesterone-endogest-200mg-x10.html +++ b/diyhrt.market/meds/products/progesterone-endogest-200mg-x10.html @@ -335,7 +335,7 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v
- + @@ -378,55 +378,6 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1288,7 +1288,7 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v
- + @@ -1331,55 +1331,6 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -2706,7 +2706,7 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v - + @@ -2717,5 +2717,5 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/progesterone-gestheal-200mg-x10.html b/diyhrt.market/meds/products/progesterone-gestheal-200mg-x10.html index e30508cef..40e98739f 100644 --- a/diyhrt.market/meds/products/progesterone-gestheal-200mg-x10.html +++ b/diyhrt.market/meds/products/progesterone-gestheal-200mg-x10.html @@ -324,7 +324,7 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v
- + @@ -367,55 +367,6 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1302,7 +1302,7 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v - + @@ -1313,5 +1313,5 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/progesterone-microgest-100mg-x50.html b/diyhrt.market/meds/products/progesterone-microgest-100mg-x50.html index b92f5d980..18f53a4bb 100644 --- a/diyhrt.market/meds/products/progesterone-microgest-100mg-x50.html +++ b/diyhrt.market/meds/products/progesterone-microgest-100mg-x50.html @@ -357,7 +357,7 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v
- + @@ -400,55 +400,6 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1566,7 +1566,7 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v
- + @@ -1585,7 +1585,7 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v - 215 days ago + 222 days ago @@ -1615,55 +1615,6 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -2629,7 +2629,7 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v
- + @@ -2672,55 +2672,6 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -4174,7 +4174,7 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v
- + @@ -4217,55 +4217,6 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -5152,7 +5152,7 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v - + @@ -5163,5 +5163,5 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/progesterone-microgest-200mg-x50.html b/diyhrt.market/meds/products/progesterone-microgest-200mg-x50.html index 5a564ce56..0abd8a189 100644 --- a/diyhrt.market/meds/products/progesterone-microgest-200mg-x50.html +++ b/diyhrt.market/meds/products/progesterone-microgest-200mg-x50.html @@ -346,7 +346,7 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v
- + @@ -389,55 +389,6 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1563,7 +1563,7 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v
- + @@ -1606,55 +1606,6 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -2956,7 +2956,7 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v
- + @@ -2999,55 +2999,6 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -3966,7 +3966,7 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v - + @@ -3977,5 +3977,5 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/progesterone-progestan-100mg-x30.html b/diyhrt.market/meds/products/progesterone-progestan-100mg-x30.html index d29c25cdd..3dd72b59f 100644 --- a/diyhrt.market/meds/products/progesterone-progestan-100mg-x30.html +++ b/diyhrt.market/meds/products/progesterone-progestan-100mg-x30.html @@ -335,7 +335,7 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v
- + @@ -378,55 +378,6 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -2080,7 +2080,7 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v
- + @@ -2123,55 +2123,6 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -3050,7 +3050,7 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v - + @@ -3061,5 +3061,5 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/progesterone-progestan-200mg-x30.html b/diyhrt.market/meds/products/progesterone-progestan-200mg-x30.html index 90aea4dc4..411bfa387 100644 --- a/diyhrt.market/meds/products/progesterone-progestan-200mg-x30.html +++ b/diyhrt.market/meds/products/progesterone-progestan-200mg-x30.html @@ -335,7 +335,7 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v
- + @@ -354,7 +354,7 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v - 3 days ago + 7 days ago @@ -384,55 +384,6 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1249,13 +1249,29 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v - March 1, 2025, 7:46 a.m. + March 4, 2025, 1:49 a.m. $30.00 Out of Stock + + March 3, 2025, 1:48 a.m. + + + In Stock + + + + + March 1, 2025, 7:46 a.m. + + + Out of Stock + + + Feb. 26, 2025, 11:44 p.m. @@ -2278,7 +2294,7 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v
- + @@ -2321,55 +2337,6 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -3248,7 +3264,7 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v - + @@ -3259,5 +3275,5 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/progesterone-utrogestan-100mg-x30.html b/diyhrt.market/meds/products/progesterone-utrogestan-100mg-x30.html index 949aa9229..d6b9e0a98 100644 --- a/diyhrt.market/meds/products/progesterone-utrogestan-100mg-x30.html +++ b/diyhrt.market/meds/products/progesterone-utrogestan-100mg-x30.html @@ -324,7 +324,7 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v
- + @@ -367,55 +367,6 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1494,7 +1494,7 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v - + @@ -1505,5 +1505,5 @@ Progesterone is often taken by transfeminine people along with Estradiol for a v const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/progynova-1mg-3-pack-x72.html b/diyhrt.market/meds/products/progynova-1mg-3-pack-x72.html index a1c678044..21c2b1ce1 100644 --- a/diyhrt.market/meds/products/progynova-1mg-3-pack-x72.html +++ b/diyhrt.market/meds/products/progynova-1mg-3-pack-x72.html @@ -149,7 +149,7 @@ + style="border-left-width: 0.2rem; border-left-color: #EC008B; border-right-width: 0.2rem; border-right-color: var(--bs-success);"> Inhouse Pharmacy @@ -160,7 +160,7 @@ + style="border-left-width: 0.2rem; border-left-color: #18B2CB; border-right-width: 0.2rem; border-right-color: var(--bs-danger);"> United Pharmacies UK @@ -171,7 +171,7 @@ + style="border-left-width: 0.2rem; border-left-color: #0D7581; border-right-width: 0.2rem; border-right-color: var(--bs-danger);"> United Pharmacies US @@ -343,7 +343,7 @@
+ style="border-left-width: 0.2rem; border-left-color: #EC008B; border-right-width: 0.2rem; border-right-color: var(--bs-success);">
@@ -354,7 +354,7 @@
- + @@ -362,21 +362,15 @@
- - - - @@ -146,5 +146,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/qr-codes.html b/diyhrt.market/qr-codes.html index dd8840c4e..c054453cf 100644 --- a/diyhrt.market/qr-codes.html +++ b/diyhrt.market/qr-codes.html @@ -174,5 +174,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/register.html b/diyhrt.market/register.html index d08630a85..4de0e620c 100644 --- a/diyhrt.market/register.html +++ b/diyhrt.market/register.html @@ -95,7 +95,7 @@ - +
Enter the same password again
@@ -143,5 +143,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/resources.html b/diyhrt.market/resources.html index 41ed5e850..0c25caa40 100644 --- a/diyhrt.market/resources.html +++ b/diyhrt.market/resources.html @@ -155,5 +155,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/stores/4nrx-pharmacy-uk.html b/diyhrt.market/stores/4nrx-pharmacy-uk.html index 769891601..d559cc52e 100644 --- a/diyhrt.market/stores/4nrx-pharmacy-uk.html +++ b/diyhrt.market/stores/4nrx-pharmacy-uk.html @@ -1731,5 +1731,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/stores/4nrx-pharmacy-uk/reviews.html b/diyhrt.market/stores/4nrx-pharmacy-uk/reviews.html index 4fd84d6dd..3a9473c0e 100644 --- a/diyhrt.market/stores/4nrx-pharmacy-uk/reviews.html +++ b/diyhrt.market/stores/4nrx-pharmacy-uk/reviews.html @@ -179,7 +179,7 @@

Leave a Review

- +
Your Name (Optional)
+
Your Name (Optional)
+
Your Name (Optional)
+
Your Name (Optional)
+
Your Name (Optional)
+
Your Name (Optional)
+
Your Name (Optional)
+
Your Name (Optional)
+
Your Name (Optional)
+
Your Name (Optional)
+
Your Name (Optional)
+
Your Name (Optional)
+
Your Name (Optional)
+
Your Name (Optional)
+
Your Name (Optional)
+
Your Name (Optional)
+
Your Name (Optional)
+
Your Name (Optional)
+
Your Name (Optional)
+
Your Name (Optional)